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The thesis describes the work related to synthesis, structure elucidation 
stereochemistry and biological assay (anticancer and antimicrobial screening) 
grouped in three parts Wdti six chapters as long alkyl chain substituted-j'-
tr iazolo-thiadiazepines, long alkyl chain substi tuted-benzopyrano-^-tr iazolo-
thiadiazepines, long alkyl chain substi tuted-^-triazolo-thiadiazoles, 2-aryl-3-
7V-long alkyl chain substi tuted-thiazolidin-4-ones/thiazan-4-one, 2-aryl-2-
methyi-3-A^-long alkyl chain- •substituted-thiazolidin-4-one and biological 
screening: study for anticancer and antimicrobial activity. 
The techniques used for structure elucidation are 'H-NMR, '^C-NMR, 
APT,NOE, 2DNMR (COSY, HETCOR) including DCI-MS, IR and FTIR. 
PART ONE 
l,2,4-TRIAZOLOf3,4-b|fl,3,4]THIADIAZEPINES/THIDIAZOLES 
CHAPTER I. Long alkyl chain substituted-s-Triazolo-
Thiadiazepines 
4-Amino-5-mercapto- l ,2 ,4- t r iazoles and their A^-bridged heterocyclic 
derivatives have received much attention during recent years on account of 
their wide spectrum biological potentialities. The 1,2,4-triazole nucleus has 
been incorporated into a wide variety of therapeutically interesting drugs 
including Hi/H2-Histamine receptor blockers, cholinesterase active agents, 
CNS stimulants, antianxiety agents and sedatives. Also 1,3,4-thiadiazepine 
derivatives are associated with a varied range of biological activities such as 
anticancer, anti-HIV, anticholinergic, antidepressant, anaesthetic, calcium 
antagonist choleretics and ACE inhibitory activity. Prompted by these 
observations and as part of our continuing programme in the search of 
biologically active compounds with sulphur and ni t rogen containing 
heterocycles, we have undertaken the synthesis of two novel compounds, 
2-(4-chlorophenyl)-4-[2-(4-chlorophenyl)ethenyl]-7-(9-decenyl)-2,3-dihydro 
-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine (4) and 2,4-bis(4-chlorophenyl)-7-
(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine (7) by the 
reaction of 4-amino-3-(9-decenyl)-5-mercapto- l ,2 ,4- t r iazole (1) with ( i ) l ,5-
bis(4-chlorophenyl)pent- l ,4-dien-3-one (2) and (ii) 4 ,4 ' -dichlorochalcone (5) 
.In each of the above synthesis, a Michael adduct of (2)/(5) and the s-triazole 
(1) were also obtained. The reaction of (1) with l ,3 -b is (2- th ienyl )propen- l -
one (8) furnished only the Michael adduct (9) as the sole product . (Scheme 1) 
The structures of these compounds were established on the basis of 
spectral studies such as IR, DCI-MS, EI-MS, 'H-NMR, and '^C-NMR spectra. 
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CHAPTER II. Long alkyl chain substituted-Benzopyrano-s-Triazolo-
Thiadiazepines 
As part of our programme in search of biologically active compounds and in 
continuation of the work described in previous chapter, we extended our work on the 
reaction of the ^-triazole (1) with exocyclic a;y^unsaturated enone systems and 
synthesised two novel compounds, 2,3-bis(4-chlorophenyl)-ll-(9-decenyl)-2a,3-
dihydro[l]benzopyrano[3,4-e]-2,2a-dihydro-l,2t4-triazolo[3,4-b][l,3,4]thiadiazep-
ine (12) and 2,3-bis(phenyl)-ll-(9-decenyl)-2a,3-dihydro[l]benzopyrano[3,4-e}-
2,2a-dihydro-l,2,4-triaz olo[3,4-b][l,3,4]thiadiazepine (15) by the reaction of the i--
triazole (1) with £'-3-(4-chlorobenzylidene)-4'-chloro flavanone (10) and E-3-
benzyiidene flavanone (13) in dry benzene using j:?-TsOH as catalyst. An adduct, 2-
(4-chIorophenyl)-3-[3-(9-decenyl)-4-amino-5-(4-chlorobenzylthio)-l,2,4-triazolyl]-
2,3-dihydro-4-benzopyrone (11) in the former and 2-(phenyl)-3-[3-(9-decenyl)-4-
amino-5-(benzylthio)-l,2,4-triazolyl]-2,3-dihydro-4-benzopyrone (14) in the latter 
was also obtained in good yields(Scheme 2). 
(11), (14) 
( 1 1 ) , ( 1 2 ) : R = R ' = C I 
( 1 4 ) , ( 1 5 ) : R = R ' = H 
( 1 2 ) , ( 1 5 ) 
The structures of these compounds were confirmed by IR, DCI-MS, 'H-NMR. 
'^C-NMR, COSY and HETCOR spectral studies. The configurations at the three 
stereogenic centres C-2, C-3 and C-l '" in compounds (11) and (14) were established 




(10) R = R' = C1 
(13) R = R' = H 
Molar ratio (1:1) 
Diy benzene 
Reflux 38/32 h 
(11) R = R' = C1 
(14) R = R' = H 
(12) R = R' = C1 
(15) R = R' = H 
SCHEME 2 
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CHAPTER HI. Long alkvl chain substituted-5-Triazolo-Thiadiazoles 
1,2,4-Triazole and its derivat ives have been found to play vital role in 
medic ine , agricul ture and industry. The fused r ing sys tems such as 
5- t r iazolo[3 ,4-b] [ l ,3 ,4] th iad iazoles have varied range of b io logica l activities 
as ant ibacter ia l , ant i fungal , antiinflammatory, antihypertensive, analgesic and 
an the lmin t ic agents. These findings have tempted us to under take this 
p rob lem on the synthesis of three new compounds, (i) 2-(4-methoxyphenyl)-
5-(9-decenyl)-2,3-dihydro-l,2,4-tnazolo[3,4-b] [l,3,4]thiadiazole (17) (ii) 2-
(4-chlorophenyl)-5-(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thia-
diazole (19) and (in) 2-(2-thienyl)-5-(9-decenyl)-2,3-dihydro-l,2,4-
triazolo[3,4-b][l,3,4]thiadiazole (21) f rom (i) p - a n i s a l d e h y d e ^ (ii) 
/7-chlorobenzaldehyde and (iii) th iophen-2-a ldehyde respec t ive ly using 
4-amino-3- (9-decenyl ) -5 -mercap to- l ,2 ,4 - t r i azo le (1) in the presence of a 
catalyt ic amount of / j -TsOH. In each react ion, the co r re spond ing Schi f f bases 
(16), (18), and (20) have also been obtained. The react ion of fu r fu ra ldehyde 
with the t r iazole (1) yielded only the Schif f base (22) ( S c h e m e 3). 
The structure of these compounds were es tabl ished on the basis of 







O - CHO 
N N 
I 
N = C H -
(16) R = 0CH3 
( 1 8 ) R = C1 
N — N 
( 2 0 ) X = S 






( 1 7 ) R = 0 C H 3 
( 1 9 ) R = CI 




CHAPTER IV. 2-Arvl-3-iV-Long alkvl chain substituted-Thiazolidin-
4-ones/Thiazan-4-one, 
The interest in substituted thiazolidin-4-ones and thiazan-4-ones in 
particular for medical application is increasing strongly. The thiazolidin-4-
ones, their derivatives and analogues have been found to exhibit usually high 
in vitro activity against Mycobacterium tuberculosis, highly potent and 
selective anti-Platelet Activating Factor activity and broad spectrum activity 
against various diseases. Because 4-thiazolidinones substi tuted in the 
2-posit ion were proven to be biologically very potent and selective and in 
anticipation that by incorporating a long chain alkyl thioether moiety to 
thiazolidin-4-one ring, the biological activity may be enhanced due to 
lipophilization of the resulting molecule, we have under taken this problem. It 
consists of the synthesis of the following four novel compounds , (i) 2-(3-
nitrophenyl)-3-[ll-(carboxymethylthio)undecanamido]thiazolidin-4-one (26), 
(ii) 2-(3-nitrophenyl)-5-(methyl)-3-(10-undecenamido)thiazolidin-4-one (27) 
and 2-(3-nitrophenyl)-5-(methyl)-3-[ll-{(l-carboxy)ethylthio}undecan-
amidoJthiazolidin-4-one (28), (Hi) 2-(3-nitrophenyl)-3-[ll-(2-carboxyethyl-
thio)undecanamido]tltiazan-4-one (30) f rom m-ni trobenzaldehyde-10-
undecenohydrazone (24) using mercaptoacetic acid in (i), 2-mercapto-
propionic acid in (ii) and 3-mercaptopropionic acid in (iii) in dry benzene. An 
adduct, (25) in the former and (29) in the latter was also obtained in good 
yields. (Scheme 1) 
The compounds (24), (25) and (29) were found to exist in to be in its 
two forms, synperiplanar (major) and antiperiplanar (minor) as represented 
in F ig . 1. The s tructure and s tereochemistry of these compounds were 
es tabl ished on the basis of IR, DCI-MS, 'H-NMR, '^C-NMR, NOE 




( 2 4 ) R = — C H = < ; ^ 
HZ 
( 2 5 ) R = — ( C H 2 ) 2 — S — C F ^ - C O O H 




(27) R = 
(28) R= -
-(CH2)2—S— CF^-COOH R' = H 




R = CH3 
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CHAPTER V. 2-ArvI-2-Methvl-3-7V-Long alkyl chain substituted-
Thiazolidin-4-one 
As part of our programme in search of biologically active compounds with 
sulphur and nitrogen containing heterocycles and in continuation of the above 
mentioned work, we have undertaken this problem on the synthesis of 2-(4-
chlorophenyl-2-methyl-3-[l l-(carboxymethyl/2-carboxyethylthio)undecanamido]thi-
azolidin-4-ones/thiazan-4-one from /7-chloroacetophenone-10-undeceno-hydrazone 
(31) using (i) mercaptoacetic acid and (ii) 3-mercapto propionic acid. An adduct, 
(32) in the former and (35) as the sole product in the latter was also obtained 
in good yields. (Scheme 1) 
The structures of these compounds were established by IR, DCI-MS. 
'H-NMR, '^C-NMR, NOE experiments, COSY and HETCOR spectral studies. Here 
again the compounds (31), (32) and (35) were found to exist in its two forms, 
synperiplanar (major) and antiperiplanar (minor) as represented in Fig. 2 
( 3 2 ) R = — ( C H 2 ) 2 — S — C H 2 - C O O H 
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PART THREE 
SCREENING FOR BIOLOGICAL ACTIVITY 
CHAPTER VI. Study for Anticancer and Antimicrobial Activities 
(A) A N T I C A N C E R A C T I V I T Y 
The compounds (I) , (4), (7), (9), (12), (16), (17), (20), (21), (22), (24), 
(26), (27), (30), (31) and (32) have been evaluated for ant icancer activity first 
in the 3-cell lines of three types of human cancers: breast (MCF7), Lung 
(NCI-H460) and CNS (SF-268) at one concentration as the one dose primary 
anticancer assay. Out of the sixteen compounds screened, only one 
compound, (27) was found to be active. This compound was then screened for 
cytotoxic activity at five different concentrations against 60 cell lines of nine 
types of human cancers: leukaemia, lung, colon, CNS, melanoma, ovarian, 
renal, prostate and breast. This compound showed anticancer activity only at 
higher concentration, Ix 10"^. Noteworthy results was obtained in the case of 
non-small lung cancer, melanoma and renal where the reduct ion in growth is 
75, 74 and 70 and 77% respectively . 
(B) A N T I M I C R O B I A L ACTIVITY 
A total of 10 compounds were tested against two Gram +ve bacteria 
{Staphylococcus aureus, Bacillus subtilis) and two Gram -ve bacteria {Escherichia 
coli, Pseudomonas aeruginosa) and a yeast, Candida albicans. Varying level of anti-
microbial activity was detected against one or more test organisms. Solvent control 
(DMSO) showed non-significant inhibition to test microorganisms. Antimicrobial 
activity against Gram -ve bacteria was deduced in all compounds. However such 
activity could be detected only in four compounds against Gram +ve bacteria. The 
14 
compounds (25), (26), (30) and (31) demonstrated activity against both Gram +ve 
and Gram -ve bacteria. 
The compounds exhibited antimicrobial activity in the concentration range 
200 ng to 500 fig/100 |il. Two compounds, (30) and (31) also demonstrated 
antifungal (anticandidal) activity. Overall broad spectrum antimicrobial activity 
i.e. active against Gram +ve and Gram -ve was deduced in (25), (26), (30) and (31). 
These compounds may be directly explored in the preparation of topical antiinfective 
agents. However, further exploration requires detailed study on exact MIC values and 
least toxicity to host cell and system. 
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GENERAL INTRODUCTION 
Heterocyclic compounds are very widely distributed in nature and are 
essential to life as they play a vital role in the metabol ism of all living cells. 
Thus, for example, the fol lowing are heterocyclic compounds: the pyrimidine 
and purine bases of the genetic material DNA; the essential amino acids 
proline, histidine and tryptophan; the vitamins and coenzyme precursors 
thiamine, r iboflavine, pyridoxine, folic acid and biotin; the B12 and E families 
of vitamin; the photosynthesizing pigment chlorophyll ; the oxygen 
transport ing pigment hemoglobin, and its breakdown products the bile 
pigments; the hormones kinetin, heteroauxin, serotonin and histamine, 
together with most of the sugars. There are a vast number of 
pharmacological ly active heterocyclic compounds, many of which are in 
regular clinical use. Some of these are natural products , for example 
antibiotics such as penicillin and cephalosporin, alkaloids such as vinblastine, 
ellipticine, morphine and reserpine, and cardiac glycosides such as those of 
digitalis. However, the large majori ty are synthetic heterocycl ics which have 
found widespread use, for example as anticancer agents, analeptics, 
analgesics, hypnotics and vasopressor modif iers , and as pesticides, 
insecticides, weedkillers and rodenticides. 
There is also a large number of synthetic heterocycl ic compounds with 
other important practical applications, as dyestuffs , copolymers , solvents, 
photographic sensitizers and developers, as ant ioxidants and vulcanization 
accelerators in the rubber industry, and many are valuable intermediates in 
synthesis. 
The broad spectrum of biological activities associated with these 
compounds and the multiplicity of action displayed by certain individual 
members make them one of most interesting class of compounds . The current 
research in organic chemistry and closely allied branches of biology is 
characterized by extensive investigation of physiologically active compounds 
encountered in the plant and animal world. The search for these active 
constituents which control the biological process of various systems have 
acted as a powerful st imulus to the further development of the chemistry of 
heterocyclic compounds. Synthesising any useful organic compound is easier 
than to isolate the same from natural resources. Therefore , in recent years 
much effor t are being applied by chemists in synthesising such organic 
compounds which possess high degree of biological activities. Innumerable 
heterocyclic compounds have been prepared across the world for better 
therapeutics, part icularly the compounds having hetero atoms such as O, S 
and N. 
A study on the inf luence of structure on activity shows that sometimes 
a minor change in heterocyclic nuclei enhances the pharmacological profi le 
many folds than its parent nuclei. The search for new eff ic ient and safe nuclei 
lead to an improvement in the existing drugs by increasing their potency, 
duration of action and decreasing side effects as well as creating new 
biologically active agents by molecular modificat ion. 
The successful application of heterocyclic compounds in these and 
many other ways, and their appeal as materials in applied chemistry and in 
more and fundamental and theoretical studies ensures virtually limitless 
series of structurally novel heterocyclic compounds with wide range of 
physical, chemical and biological properties. 
Keeping in view of the importance of heterocyclic compounds , we 
have undertaken this problem on 'Design and Synthesis of Biologically 
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THEORETICAL 
Thiadiazepines and thiadiazoles are two important classes of 
biologically active seven and five membered heterocycles containing one 
sulfur and two nitrogen atoms. The isomeric structures are also possible for 
thiadiazepine and thiadiazole rings depending upon the relat ive posit ions of 
the three heteroatoms and the degree of oxidation of the ring systems. 
Thiadiazepines and thiadiazoles having sulfur and ni t rogen atoms at 1,3,4-




















R = Alkyl/Aryl/Heterocyclic 
r ' = Alkyl/Aryl/Heterocyclic 







l ,2 ,4-Triazolo[3,4-b][ l ,3 ,4] thiadiazepine/ thiadiazole ( I I I / IV) are the 
fused rings system of 1,2,4-triazole with l ,3 ,4- th iadiazepine/ l ,3 ,4- th iadiazole 
and their dihydro derivatives are represented by the s t ructures (V) and (VI) 
respectively. 
2 
1,3,4-Thiadiazepine derivatives are associated witli a varied range of 
biological activities such as antimicrobial'"^, anticancer^, he rb i c ida^ ' ^ anti-
viral^, anti-HIV'®"'"', anticholinergic'^, antidepressant'^"'^, anaes thet ic '^ 
cholere t ics '^ calcium antagonist '^ and A C E inhibitory'^ activity. They have 
also gained industrial imiportance as charge generators for 
electrophotographic photoconductors^"®-'' and photoreceptors^^^ 
The 5-Triazoio-thiadiazole derivatives have been extensively studied in 
the recent past. Numerous reports are available in the literature which 
highlight their chemistry and use. l ,2 ,4-Tr iazolo[3 ,4-b][ l ,3 ,4] th iadiazole 
derivatives have been found to be associated with diverse biological activities 
such as antibacteriaP'"^^ antifungaP'"^^'^^"^®, anti-inflammatory^"''^'"^-', 
anthelmintic^'•^^ ana lges ic" , antihypertensive^^-^^'"''', herbicidal' '" and 
pesticidal activity'^'. 
Several methods are reported for the synthesis of 1,2,4-triazolo[3,4-
b][ l ,3 ,4] thiadiazepines and l ,2 ,4~tr iazolo[3,4-b][ l ,3 ,4] thiadiazoles . 
l , 2 ,4 -Tr iazo lo f3 ,4 -b] f l , 3^4] th iad iazep ines 
The substituted and unsubst i tu ted-4-amino-3-mercapto- l ,2 ,4- t r iazoles 
on cyclocondensat ion with ^./^-unsaturated ketones in presence of acidic or 
basic catalyst yield 6 ,8-disubst i tu ted- l ,2 ,4- t r iazolo[3 ,4-b][ l ,3 ,4] th iadia-
zepines. 
N.N. Koles et al.''^" have reported the s tereoselect ive addition of 
4-amino-3-mercapto- l ,2 ,4- t r iazole with acetylenic ketone to give the Michael 
adduct (VII) which on cyclocondensation with D M F yielded 6,8-diphenyl-
1,2,4-triazolo [3,4-bJ [1,3,4] thiadiazepines (VIII). Similar reaction of the 
4-amino-3 -mercap to - l , 2 ,4 - t r i azo le with 4-n i t rocha lcone a f fo rded only the 


















J.E. Glo tova et a l / ^ have shown that the pheny l subs t i tu ted acetyl inic 
ke tone with 4 -amino-3 -mercap to - l , 2 ,4 - t r i azo le in acet ic acid g ives6 ,8-d iphe-
nylsubs t i tu ted- l ,2 ,4- t r iazolo[3 ,4- -b] [ l ,3 ,4] th iad iazepine (X ) whi le unsubst i -
















Recent ly , U.V.Laddi et al."^'' have synthes ised 3-subs t i tu ted-6 ,8-
d iphenyl -d ihydro- l ,2 ,4 - t r i azo lo [3 ,4 -b] [ l ,3 ,4 ] th iad iazep ine (XII) by the 
cyc locondensa t ion of 3 - subs t i tu ted-4-amino-5-mercap to- l ,2 ,4 - t r i azo les with 
cha lcone in presence of catalytic amount of acetic acid. 
N N 



















B. Kal luraya et al.'*''^ reported that the ace ty len ic ke tones on 
condensa t ion with 3 - subs t i tu ted-4 -amino-5-mercap to - l ,2 ,4 - t r i azo les in 
ethanol f irst gave the Michael adduct , l - a ry l -3 - (5 -n i t ro -2- th ieny l ) -3 - [3 -
sus t i tu ted-4-amino-5-mercap to- l ,2 ,4 - t r i azo le (XIII) wh ich on fur ther 
t rea tment wi th conc. H2SO4 yielded 6 -a ry l -8 - (5 -n i t ro -2- th ieny l ) - l ,2 ,4 - t r i azo lo 



















X I I I 
N02 
R = H, CH3, C2H5, C3H7, Phenyl, jPtolyloxymethyl 
In a similar reaction'*''®''', a - b r o m o c h a l c o n e on condensa t ion with 
3 - subs t i tu ted-4-amino-5-mercap to- l ,2 ,4 - t r i azo les us ing sodium acetate as 
catalyst a f fo rded the Michael adducts (XVa-d) which on cycl i sa t ion furnished 





NaOAc / EtOH. 
0 
R / ^ N - - S H 






XVI a d 
a: Ar = Phenyl Ar' = 2-Nitrothienyl 
b: Ar = Phenyl Ar' = /?-anisyl 
c: Ar = p-chiorophenyl, Ar' =p-Tolyl. 














\ O h 
Br 
Ar' 
When 3-ary l -2-bromo-1 - [4- (n i t ro-2- th ienyl ) ]propen-1 -one condensed 
with 3 - subs t i tu ted-4-amino-5-mercap to - l ,2 ,4 - t r i azo les , the produc t obtained 
was 3-subs t i tu ted-7-a ry l idene-6- (4-n i t ro -2- th ienyl ) - l ,2 ,4 - t r i azo lo[3 ,4-b] 
[l,3,4]thiadiazines'*'*'^ (XVII) instead of the expec ted t r iazo lo- th iad iazepines . 
NO2 N- -N 















Ar = Phenyl,/?- anisyl, 
p-chlorophenyl, /p-methylphenyl XVll 
^CH-Ar 
O2N 
They'*'''' have also synthesised novel 3-subs t i tu ted-6- (3-ary l 
sydnony l ) -8 -a ry l - l ,2 ,4 - t r i azo lo [3 ,4 -b ] [ l ,3 ,4 ] th iad iazep ines ( X V I I I ) by 
reac t ing 2 -b romo- l - (3 - a ry l sydnony l ) -3 - a ry l -2 -p ropen - l -one wi th 3-subst i -
tu t ed -4 -amino-5-mercap to - l ,2 ,4 - t r i azo les in ethanol in p resence of sodium 
acetate. 
N - • N 
R ' "N SH 
N H , O O^  
Ar = Ph, Ph-0CH3 
R = CH3_ Ph, o-cresyloxymethyl, 
p-cresyloxymethyl 
R'= H, CH3, OCH3. 
N -











G.J. Reddy et al.'^^ have synthesised 7 - (2 ' -hydroxybenzo ly l ) -3 -phenyl -
l ,2 ,4 - t r i azo lo [3 ,4 -b ] [ l ,3 ,4 ] th iad iazep ines (XIX) by the react ion of 
3 - f o r m y l c h r o m o n e s with 3 -pheny l -4 -amino-5 -mercap to - l , 2 ,4 - t r i azo le s in 
presence o fBu4N^HS04~ catalyst . 
N N 
P h - ^ N ^ S H 
O H C 
N H , 
r ' = H, Me, CI, Br, 
R^ = H, Me 
XIX 
A.M. El -Sayed et al.'^^ have repor ted the synthes is of 3-( t r i f luro-
methyl ) -6-amino-7 ,8-d isubs t i tu ted-1 ,2 ,4- t r iazo lo[3 ,4-b] [ 1 ,3 ,4] th iadiazepines 
(XX) by the react ion of 4 -amino-5 -mercap to - (3 - t r i f l u rome thy l ) - l , 2 ,4 - t r i azo le 
with yl id ine malononi t r i les . 
N N N C 33 IM N 
F3C Y SH ^ 
NHj 
, 1 
R' F r- "N F3C I 
N 
R = H, Ph, 4-CIC6H4, 
4-NO2C6H4,2-Pyrrolyl, HjN 
2-Pyridyl 
R^ = CN, C02Et 
R" 
X X 
The react ion of 3 - subs t i tu ted -4 -amino-5-mercap to - l ,2 ,4 - t r i azo les with 
2 ,4 -pen tand ione yielded 3-subs t i tu ted-6 ,8-d imethyl - l ,2 ,4- t r iazolo[3 ,4-
b][13,4] th iadiazepines ( X X l / ' - ' ^ 
N N 
H" R 




N i z a m u d d i n et al.^ have prepared some 3 -a ry loxyme thy l -8 -n i t ro - l , 2 , 4 -
t r i azo lo[3 ,4 -b] [ l ,3 ,4 ]benzoth iad iazep ines ( X X I I I ) as po ten t herb ic ida l agent 
by the cycl isa t ion of 5 -a ry loxymethy l -4 - (2 -ch loro-5-n i t robenzy l ideneamine) -









R N N 
-OCH2- -^SH CI 














B Prabhuswami et al have synthesised s- tr iazolo th iadiazepino-
quinol ines (XXIV) by the condensat ion of ch loroformyl quinol ines with 
3 - subs t i t u t ed -4 -amino -5 -mercap to - l , 2 ,4 - tnazo l e s The base catalysed faci le 
in t ramolecular rearrangement of (XXIV) yielded 5- t r iazolothiadiazino-
qumol ines (XXV) by the rearrangement involving N - N bond scission 
CHO N N 
NH, 
XXIV XXV 
R = H Mc CI 
R' = Me Ph 
X = C1 
A Brukstus et al ^^  have shown that the cyc locondensa t ion ol 
pyr imidine carboxaldehyde with benz imidazole th iones gave benzimidazo 
[2 , l -b ]pyr imido[5 ,4 - f ] [ l , 3 ,4 ] th i ad iazep ine ( X X V I ) and 5H-benz imidazo 
[ 2 ' , r 2 ,3 ] [ l ,3 ] th iaz ino[6 ,5 -d]pyr imid ine (XXVII ) 















A.Kakeh i et al.^' have carried out the react ion of unsymmetr ica l ly 
subst i tu ted 1-pyr id in ioamidates (XXVIIIa-e) wi th d imethylace ty lene 
d icarboxyla te ( D M A D ) which a f fo rded the corresponding d imethyl -2-ary l -6-
me thy l -5aH-pyr ido [ l , 2 -d ] [ l , 3 ,4 ] th i ad iazep in -4 ,5 -d ica rboxy la t e s (XXIXa-e) 
along wi th the rearranged produc ts (XXXa-e) in minor amount . Similar 
react ion of l - (2 -methy lqu ino l ino)amida tes (XXVIII f ,g ) wi th D M A D gave 
only d ime thy l -2 -a ry l -5a -methy l -5aH- l ,3 ,4 - thad iazep ino [4,5-a] quinol ine-





R', R2 = (CH=CH)2-
R4 = Me 
r ' = R'' = H, R^  = Me 











n : Ar = 2-thienyl 
XXX a - e 
COiMe 
R' R^ Ar 
Me H H Ph 
Me H H ;?-MeC6H4 
Me H H p- M e O C e H 
Me H H P-CIC6H4 
Me H H 2- th ienyl 
H Me Ph 















J Bolos et al have reported the multistep asymmetr ic synthesis of 
(3R,rS)-3-[ l ( -carboxy-3-phenylpropyl)amino]-4-oxo-2,3 ,4 ,5- te t rahydropyrrolo-
[2 , ] -b ] [ ] ,3 ,4 ] th iad iazep ine-5-ace t ic acid (XXXIId ) , a potent A C E inhibition 
active agent f rom A/^-carbobenzoxy-L-senne through a sequence involving 
pyrrole th iocyanat ion, fo l lowed by the reduct ive c leavage of the th iocyanate 
group, and cyclisat ion of the result ing halo-thiol m the key synthet ic steps 
Thus ( /^ ) -2- [ (benzyloxycarbonyl )amino] -3- iodo- / / - (2 - th iocyana to- l -pyr ro ly l ) 
p ropanamide (XXXI) (prepared f rom A^-carbo-benzoxy-L-serine) , on 
reduct ive t reatment with NaBH4 afforded ( /^ ) -3- [ (benzyloxycarbonyl )amino]-
2 .3 ,4 ,5- te t rahydropyr ro lo[2 , l -b] [1 .3 ,4] th iad iazepin-4-one ( X X X I I ) 
NHZ HO. ^ 
HO i) DDC/N-H^drovs'succinimidc 
^COOH ^ ^ 
») N-NH2 
N 
Z N H ^ \ / N H 
o 
I 
Z N H — - NH 
O 
XXXI 
Thiadiazepin-4-one (XXXII ) on t reatment with e thy lb romoace ta t e in 
the presence of sodiumethoxide af forded ( X X X I I a ) wh ich on hydrolyt ic 
c leavage with lodo tnmethy l s i l ane (ISiMes) a f fo rded ( X X X I I b ) Alkylat ion of 
( X X X I I b ) with racemic e thy l -2-bromo-4-phenylbu tanoa te gave ( X X X I I c ) 
which on hydrolysis a f forded the target molecule ( X X X I I d ) 
1 1 
Z N H ' 
/ N ' 
I BrCHzCOOEt 







/ ^ N - ^ 
V S 
o C O O E t 
(XXXIIa) 
i) IS iMe j 
ii) M e O H 
R = Et R = H 
(XXXIId) 
Recently, V.A. Bakulev and co-worker s . " have reported the first 
synthesis of some novel bis t r iazolo[ l ,3 ,6] thiadiazepine derivatives by the 
base catalysed condensation of aromatic and al iphatic 1,2-diamine with 
5-chloro- l ,2 ,3- th iadiazoles via a multistep process which is thought to 
involve two Dimroth rearrangements and subsequent loss of hydrogen-
sulphide by intramolecular nucleophilic subst i tut ion. Thus, when 
5-chlorothiadiazole ester (2 equiv) on reaction with 1,2-phenylenediamine 
( l equ iv ) in presence of EtsN undergo Dimroth rear rangement to yield a 
mixture of 5-( l ,2 ,3- t r iazol -5-ylsul fanyl) - l ,2 ,3- th iadiazoles (XXXIIIa-e) and 
novel b is t r iazolo[ l ,5-b;5 ' , r - f ] [ l ,3 ,6] thiadiazepine derivatives (XXXIVa,d-e). 
Prolonged heating of the reaction mixture gave (XXXIVa,d-e ) as the pure 
products. Saponificat ion of (XXXIVa,d-e) gave the diacid (XXXIVf) which 
on decarboxylat ion by heating to melt at 180 °C gave the bistriazolo 
[ l ,3 ,6] thiadiazepine (XXXIVg) 
1 2 





a: r ' = R^ = COjEt 
b: r ' = R^  = CONH2 
c: r ' = R^ = CONHMe 
d: r ' = CONH2, R^ = C02Et 




. N H , 
N -




N '/ \ 
N S^H 
,NH2 
N W / N-N N-
XXXIV a, d-e 






(Decarboxylation) N - N N - n ' 
/ ' ^ \ 
XXXIV g 
XXXIV f 
l ,2 ,4-TriazoIof3 ,4-b][ l ,3 ,41thiadiazoles . 
3,6-Disubsti tuted-2,3-dihydro-l ,2,4-tr iazolo[3,4-b][l ,3,4]thiadiazoles 
can be conveniently synthesised by reacting 3-substi tuted-4-amino-5-
mercapto-l ,2,4-tr iazoles with aldehydes in presence of an acid catalyst like p-
TsOH, HCl etc. 
S. Sangeetha et al.^^'^^ have prepared a number of 3-substituted-6-
(2 ' ,4 ' -dialkoxy-5-alkyl)phenyl-5,6-dihydro-l ,2,4-tr iazolo[3,4-b][l ,3,4]thiadi-
azoles (XXXV) by the reaction of 4-amino-3-phenyl substi tuted-5-mercapto
1 3 
1,2,4-tr iazoles with 2 ,4-d ia lkoxy-5-a lky lbenza ldehydes in presence of 









R = 2-Me.C6H4, 2—OH.C6H4,2—CLC6H4 
r ' = Et, Pr 
R^ R^  = Me, Et 
XXXV 
S. Hai jan et al^^^'^^ have synthesised var ious 3 ,6-disubs t i tu ted-2 ,3-
d ihydro - l , 2 ,4 - t r i azo lo [3 ,4 -b ] [ l , 3 ,4 ] th iadiazoies ( X X X V I ) by the react ion of 
3-ary lsubs t i tu ted-4-amino-5-mercapto-1 ,2 ,4- t r iazo les wi th d i f fe ren t a ldehydes 













Ar = 4-NO2.C6H4, 3-NO2.C6H4, 2—CLC6H4, 2-MeO ,2-Furfuryl, CH3.CH=CH 
R = 4-MeO.C6H4, 4-Me2N.C6H4, 4—CLCeH,, 2—OH.C6H4, 3-MeO.C6H4, 
C6H5-CH=CH 
A number of 5 ,6 -d ihydro-6- (subs t i tu ted-phenyl ) -5- (2 ,3-epoxypropyl ) -
3 -methy l - l , 2 ,4 - t r i azo lo [3 ,4 -b ] [ l , 3 ,4 ] th iad iazo les^^ ' (XXXVI) have been 
prepared by first condens ing 3 -methy l subs t i tu ted-4-amino-5-mercap to-1 ,2 ,4 -
t r iazo leswi th var ious subst i tuted aromat ic a ldehydes in b e n z e n e using Dean 
Stark appara tus in presence of /7-TsOH as catalyst f o l l owed by alkylat ion 











K2CO3 C H 2 - C H - C H 2 C I 
O 
N N 







R = 4-MeO.C6H4, 3,4—(MeO)2.C6H3. 4—CLC6H4, 3, 4—(OCH20).C6H3 
In a s imilar react ion, they have also prepared some 2-subs t i tu ted 
phenyl -3- (3-a lky l /a ry l ) -5 ,6 -d ihydro-1 .2 ,4 - t r i azo lo[3 ,4 -b] [ l ,3 ,4 ] th iad iazo l -6-
y l indoles (XXXVIII ) by the condensat ion of 2 -a ry l indo le -3 -a ldehydes with 
3-subs t i tu ted-4-amino-5-mecapto-1 .2 .4- t r iazo les in p resence of /?-TsOH as 
catalyst . 
N N 




D M F 
N N 





R = CH3, C2H5, C3H7, CfiHj, CH2.C6H5, 2 - M e CeHj , 4 - M e O . C 6 H 4 
r ' = CH3, CI 
XXXVIIl 
G. A. E l - S a r a r ° has syn thes i sed s o m e 3 - ( 2 - b e n z o f u r a n y l ) - 5 , 6 -
d i h y d r o - 6 - s u b s t i t u t e d - l , 2 , 4 - t r i a z o l o [ 3 , 4 - b ] [ l , 3 , 4 ] t h i a d i a z o l e s ( X X X I X ) by 
r e a c t i n g 4 - a m i n o - 3 - ( 2 - b e n z o f u r a n y l ) - 5 - m e r c a p t o - 1 , 2 , 4 - t r i a z o l e wi th 
1 5 
d i f f e r e n t a l d e h y d e s such as jO-anisaldehyde, s a l i c y l a l d e h y d e , /?-chloro-
b e n z a l d e h y d e and 2 - t h i o p h e n a l d e h y d e in p r e s e n c e of p y r i d i n e as ca ta lys t . 
Q 
N N 
+ R - C H O 




a b s . E t O H 
S H 
H N -
X X X I X 
R = 2 - O H . C 6 H 5 , 4 - M e O . C 6 H 4 , 4—CI .C6H4, 2 — t h i o p h e n y l 
Z.Wang et al.^'^ have carried out the s te reose lec t ive synthes is of a 
number of new chiral 3 ,6 -d ia ry l -5 ,6 -d ihydro t r i azo lo [3 ,4 -b] [ l ,3 ,4 ] th iadiazoles 
( X L ) by the Mannich react ion of 3 -a ry l -4 -amino-5 -mercap to - l , 2 ,4 - t r i azo le s 
with var ious alkyl or aryla ldehydes in the presence of cata lyt ic amount of 
L-(+)- tar tar ic acid. 
N- -N 
^ r + R—CHO L-(+)-Tartaric acid 
C H 3 ^ Y S H 




Ar = 2-MeO.C6H4, 4-MeO.C6H4 
R = C H = C H - C H 3 , 2 - M E O . C 6 H 4 , CGHJ, 2 - O H . C 6 H 4 , 4 - O H . C 6 H 4 , 
4-NO2.C6H4, 4-Me2N.C6H4, 4-CI.C6H4 
In a s imilar react ion, they have prepared 3 - (3 -pyr idy l ) -6 - (pheny l / 
2 - fu ry l ) subs t i tu ted - l ,2 ,4 - t r i azoIo [3 ,4 -b ] [ l ,3 ,4 ] th iad iazoIes 5 4 ( X L I ) by 
reac t ing 3 - (3 -pyr idy l ) -4 -amino-5-mercap to - l ,2 ,4 - t r i azo le wi th benza ldehyde 
or 2 - f u r f u r a l d e h y d e in the presence of L-(+)- tar tar ic acid . But , in this case, 
the absolu te conf igura t ion was not detected. 
1 6 
CPJO L-(+) -Tartaric acid 
N N 
R = C6H5, ^ O O 
XLI 
R. Gupta et al .^^have also synthesised a series of novel 7/9-subst i tuted-
4 - (3 -a lky l / a ry l ) -5 ,6 -d ihydro- l ,2 ,4 - t r i azo lo [3 ,4 -b ] [ l , 3 ,4 ] th iad ia zol-6-yl) te t ra-
zo lo [ l , 5 -a ]qu ino l ines ( X L I I ) by the condensa t ion of 7 ,9-disubs t i tu ted-4-
fo rmyl t e t r azo lo [ l , 5 -a ]qu ino l ines with 3 -subs t i tu ted-4-amino-3-n ie rcap to-









R = CH3, C2H5, C3H7, CH2.C6H5, 4-OMe.C6H4, 2-Me.C6H4, 4-OMe.C6H4 1 1 
N = N 
R' = H, CH3, OCH3 
R^  = H, CH3 
M. Kidwai et al.^^ have shown that the react ion of 4 -amino-5 -mercap to -
3- (4 ' -methylquinol iny l -2 ' -oxymethyl ) / ( te t razo ly l -1 ' -methy l ) -1 ,2 ,4 - t r i azo les 
with benza ldehyde in D M F under mic rowave i r radia t ion y ie lded the 
cor responding 3 - subs t i t u t ed -6 -pheny l -5 ,6 -d ihydro - l , 2 ,4 - t r i azo lo [3 ,4 -b ] [ l , 3 ,4 ] 









R = C6H5, O 0 
N ' "OCHr 
n . n XLIII 
R 
N - C H 2 -
1 7 
The react ion of 3 -subs t i tu ted-4-an i l ino-5-mercapto- l ,2 ,4 - t r iazo les with 
oo-bromoacetophenones yielded 4-an i l ino-5-phenacylmercap to-3- th iophe-
noxyme thy l - l , 2 ,4 - t r i a zo l e s which on brominat ion fo l lowed by cyciisat ion 
a f fo rded 3-subs t i tu ted-5-phenyl -6-benzoylsubs t i tu ted- l ,2 ,4 - t r i azo lo[3 ,4-b] 















P h N H 


















R = CjHj 0 CHj, 4-CH3 CaH) OCH2,4-CLC6H4 SCH,. 2.4-CI2 C6H3OCH2 
C f i H j SCH2, 4-CH3 C a R , SCH2, 4-CLC6H4 SCH2 
R= H, CI, CH3 
R^  = H, 4-CLC6H4S, 4-CLC6H4O, CfiHj 
N.D. Heinde l et al.^^ have reported the synthesis of 3 ,6-disubs t i tu ted-
l ,2 ,4- t r iazo lo[3 ,4-b] [1 .3 ,4] th iad iazoles (XLV) by the condensa t ion of 1,2,4-
t r iazoles wi th c innamaldehyde in ethanol. Dur ing this reac t ion , the format ion 
of 3 -R-8-a ry l - l , 2 ,4 - t r i azo lo [3 ,4 -b ] [ l , 3 ,4 ] th iad iazep ines in mino r amount was 










R. Gupta et al.^"' have prepared several 3-alkyl /aryl-6-(2-chloro-2-
subst i tu ted-phenylethenyl)-5 ,6-dihydro- l ,2 ,4- t r iazolo[3,4-b][ l ,3 ,4] thiadiazo-
les ( X L V I ) by the condensation of 3-subst i tuted-4-amino-5-mercapto-1,2,4-
triazoles with /7-chlorocinnamaldehyde in benzene conta in ing catalytic 
quantity of p - T s O H using Dean Stark apparatus. 
N - - N 
SH 
)3-TSOH 
E t O H 
N H . 
X L V I 
R = CH3, C2H5, C3H7, CH2.C6H5,4-OMe.C6H4, 2-Me.C6H5 
R, = CI, Br. OMe 
Z. Y. Zhang and co-workers^^ have shown that the react ion of 4-amino-
3-( l - jC-chlorophenyl-5-methyl- l ,2 ,3- t r iazol-4-yl) -5-mercapto- l ,2 ,4- t r iazole 
with p-chlorobenzaldehyde/benzaldehyde in presence of catalytic amount of 
p - T s O H in ethanol afforded 4-benzyl ideneamino-3- ( l -p-chlorophenyl -5-
methyl- l ,2 ,3- t r iazol-4-yl- ) - l ,2 ,4- t r iazol-5- thiones ( X L V I I ) instead of the 
cyclised product . 
N - - N H 
N N H 




( X N = C H -
N " ^ C H 3 
N C H 3 
O 
Q 
R = H, CI 
X L V I I 
CI 
CI 
B. Kalluraya et a l . " have reported the condensat ion of 5-nitro-2-
(diacetoxymethyl) thiophene with 3-substi tuted 4-amino-5-mercapto-1 ,2 ,4-
triazole yielded the corresponding Sch i f f ' s base ( X L V I I I ) 
N NH 
~ I ^ S 
NH2 






N = CH 
XLVIII 
-NO2 
Similar condensat ion of 3 -subs t i tu ted-4-amino-5-mercap to-1 ,2 ,4 -
t r iazoles with 5 - (2 ,4 -d ich lo ropheny l ) -2 - fu r fu ra ldehyde y ie lded 3 -subs t i tu ted-
4 - [5 - (2 ,4 -d i ch lo ropheny l ) -2 - fu r fu ry l iden^^ ( X L I X ) 
N N H 
^ N ^ , + O H C -
I ^ 





N N H 
A N -C 
I ^ 







Long alkyl chain substituted-





The M'ork described in this chapter includes the reaction of 3-(9-decenyl)-4-
amino-5-mercapto-1,2,4-triazole (1) with: 
i) l,5-Bis(4-chlorophenyl)pent-l,4-dien-3-one (2) which afforded an 
adduct, 1,5-bis(4-chlorophenyl)-5-[3-(9-decenyl)-4-amino-5-thio-1,2,4-
triazolyljpent-]-en-3-one (3) and a novel compound, 2-(4-
chlorophenyl)-4-[2-(4-chlorophenyl)ethenyl]-7-(9-decenyl)-2,3-dihydro-
1,2,4-triazolo [3,4-b][1,3,4]thiadiazepine (4). 
ii) 4,4'-Dichlorochalcone (5) which yielded an adduct, 1,3-bis(4-chloro-
phenyl)-3-[3-(9'decenyl)-4-amino-5-thio-1,2.4-triazolyl]propan-l-one (6) 
and a novel compound, 2,4-bis(4-chlorophenyl)-7-(9-decenyl)-2.3-
dihydro-1,2,4-lriazolo[3A-b][l,3,4]thiadiazepine (7). 
Hi) 1,3-Bis(2-thienyl)propen-l-one (8) which furnished an adduct. f3-his(2-
thienyl)-3-f3-(9-decenyl)-4-amino-5-lhio-J,2.4-lriazolyljpropan-I-one (9) 
as the sole product. 
INTRODUCTION 
4-Amino-5-mercapto- l ,2 ,4- t r iazoles and their /V-bridged heterocyclic 
derivatives have received much attention during recent years on account of 
their wide spectrum biological potentialities as anthelmintic^' ', 
antihypertensive^^ antitubercular''^'', antibacterial"' ' . ant i fungal" ' , 
antiinflammatory''®, anti-HIV^', antiviral^^ inhibition of cholinesterase ' ' ' . 
analgesic^'' and anticonvuisant^^'^^. The 1,2,4-triazole nucleus has been 
incorporated into a wide variety of therapeutically interest ing drugs' ' ' 
including Hi/H2-Histamine receptor blockers, cholinesterase active agents, 
CNS stimulants, antianxiety agents and sedatives. Also 1,3,4-thiadiazepine 
derivatives are associated with a varied range of biological activities such as 
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antimicrobial '"^, anticancer^, herbicidal^"^, antiviral^, anti-HIV'*^"''', 
ant icholinergic"^ antidepressant'^"'^, anaes thet ic '^ calcium antagonist '^ 
choleretics'® and ACE inhibitory'^ activity. Prompted by these observations 
and as part of our continuing programme in the search of biological ly active 
compounds with sulphur and nitrogen containing heterocycles , we have 
undertaken this problem. It consists of the reaction of 3-(9-decenyl) -4-amino-
5-mercapto- l ,2 ,4- t r iazole (1) with ( i ) l ,5 -b is (4-chlorophenyl )pent - l ,4-d ien-3-
one (2) which afforded an adduct, l ,5-bis(4-chlorophenyl)-5-[3-(9-decenyl)-
4-amino-5- th io- l ,2 .4- t r iazoly l ]pent - l -en-3-one (3) and a novel compound, 2-
(4-chlorophenyl)-4-[2-(4-chlorophenyl)ethenyl]-7-(9-decenyl)-2,3-dihydro-
l ,2 ,4- t r iazolo[3,4-b][ l ,3 ,4] thiadiazepine (4). (ii) 4 ,4 ' -d ichlorochalcone (5) 
which yielded an adduct, l ,3-bis(4-chlorophenyl)-3-[3-(9-decenyl)-4-amino-
5- th io- l ,2 ,4- t r iazoly l ]propan- l -one (6) and a novel compound, 2,4-bis(4-
chlorophenyl) -7-(9-decenyl) -2 ,3-dihydro- l ,2 ,4- t r iazolo[3 ,4-b][ l ,3 ,4] th iadia-
zepine (7) and (iii) l ,3-bis(2- thienyI)propen- l -one (8) which furnished an 
adduct, l ,3-bis(2- thienyl)-3-[3-(9-decenyl)-4-amino-5- thio- l ,2 ,4- t r iazolyl] 
p ropan- l -one (9) as the sole product. 
Structural assignment and biological assay are discussed. Screening 
results of the compounds (4), (7) and (9) are summar ised for anticancer 
activity against 3-cell lines of three types of human cancers : lung, breast and 
CNS. Screening results of the compounds (4) and (7) are also summarised for 
antimicrobial activity against four bacteria, Escherichia coli, Bacillus 
subtilis, Staphylococcus aureus, Pseudomonas aeruginosa and one fungi 










R E S U L T S A N D DISCUSSION 
The syntheses of compounds (3), (4); (6), (7) and (9) have been 
performed by the reaction between a triazole (1) and <3r,;^-unsaturated 
carbonyl compounds. The triazole, 3-(9-decenyl)-4-amino-5-mercapto-1,2,4-
triazole FTZ (1) was first prepared following the method adopted by Peng-
Fei Xu et al.^^ by fusing 10-undecenoic acid with thiocarbohydrazide (molar 
ratio, 1:1) at 170 °C, as white crystalline needles in 85 % yield. It was then 
treated with (i) l ,5-bis(4-chlorophenyl)pent-l ,4-dien-3-one (2) (ii) 4.4'-
dichlorochalcone (5) and (iii) l ,3-bis(2-thienyl)propen-l-one (8) (molar ratio, 
1:1) in dry benzene in presence of /?-TsOH. (Scheme 1). The products on 
chromatography over a silica gel column using pet. ether-EtOAc (8:2 v/v) as 
eluent yielded compounds FBCA (3) and FBCB (4) in (i), F T Z X 4 A (6) and 
F T Z X 4 B (7) in (ii) and FTCA (9) in (iii). The reaction of the triazole with 
l ,3-bis(2-thienyl)propen-l-one (8) didn't yield the desired product, triazolo-
thiadiazepine, but yielded only the adduct (9) as the sole product. 
2 5 
2. 






N c <u x> 




<D c 0 1 
^ 




o N ^ 
C —' U ^ JD 













s s o o. _o O "c3 ^ 
o " 










3-(9-Decenyl)-4-amino-5-mercapto-l,2,4-triazole F T Z (1) 
The outl ine of its synthesis is as fol lows: 
. r „ Vr II S 
1 7 0 ° C , 1 . 5 h ( O H 
10-Undecenoic acid ^ 
' -H2O 








H N — N H 
( > P h n HN 
I 
NH2 
Structure Elucidat ion of FTZ (1) 
It was a whi te crystal l ine solid, m.p. 82 °C. The s t ruc ture of F T Z was 
fu l ly es tabl ished by IR, DCI-MS, ' H - N M R and ' ^ C - N M R spectra . IR-
spec t rum (KBr) gave character is t ic peaks at 3250, 3100 ( N H ), 2900(CH) 
2350 (SH) , 1640 (C=C), and 1610 (C=N) cm"'. The D C I - M S spec t rum of the 
sample F T Z showed a [M+1]"^ signal at m/z 255 c o n f i r m i n g its molecular 
weight 254 which corresponds with the ion [C12H22N4S] . Th i s is equal to the 
sum of the molecular weights of 10-undecenoic acid (184) and th iocarbo-
hydraz ide (106) minus two molecules of water. This sugges ted the format ion 
of 5- tr iazole r ing by the condensat ion of t h i o c a r b o h y d r a z i d e with 
2 7 
10-undecenoic acid. It also showed two prominent f ragment ion peaks at 
m/z 130 [(M+O-CgHn]^- and m/z 143 [M-CgHu]^ due to the (5- and y-
cleavage to the triazole ring on the long alkyl side chain. 
All the signals in 'H-NMR and '^C-NMR spectra (acetone-c/g) (Fig. l a 
and l b ) have been assigned to specific H- and C-atoms (Table 1) f rom their 
typical chemical shift values, multiplicity and relative integrations. The 
' H - N M R spectrum showed a weak broad singlet at 5 12.25 and a sharp 
intense singlet at 5 5.18 which were attributed to the thiol and amino 
protons. The two double doublets at 5 4.90 (J=10.26, 2.20, He) and 6 4.98 
(J=17.21, 2.20, Hz) coupled with each other and with the ad jacent methine 
proton were assigned to the two terminal o lefmic protons. HE -10 ' and H ^ - I O ' 
respectively. The signals appeared as triplet double doublet at 5 5.81 (J=6.78. 
10.26, 17.03) were due to the coupling of the methine proton ( - C H = , H - 9 ' ) 
with the protons at H-8' and HE-10', HZ-10'. Also in '^C-NMR spectrum, the 
characterist ic signals appeared at 5 153.34 and 5 168.26 were assigned to the 
triazole ring carbons at C-3 and C-5. The other signals were at tr ibuted to the 
9-decenyl side chain carbons. 
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J (Hz) C-nr S(ppm) 
SH 12.25 IH brs 3 153.34 
NH, 5.18 2H s 5 168.26 
] ' 2.73 2H t ] ' 25.40 
2' 1.75 2H br p J « 7.46 2' 26.68 
3'-7' 1.33 5x2H br s 3'-7' 29.40-30.20 
8' 2.03 2H m 8' 34.40 
9' 5.81 IH tdd J9',8' 6.78, Jq'^  he 10.26. 9' 139.82 
J9',Hz 17.03 
114.61 HH-IO' 4.90 IH dd JHE,9' 10.26, JHL, Hz 2.20 10' 
Hz-10' 4.98 IH dd JHZ„9' 17.21, JHE, Hz 2.20 
l,5-Bis(4-chlorophenyl)-5-[3-(9-decenyl)-4'amino-5-thio-l,2,4-triazolyl] 
pent-l-en-3-one FBCA (3) and 2-(4-chlorophenyl)-4-[2-(4-chlorophenyl) 
ethenyl]-7-(9-decenyl)]-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine 
FBCB (4). [Reaction of the ^-triazole (1) with l ,5-bis(4-chlorophenyl) 
pent-l,4-dien-3-one (2)J, 
A solution of the 5-triazole (1) and l ,5-bis(4-chIorophenyl)penl-1.4-
dien-3-one (2) (molar ratio, 1:1) in dry benzene was ref luxed with stirring for 
32 h in presence of a catalytic amount of /7-TsOH. The products on usual 
work up and column chromatography (silica gel, pet. e ther-EtOAc, 8:2 v/v) 
yielded a colourless solid FBCA (3) (38%) and a yellow solid, FBCB (4) in 
47.5% yield. The reaction sequence is as follows. 
3 1 
N N CI 
FTZ (1) 
i) p-TsOH /dry benzene 




N ^ S ' 
NH2 
N N N N 
CI 
FBCA (3) 
Structure Eluc idat ion of F B C A (3) 
It was a colour less glassy f lakes, m.p. 84 °C. The s t ruc ture of F B C A 
was es tabl i shed by DCI-MS, ' H - N M R and '^C-NMR spectra . The DCI -MS 
spec t rum (Fig. 2a) of FBCA showed a set of [M+I]"^ peaks at m/z 
557/559/561 showing its molecular weight 556 /558 /560 [C29H34N40C1^S], 
which is equal to the sum of the molecular weights of ^- t r iazole (1) (254) and 
the d ienone (2) (302). This indicated that an addi t ion p roduc t has been 
formed by the nucleophi l ic addi t ion of the thiol g roup to the enone func t ion 
of the d ienone (2) and showing that the one ene g roup r ema ins intact . The 
prominen t f r agment ion peaks were observed at m/z 255 [ (M+l ) -C i iH80S2]^ 
as the base peak and at m/z 303/305/307 [(M+1)-C,2H22N4S]^ fo rmed by the 
3 2 
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re t ro-Michael addit ion of F B C A , in addit ion to other peaks at m/z 165, 143 
and m/z 130 as shown in Chart 1. 
CH.. 
[M +1] m/z 557/559/561( 35.4 / 19.6/3.4) 
retro-Michael addition 
< 














m/z 165 /167 (28.8/9.2) 
' H - N M R and '^C-NMR spectra (Fig. 2b and 2c) showed the s ignals as 
assigned (Table 2). ' H - N M R spect rum showed a sharp singlet for amino 
protons at 6 5.21. The signals cor responding to the methy lene p ro tons at C-4 
appeared as two double doublets at 5 3.47 (J=17.25, 5.50, H-4up) and S 3.97 
(J=17.25, 9.31, H-4dn). The signal for the meth ine proton at C-5 appeared as a 
double doublet at 5 6.43 (J=9.31, 5.50, H-5) . The signals for the t rans-olef in ic 
protons at 5 6.90 (J=16.33, H-2) and 5 7.67 (J=16.33, H-1) indica ted that the 
Michael addit ion of thiol has occurred to only one ca rbon-ca rbon double bond 
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exhibited peaks for the saturated carbon-carbon bond at 5 57.69 (C-5) and 
5 45.05 (C-4) and the carbonyl carbon 5 196.04 (C-3). It also showed the 
signals corresponding to the ^./^-unsaturated olefenic carbons at 5 127.64 
(C-2) and 6 142.08 (C-1), in addition to the usual peaks of i '-triazole moiety 
and 9-decenyl side chain carbons as shown in Table 2. 
On the basis of the above facts, the structure of compound FBCA was 
conf i rmed as 1,5-bis(4-chlorophenyl)-5-[3-(9-decenyl)-4-amino-5-thio-1,2.4-
triazolyljpent-l-en-3-one (3). 
FBCA (3) 
Structure Elucidation of FBCB (4) 
It was a yellow globular shaped crystalline solid, m.p 161 °C. The 
structure of FBCB has been established by DCI-MS, 'H-NMR and '^C-NMR 
spectra. The DCI-MS spectrum of the sample FBCB (Fig. 3a) showed a set of 
[M+l]"^ peaks as the base peak at m/z 539/541/543^ showing its molecular 
weight 538/540/542 [C29H32N4SCI2] which is equal to the molecular weight 
of (3) (556) minus one molecule of water. This indicated the formation of the 
thiadiazepine ring by the intramolecular cyclocondensat ion between the NH2 
and CO groups of (3). The formation of the molecular ion as the base peak 
indicated the stability of the molecule. The peak at m/z 415/417/419 
3 8 
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[(M+O-CgHij]"^ was arised by /7-cleavage of the long alkyl chain to the 
t r iazole ring. The peaks at m/z 302/304/306 [(M+l)-C,2H2iN3S]^ and an 
another peak at m/z 240 [ (M+O-CiyHj jNCla]^ arised by the c leavage of 1-7 
and 3-4 bonds are the diagnost ic peaks for the t r iazolo- th iadiazepine ring 








^ N f S s 
McLaffe r ty rear rangement 3 ^ 6 
XI Q "a 
m/z 539/541/543 (100.0/75.7/18.7) 
m/z 415 /417 /419 (7.6/5 8) 
N N 
m/z 240(25.1) n ^ o / 
P-cleavage 
m/z 302 /304/306 (30.6/16.5/4 .2) 
H 
^ S H N N 
H 
miz 128 (5 9) 
N ^ S H 
H 
m/z 115 (6.3) 
N N 
X X 
H ^ N - ^ S H 
H 
m/z 102 (9.3) 
C H A R T 2 
'H -NMR and '^C-NMR signals (Fig. 3b and 3c) were assigned to individual 
H-and C-atoms (Table 3) from their typical chemical shift values, multiplicity, 
relative integrations and by the comparison with the spectra of (3) (Table 2). The 
signal corresponding to NH2 protons at 5 5.12 of (3) has disappeared in the 
'H-NMR spectrum of FBCB, showing that NH2 group was involved in 
4 0 
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the formation of the ring. The absence of NH2 protons signal (§ 5.12) in 
' H - N M R spectrum and CO signal (5 196.04) in '^C-NMR spectrum of F B C B 
confirmed the formation of thiadiazepine ring. The format ion of the ring has 
also been supported by the shifts of two diastereotopic hydrogens to higher 
fields, f rom 5 3.47 (Hup-4) to 5 3.07 and from 5 3.97 (Hdn-4) to 6 3.52 and also 
of the methine proton from 5 6.43 (H-5) to 5 5.22. The exocycl ic t rans-olefinic 
protons signals appeared as doublets at 6 7.27 (J=16.48, H - l " ) and 5 7.66 
(J=16.48, H-2"). In '^C-NMR spectrum, in place of CO signal at 6 196.04 
(C-3), a signal appeared at higher field at 5 143.16 (C-4) in the formation of 
ring. The other thiadiazepine carbons appeared at 5 53.59 (C-2) and 5 36.92 
(C-3). The exocyclic olefinic carbon signals appeared at 6 126.76 (C-1") and 
5 140.69 (C-2"). The terminal o lefmic carbons appeared at 5 139.81 (C-9') 
and 5 114.59 (C-10'). 
Based on the above discussion, compound F B C B was characterised as 
2-(4-chlorophenyl)-4-[2-(4-chlorophenyl)ethenyl]-7-(9-decenyl)]-2,3-dihydro 
-1,2,4-triazolo[S,4-b][ 1,3,4]thiadiazepine (4). 
4 4 
l,3-Bis(4-cltlorophenyl)-3-[3-(9-decenyl)-4-amino-5-tltio-l,2,4-triazolylJpro-
pan-l-one FTZX4A (6) and 2,4-bis(4-chlorophenyl)-7-(9-decenyl)-2,3-
dihydro-l,2,4-triazolo[3,4-b]ll,3,4]thiadiazepine, FTZX4B (7) [Reaction of 
the 5-triazole (1) with 4 ,4 ' -dichlorochalcone (5)] 
A solut ion of the ^-tr iazole (1) and 4 ,4 ' -d ichIorocha lcone (5) (molar 
ratio. 1:1) in dry benzene was re f luxed with st i rr ing for 26 h in presence of a 
catalytic amount o f p - T s O H . . The products on ch romatography over silica gel 
column using pet. e ther -EtOAc (8:2 v/v) as an eluent a f fo rded two 
compounds , a colourless oily liquid FTZX4A (6) (37%) and a yel low 










(i) p-TsOH/dry benzene 
Reflux 26 h 
N N 
Q 
FrZX4A (6) FTZX4B (7) 
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Structure Elucidat ion of FTZX4A ( 6) 
It was a colour less oily liquid. The s tructure of FTZX4A has been 
es tabl ished by FTIR, EI -MS and ' H - N M R spectra. FTIR spect rum gave 
character is t ic bands at 3178.55, 3074.26 (NH2), 2927.0 (CH) , 1689.17 ( C = 0 ) , 
1639.66 ( C - N ) and 1590.04 (C=C) cm"'. In EI -MS spec t rum, the molecular 
ion peak was absent , but two prominent peaks, one at m/z 254 [ (M+I) -
C i s H n O C b ] ^ ' and another at m/z 277/279/281 [(M+1)-C,2H,4N4S]^ 
cor respond ing with the tr iazole f ragment and 4 ,4 ' -d ich lo rocha lcone f ragment 
ions, appeared possibly by the re t ro-Michael addi t ion of (6) The 









m/z 254 (89.0) 




m/z 143 (28.3) 
H 
m/z 277/279/281 (16.0/9.2) 







m/z 130 (67.8) 
m/z 139/141 (100.0/37.8) 
CHART 3 
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The 'H-NMR (acetone-cf^) signals were assigned to individual 
hydrogen atoms (Table 4) on the basis of typical 5-values , multiplicity, 
relative integrations and by comparison with the spectral data of (1) (Table 1) 
and the previously established compound (3) (Table 2). The spectrum showed 
no signal corresponding to thiol proton at 5 12.25 and in place additional 
signals appeared due to the addition of the SH group to a,y5-unsaturated 
funct ion of chalcone forming an adduct. A double doublet at 5 6.40 (J=9.08, 
5.58) was assigned to H-3 and the two double doublets at 6 3.60 (J=17.10, 
5.58) and 5 4.20 (J=17.10, 9.08) were attributed to the two diastereotopic 
protons, Hup-2 and Hdn-2. The aromatic protons signals appeared as A2B2 
pattern at 5 7.20 (d, J=8.55) and 6 7.42 (d, J=8.55) for one benzene ring and 
at S 7.84 (d, J=8.42) and 6 7.70 (d, J=8.42) for another benzene ring. The 
other signals were assigned to the 9-decenyl side chain protons. 
Based on the above evidence, FTZX4A was character ised as 1,3-bis 
(4-chlorophenyl)-3-[3-(9-decenyl)-4-amino-5-thio-l ,2,4-triazolylJpropan-l-
one (6). 
' S ^ N 
FTZX4A (6) 
4 7 
Table 4. 'H-NMR spectral data of FTZX4A (6). 
H-ni 6(ppm) Integra-tion 
Multi-
plicity J (Hz) 
N H , 5.14 2 H s 
3 6.40 I H dd J3.2dn 9.08, J3.2UP 5.58 
2up 3.60 I H dd J2up.2dn 17.10, J2UP.3 5.58 
2dii 4.20 I H dd J2up,2dn 17.10, J2dn. 3 9.08 
1" 2.68 2 H t J,..2" 7.46 
1.64 2 H br p J « 7.33 
1 
1 H "711 J - / 1.23 5x2H br s 
8" 
1 
1.98 2 H m 
! 9" 1 5.70 i 1 I H tdd 
1 
J9..8.. 6.71. V „ r , 10.22. J9". Hz 17.08 | 
1 Ht-10" 4.88 I H dd .IHC 9" 10.22. Jn, , , 1 .2 .28 ; 
1H/-IO" 4.97 i ! i 
I H dd J„,,9" 17.08. 2.28 ' 
Ar-2.6 7.20 2 H d JAr-2.6. Ar-3,5 8 . 5 5 
1 
1 Ar-3.5 7.42 2 H d JAr-2.6, Ar-3.5 8 . 5 5 
Ar'-2.6 7.84 2 H d JAr'-2.6,Ar'-3.5 8 . 4 2 
Ar'-3,5 7.70 2 H d JAr'-2.6, Ar'-3.5 8 . 4 2 
Structure Elucidation of FTZX^B (7) 
It was a pale yellow globule shaped crystalline solid, m.p 148 °C. The 
structure of FTZX4B has been fully established by DCI-MS. 'H-NMR and 
'^C-NMR spectra. The DCI-MS spectrum displayed a set of peaks 
corresponding to [M+l]"^ as the base peak at m/z 513/515/517 showing its 
molecular weight to be 512/514/516 [C27H30N4SCI2] which is equal to the 
molecular weight of (6) (530) minus one molecule of water. This 
4 8 
indicated that tlie format ion of thiadiazepine ring has occurred by the 
in t ramolecular cyclocondensat ion of (6). Moreover , the appearance of the 
molecular ion peak as the base peak highl ighted the stabil i ty of the molecule . 
A set of peaks at m/z 276/278/280 and an another peak at m/z 240 arised by 
the c leavage of 3-4 and 1-7 bonds are the diagnost ic peaks for the tr iazolo-
th iadiazepine r ing system. The other f ragment ion peaks at m/z 102, 115, and 
m/z 128 were obta ined f rom the ion m/z 240 by the c leavage on the long alkyl 
side chain at a , P and y-posit ions to the tr iazole ring as shown in chart 4 
N N a-cledvaae 
N ^ S H 
H 




m/z 1 1 5 ( 7 9) 
C H , 
N N 
"CI 
[M+H] m/z 513/515 /517 (100 0/72 1/18 3) 
1 -7 and 3-4 -bond clca\ due 
N-^  "SH 
H 




m/z 128 (5.1) 
CHART 4 
m/z 276/278/280 (54 3/27 8/6 8) 
Cl- - C = N O 
m/z 138/140 (5.9) 
The ' H - N M R and '^C-NMR signals (Fig.4a and 4b) we re assigned to 
individual H- and C-a toms (Table 5) on the basis of chemica l shif t values, 
mult ipl ic i ty , re la t ive integrat ions and by compar ing the spectra l data with that 
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5 2 
' H - N M R spectrum of FTZX4B and shifts of 5 values of the two 
diastereotopic methylene hydrogens to higher fields from 5 3.60 (Hup-2) and 
S 4.20 (Hdn-2) to 5 3.27 and 5 3.66 respectively and also of the methine 
proton from 6 6.40 (H-3) to 5 5.27 indicated the format ion of 1,3,4-
thiadiazepine ring. This was also supported by '^C-NMR spectrum. The signal 
corresponding to CO group did not appear and in place other signals 
corresponding to thiadiazepine ring carbons appeared which were assigned as 
5 143.05 (C-4), 38.42 (C-3), 53.72 (C-2) and 170.18 (C-9a). In addition, the 
signals corresponding to the 9-decenyl side chain and the 1,2,4-triazole ring 
carbons appeared as shown in T a b l e 5. 






one F T C A (9) [Reaction of the s - tr iazoie (1) wi th l ,3 -b i s (2- th ienyl ) 
p r o p e n - l - o n e (8)]* 
*[This react ion fai led to yield the desired produc t 2,4-bis(2-thienyl)-7-(9-
decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-bJ[l,3,4Jthiadiazepine]. 
A solut ion of 5-tr iazole (1) and l , 3 -b i s (2 - t h i eny l )p ropen - l -one (8) 
(molar ratio, 1:1) in dry benzene was re f luxed wi th s t i r r ing for 30 h in 
presence of catalyt ic amount of /7-TsOH. TLC examina t ion of the reaction 
mixture revealed only a single spot. The react ion was con t inued for further 
10 h, but no other spot developed. The products on pur i f ica t ion by column 
chromatography a f fo rded F T C A (9) as the sole produc t as a pale yel low oily 











i) /7-TSOH /dry benzene 
Reflux 30 h 
F T C A (9) 
5 4 
Structure Elucidation of F T C A (9) 
It was a pale yel low oily liquid. The structure of F T C A has been ful ly 
es tabl ished by DCI-MS, ' H - N M R and '^C-NMR spectra . The DCI-MS 
spectrum showed [M+l]"^ peak at m/z 475 showing its molecu la r weight to be 
474 [C23H30N4OS3] which is equal to the sum of the molecu la r weights of (1) 
(254) and l ,3 -b is (2- th ienyI )propen- I -one (8) (220). This sugges ted that an 
adduct of (8) and (1) has been fo rmed by the nuc leophi l ic addi t ion (1,4) of 
SH group to or.y^-unsaturated carbonyl funct ion. The m o d e of f ragmenta t ion 






















m/z 143 (3.7) 
^SH 
NH2 
m/z 130 (5.7) 
retro-Michael addition 
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m/z 111 (32.0) 
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The signals in 'H-NMR and '^C-NMR spectra (Fig. 5a and 5b) have 
been assigned to specific H- and C-atoms (Table. 6) f rom the chemical shift 
values, multiplicity, relative integrations and by comparing with the spectral 
data of a previously established structure of compound (6) (Table 4). The 
absence of the thiol proton signal at 6 12.25 and <2,y9-unsaturated protons 
signals at 6 7.48 and 5 7.93 of the substrate (8) (experimental) and appearance 
of the diastereotopic proton signals at 5 3.82 (Hup-2) and 5 4.25 (Hdn-2) is the 
clear evidence for the formation of the adduct. The signal of the methine 
proton (H-3) appeared as a double doublet at 5 6.79 (J=9.01, 5.80) due to the 
coupling with the two diastereotopic protons (Hup-2) and (Hd„-2). The structure 
was further confirmed by '^C-NMR spectrum. The disappearance of the signals 
corresponding to the a , (3-unsaturated carbons, C-2 (5 121.36) and C-3 
(5 140.95) of (8) (see experimental) and the appearance of the signals of the 
same positions at higher fields, 5 44.25 (C-3) and 5 54.03 (C-2) indicated the 
formation of adduct. The carbon signals have been assigned as 6 189.06 
(C-1). 5 152.51 (C-3') and 5 167.48 (C-5'). The signals of 9-decenyl side chain 
and the aromatic ring carbons appeared as usual. 
Based on the above spectral facts, the structure of the compound FTCA 
was established as \,3-bis(2-thienyl)-3-[3-(9-decenyl)-4-amino-5-thio-],2,4-
triozolylJ propan- J -one (9). 
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Reagent and solvents were of commercial grade and were used without 
further purification, 10-undecenoic acid was also of commercial grade (Fluka, 
AG, Switzerland). All melting points were determined on a Koff le r hot-plate 
apparatus and are uncorrected. IR spectra were determined on a Perkin-Elmer 
621 spectrophotometer in KBr-pellets. FTIR were recorded on Perkin-Elmer 
spectrophotometer RXj and wave numbers (v^ax ) were recorded in cm"'. 'H-
NMR and '^C-NMR spectra were recorded in Bruker Ac 300, Brucker DRX 
300 and Varian Unity 400 in acetone-^/^ and DMSO-t/^ with TMS as the 
internal standard. The abbreviations s, d, t, m, dd. ddd, br p, dt denote singlet, 
doublet, triplet, multiplet, double doublet, triple doublet, broad pentet and 
double triplet. ' X - N M R were recorded on a Varian unity 75 and 100 
spectrometers. ElMS were recorded on V.G. Micromas model ZAB-IF 
apparatus at 70 ev ionization voltage. DCI-MS spectra were recorded with a 
Ribermag RIO-IOB quadrupole mass spectrometer, using ammonia as reagent 
gas. Thin layer chromatography (TLC) was carried out on 0.25 mm layer 
plates with silica gel G (Merck). Spots were visualised on exposure to iodine 
vapour using iodine chamber. The column chromatography was performed on 
silica gel [Merck. (60-120) mesh] using 25-30 g. per g of material to be 
separated and purified. Dry solvents were prepared according to standard 
procedures. The organic solvents used were of LR grade and were distilled 
before use. The abbreviation used pet. ether for petroleum ether and EtOAc 
for ethyl acetate, 
6 0 
4-Amino -3-(9-decenyl)-5-mercapto-l,2,4-triazole FTZ (1) 
A mixture of 10-undecenoic acid (6.0 g, 0.0325 mol) and thiocarbo-
hydrazide (3.456 g, 0.0325 mol) taken in a 100 ml round bot tom flask was 
fused by heating at 170 °C on an oil bath for 1V2 h, moni tor ing the progress 
of the reaction (TLC, silica gel G, pet .ether-EtOAc, 8:2 v/v) which revealed 
the formation of a single spot corresponding to the product . The reaction 
mixture was then extracted with ethyl acetate, washed successively with 
water (3x50 ml), 5% NaHCOs solution (2x50 ml), again with water (3x50 
ml) and finally dried over anhydrous Na2S04. The solvent was removed under 
reduced pressure and the solid residue thus obtained was crystall ised from 
EtOAc-benzene as white crystalline needles, 7.078 g (85.6%), m.p. 82 °C, 
R, 0.63 (pet. ether-EtOAc, 8:2 v/v) 
Spectral data of FTZ (1) 
IR (KBr): v 3250, 3100 (NHj) , 2900 (CH), 2350 (SH), 1630 (C=N), 1610 
(C=C), 1550, 1470, 1410, 1370, 1280, 1230, 940, 890, 720 cm"'. 
'H-NMR (400 MHz, ace tone-^) : 5h 12.25 ( I H , SH), 5.18 (2H, s, NH2), 2.73 
( 2 H , t , J = 7 . 5 1 , H - 1 ' ) , 1 . 7 5 ( 2 H , b r p , J ~ 7 . 4 6 , H - 2 ' ) , 1 . 3 3 (LOH, b r s, H - 3 ' - 7 ' ) , 
2 . 0 3 ( 2 H , m , H - 8 ' ) , 5 . 8 1 ( I H , t d d , J = 6 . 7 8 , 1 0 . 2 6 , 1 7 . 0 3 H - 9 ' ) , 4 . 9 0 ( I H , d d , 
J = 1 0 . 2 6 , 2 . 2 0 , H E - 1 0 ' ) , 4 . 9 8 ( I H , d d , J = 1 7 . 2 1 , 2 . 2 0 , H z - 1 0 ' ) . 
'^C-NMR (100 MHz, acetone-^/g): 5c 153.34 (C-3), 5 168.26 (C-5), 25.40 
(C-1'), 26.68 (C-2'), 29.40-30.20 (C-3'-7'), 34.40 (C-8') , 139.82 (C-9'), 114.61 
(C-10'). 
6 1 
DCI-MS (NH3);; m/z (%) 254 ( M \ 7.1), 255 [ ( M + l ^ , 100.0], 256 (25.3), 257 
(9.6), 143 (9.2), 144 (3.6), 130 (17.3), 131 (3.1). 
l,5-Bis(4-chlorophenyl)pent-l,4-dien-3-one (2) 
It was prepared following a literature procedure^^'^ by condensing 
acetone with p-chlorobenzaldehyde (molar ratio, 1:2) in the presence of 2.5 
equivalents of sodium hydroxide. To a solution of /?-chlorobenzaldehyde 
(604 mg, 4.310 mmol) dissolved in ethanol (20 ml) was added acetone (250 
mg, 2.155 mmol) dropwise keeping the solution in an ice bath. To this was 
added sodium hydroxide solution (431 mg, 5.38 mmol) drop wise with 
stirring for 2 h. until a yel low precipitate was formed. It was then worked up. 
The ye l low solid thus obtained was recrystallised f rom benzene to give (2) 
as bright yel low crystalline flakes, 710 mg (72.0%), m.p 176 °C, Rf 0.72 
(pet. e ther-EtOAc, 8:2 v/v). 
Spectra l data of (2) 
' H - N M R (400 MHz, acetone-rfg): 5h 7.28 (2x lH , d, J=16.0, H-2/H-4), 7.70 
( 2 x l H , d, J=16.0, H- l /H-5) , 7.73 (4H, d, J=8.50, 2xAr-2,6) , 7.45 (4H, d, 
J=8.50, 2xAr-3,5) . 
4,4'-Dicholrochalcone (5) 
It was prepared following a published but sl ightly modified 
procedure^^® by condensing j?-chloroacetophenone with p-chlorobenzyl idene 
diacetate (both prepared according to reported procedure)^^^ in equimolar 
ratio in the presence of 2.5 equivalents of sodium hydroxide . A mixture of 
p-chiorobenzyl idene diacetate (6.5 g, 0.0268 mol) dissolved in (21 ml) 
ethanol and p-chloroacetophenone (4.13 g, 0.0268 mol) was kept on an ice 
bath in a 500 ml flask. To this, sodium hydroxide (2.65g, 0.0671 mol) was 
6 2 
added drop wise with stirring. After complete addition, the reaction mixture 
was fur ther stirred for 3 h, diluted with 300 ml of ice cold water and was then 
kept in the refr igerator overnight. The precipitate formed was filtered and 
washed successively with water to make it neutral. It was then washed with 
10 ml of cold alcohol. The yellow solid thus obtained was recrystal l ised from 
acetone-benzene to give (9) as light yellow crystalline needles, 6.29 g (85%), 
m.p. 156 °C, Rf 0.72 (pet. ether-benzene, 1:1 v/v) 
l,3-Bis(2-thienyl)propen-l-one (8) 
It was prepared following a literature procedure^^'' by condensing 
thiophen-2-aldehyde (prepared from thiophene according to reported 
procedure^^'') with 2-acetylthiophene in equimolar ratio, in the presence of 2.5 
equivalents of sodium hydroxide. A mixture of th iophen-2-a ldehyde (500 mg, 
3.96 mmol) dissolved in (20 ml) ethanol and 2-acetyl thiophene (554 mg, 3.96 
mmol) was kept on an ice bath in a 500 ml flask. To this sodium hydroxide 
(396 mg, 9.9 mmol) was added dropwise with stirring. It was stirred further 
4 h and then worked up as above. The yellow solid thus obtained was 
recrystal l ised (acetone-benzene) to give (8) as light yel low crystal l ine needles, 
765 mg (78%), m.p 89 °C, Rf 0.63 (pet .ether-EtOAc, 8:2 v/v). 
Spectral data of (8) 
' H - N M R ( 400 MHz, acetone-dfi): 5h 7.48 ( IH , d, J=15.41, H-2) , 7.93 ( IH, 
d, J=15.41, H-3), 7.67 ( IH , d, J=5.04, Ar-3), 7.60 ( I H , d, J=4.73, Ar'-3), 7.27 
( IH , d, J=3.51, Ar-4), 7.17 ( IH, d, J=3.67, Ar'-4), 8.11 ( I H , d, J=3.82, Ar-5) , 
7.91 ( IH , d, J=3.67, Ar'-5). 
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' ^C -NMR (100 MHz, acetone-dtf): 5c 181.80 (C-1), 121.36 (C-2), 140.95 
(C-3). 146.68 (Ar-C-2), 136.58 (Ar-C-5), 133.06 (Ar'-C-5), 129.34-134.25 
(Ar-C-3, Ar '-C-3, Ar-C-4, Ar'-C-4). 
DCI-MS (NH3): m/z (%) 221 (100.0), 222 (20.4), 220 (14.0), 191 (3.7). 137 
(3.8). I l l (7.2). 
l,5-Bis(4-cltlorophenyl)-5-[3-(9-decenyl)-4-amino-5-thio-l,2,4-triazolyl] 
pent-l-en-3-one FBCA (3) and 2-(4-chlorophenyl)-4-[2-(4-chlorophenyl) 
ethenyl]-7-(9-decenyl)]-2,3-dihydro-l,2,4-tnazolo[3,4-b][l,3,4]thiadiazepine 
FBCB (4). [Reaction of the 5-triazole (1) with l ,5-bis(4-
chiorophenyl)pent- l ,4-dien-3-one (2)] 
A mixture of the ^-triazole (1) (50 mg, 1.96 mmol) and 1.5-bis(4-
chlorophenyl)pent- l ,4-dien-3-one (2) (590 mg, 1.96 mmol) in dry benzene 
(20 ml) was refluxed for 33 h in presence of yC-TsOH (5 mg). The TLC 
examination of the reaction mixture revealed the presence of two spots of 
equal intensity. It was worked up and subjected to column chromatography 
(silica gel, pet. ether-EtOAc, 8:2 v/v) which afforded FBCA (3) as glassy 
flakes. 416 mg (38.2%), m.p 84 °C, Rf 0.71, pet. e ther-EtOAc (8:2 v/v). 
Further elution of the column using pet. ether-EtOAc (6:4 v/v) followed b> 
crystallisation (benzene-acetone) afforded FBCB (4) as yel low crystalline 
globules, 460 mg (47.5%), m.p 161 °C, Rf0 .30 (pet. e ther-EtOAc, 8:2 v/v). 
Spectral data of FBCA (3) 
'H-NMR (400 MHz, acetone-^/g): 5h 5.21 (2H, s, NHj), 6.43 ( IH , dd, J=9.31. 
5.50, H-5), 3.47 ( IH , dd, J=I7 .25 , 5.50, H-4up), 3.97 ( I H , dd, J=I7 .25 , 9.31, 
H-4dn), 6.90 ( IH , d, J=I6 .33 , H-2), 7.67 ( IH, d, J= 16.33, H - I ) , 2.73 (2H, t, 
J=7.48, H- l " ) , 1.70 (2H, br p, J~7.36, H-2"), 1.25 (lOH, br s, H-3"-7") , 2.00 
64 
( 2 H , m , H - 8 " ) , 5 . 8 0 ( I H , t d d , J = 6 . 7 1 , 1 0 . 2 2 , 1 7 . 0 9 , H - 9 " ) 4 . 9 0 ( I H , d d , 
J = 1 0 . 2 2 , 2 . 2 9 , H E - 1 0 " ) 4 . 9 8 ( I H , d d , J = 1 7 . 0 9 , 2 . 2 9 , H Z - 1 0 " ) , 7 . 3 6 ( I H , d, 
J = 8 . 5 4 , H - A r - 2 , 6 ) , 7 . 4 6 ( I H , d , J = 8 . 5 4 , H - A r - 3 , 5 ) , 7 . 7 2 ( I H , d , J = 8 . 3 9 , H -
A r ' - 2 , 6 ) , 7 . 4 9 ( 2 H , d , J = 8 . 3 9 , H - A r ' - 3 , 5 ) . 
'^C-NMR (100 MHz, acetone-rf^): 5c 57.69 (C-5), 45.05 (C-4), 196.04 (C-3), 
127.64 (C-2), 142.08 (C-1), 152.46 (C-3'), 167.62 (C-5'), 25.21 (C-1"), 26.70 
(C-2"), 29.20-30.40 (C-3"-7"), 45.05 (C-8"), 139.35 (C-9"), 114.64 (C-10"), 
139.85 (Ar-C-1), 129.29 (Ar-C-2,6), 129.99 (Ar-C-3,5), 134.59 (Ar-C-4), 
134.04 (Ar ' -C- l ) , 130.81 (Ar'-C-2,6), 130.09 (Ar'-C-3,5), 136.63 (Ar'-C-4) 
DCI-MS (NHs): m/z (%): 557[(M+1)^ 35.4], 558 (10.3), 559 (19.6), 560 
(8.7), 561 (7.8), 301 (5.1), 302 (15.5), 303 (73.3), 304 (22.9), 305 (47.0), 306 
(10.4), 307 (8.3), 267 (5.5), 254 (20.8), 255 (100.0), 256 (17.6), 257 (6.6), 
204 (4.3), 165 (28.8), 167 (9.2), 143 (9.2), 137 (4.8), 130 (15.7), 101 (4.1), 
102 (11.0). 
Spectral data of F B C B (4) 
'H-NMR (400 MHz, acetone-rfg): 5h 3.07 ( I H , dd, J=13.73, 11.75, H-3„p), 
3.52 ( I H , dd, J=13.73, 4.89, H-3dn), 5.22 ( IH, dd, J=11.75, 4.89, H-2), 7.27 
( IH , d, J=16.48, H-1"), 7.66 ( IH , d, J=16.48, H-2"), 2.83 (2H, t, J=7.47, H-
1'), 1.79 (2H, br p, J~7.44, H-2') , 1.29 (lOH, br s, H-3'-7 ') , 2.00 (2H, m, H-
8'), 5.78 ( I H , tdd, J= 6.7,10.22, 17.09, H-9') , 4.88 ( IH , dd, J=10.22, 2.29, HE-
10'), 4.96 ( I H , dd, J=17.09, 2.29, Hz-10'), 7.42 (2H, d, J=8.54, H-Ar-2,6) , 
7.49 (2H, d, J=8.54, H-Ar-3,5), 7.76 (2H, d, J=8.39, H-Ar '-2,6) , 7.57 (2H, d, 
J=8.39, H-Ar'-3,5). 
^^C-NMR (100 MHz, acetone-dg): 8c 171.27 (C-9a), 155.84 (C-7), 143.16 
(C-4), 36.92 (C-3), 53.59 (C-2), 126.76 (C-1"), 140.69 (C-2"), 25.51 (C-T), 
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27.36 (C-2'), 29.20-30.40 (C-3'-7'), 34.42 (C-8'), 139.81 (C-9'), 114.59 (C-
10'), 142.37 (Ar-C-1), 129.47 (Ar-C-2,6), 129.61 (Ar-C-3,5) ,135.23 (Ar-C-4), 
134.32 (Ar ' -C- l ) , 130.39 (Ar'-C-2,6), 129.95 (Ar ' -C-3,5) , 136.12 (Ar'-C-4). 
DCI-MS (NH3): m/z (%): 538 ( M \ 10.2), 539 [ (M+1)^ 100.0], 540 (45.1), 
541 (75.7), 542 (28.9), 543 (18.7), 544 (5.9), 415 (7.6), 416 (5.9), 417 (5.8), 
300 (16.5), 301 (5.9), 302 (30.6), 303 (8.5), 304 (16.5), 255 (6.8), 240 (25.1), 
128 (5.9), 1 15 (6.3), 102 (9.3). 
l,3-Bis(4-chlorophenyl)-3-[3-(9-decenyl)-4-amino-5-thio-l,2,4-tnazolyl]pro -
pan-l-one FTZX4A (6) and 2,4-bis(4-chlorophenyl)-7-(9-decenyl)-2,3-
dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine, FTZX4B (7) [Reaction of 
the 5-triazole (1) with 4,4'-dichlorochaIcone (5)] 
To a solution of ^-triazole (1) (500 mg, 1.96 mmol ) in dry benzene (20 
ml) was added 4,4'-diclilorochalcone (5) (540 mg, 1.96 mmol) and refluxed 
for 28 h in presence of /?-TsOH (5 mg). The progress of the reaction was 
monitored by TLC (silica gel G, pet .ether-EtOAc, 8:2 v/v) which showed the 
presence of two new spots, labelled as FTZX4A (6) and FTZX4B (7). The 
solvent was removed under reduced pressure and the residue left was 
dissolved in ethyl acetate, washed with water and the organic phase was dried 
over anhydrous Na2S04 The products on column chromatography over silica 
gel using pet. ether-EtOAc, (8:2 v/v) as eluent y ie lded FTZX4A (6) as 
colourless oily liquid, 384 mg (37.0%), Rf 0.63 (pet. e ther-EtOAc, 8:2 v/v). 
Further elution of the column using pet. e ther-EtOAc (4:6 v/v) as eluent 
yielded FTZX4B (7) as a yellow solid which was recrystal l ised f rom benzene 
as pale yellow crystalline globules, 540 mg (51.9%), m.p 148 °C, Rf 0.32 
(pet. e the r -E tOAc, 8:2 v/v) 
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S p e c t r a l da ta of FTZX^A (6) 
FTIR (Neat): v ^^^ 3178.55, 3074.26 (NH2), 2927.0 (CH) , 1689.17 (C=0), 
1639.66 (C=N) , 1590.04 (C=C) , 1571.40, 1491.79, 1426.78, 1402.11, 
1360.60, 1308.68, 1260.38, 1205.25, 1174.16, 1091.68, 1014.26, 991.38, 
961.79, 910.10, 827.98, 783.54, 723.97, 629.04, 531.33, 462 .77 cm"' 
^H-NMR ( 300 MHz, acetone-flfg): 5h 5.14 (2H, s, NH2), 6 .40 ( I H , dd, 
J = 9 . 0 8 , 5 . 5 8 , H - 3 ) , 3 . 6 0 ( I H , d d , J - 1 7 . 1 0 , 5 . 5 8 , H-2„P) , 4 . 2 0 ( I H , d d , J = 1 7 . 1 0 , 
9 . 0 8 , H-2DN), 2 . 6 8 ( 2 H , t , J = 7 . 4 6 , H - 1 " ) , 1 . 6 4 ( 2 H , b r p , J ~ 7 . 3 3 , H - 2 " ) , 1 .23 
(LOH, b r s , H - 3 " - 7 " ) , 1 . 9 8 ( 2 H , m , H - 8 " ) , 5 . 7 0 ( I H , t d d , J = 6 . 2 8 , 1 0 . 2 2 , 1 7 . 0 8 , 
H - 9 " ) , 4 . 8 8 ( I H , d d , J = 1 0 . 2 2 , 2 . 2 8 , H E - 1 0 " ) , 4 . 9 7 ( I H , d d , J = 1 7 . 0 8 , 2 . 2 8 , HZ-
1 0 " ) , 7 . 2 0 ( 2 H , d d , J = 8 . 5 5 , H - A r - 2 , 6 ) , 7 . 4 2 ( 2 H , d d , J = 8 . 5 5 , H - A r - 3 , 5 ) , 7 . 8 4 
( 2 H , d d , J = 8 . 4 2 , H - A r - 2 , 6 ) , 7 . 7 0 ( 2 H , d d , J = 8 . 4 2 , H - A r ' - 3 , 5 ) . 
E I - M S : m / z ( % ) 2 7 7 ( 1 6 . 0 ) , 2 7 8 ( 4 . 2 ) , 2 7 9 ( 9 . 2 ) , 2 8 0 ( 3 . 1 ) , 2 7 6 ( 1 3 . 3 ) , 2 7 5 
( 1 0 . 0 ) , 2 5 5 ( 2 1 . 2 ) , 2 5 6 ( 7 . 0 ) , 2 5 7 ( 3 . 1 ) , 2 4 2 ( 2 6 . 0 ) , 2 4 3 ( 8 . 9 ) , 2 2 1 ( 8 . 0 ) , 2 0 0 
( 7 . 2 ) , 1 9 6 ( 1 4 . 0 ) , 1 5 7 ( 1 0 . 0 ) , 1 4 3 ( 2 8 . 3 ) , 130 ( 6 7 . 8 ) , 1 2 8 ( 2 4 . 0 ) , 130 ( 6 7 . 8 ) , 
128 ( 2 4 . 0 ) , 1 0 3 ( 4 . 8 ) , 8 3 ( 9 . 0 ) . 
S p e c t r a l da ta of FTZX4B (7) 
' H - N M R ( 4 0 0 M H z , acetone-^/<5): 5 h 3 . 2 7 ( I H , d d , J = 1 3 . 9 1 , 12.08, H-3,p), 
3 . 6 6 ( I H , d d , J = 1 3 . 9 1 , 4 . 7 6 , H-3DN), 5 . 2 7 ( I H , d d , J = 1 2 . 0 8 , 4 . 7 6 , H - 2 ) , 2 . 8 9 
( 2 H , t , J = 7 . 5 1 , H - 1 ' ) , 1 . 8 2 ( 2 H , b r p , J ~ 7 . 4 6 , H - 2 ' ) , 1 . 2 9 ( L O H , b r s , H - 3 ' - 7 ' ) , 
2 . 0 0 ( 2 H , m , H - 8 ' ) , 5 . 7 9 ( I H , t d d , J = 6 . 7 8 , 1 0 . 2 9 , 1 7 . 2 1 , H - 9 ' ) , 4 . 8 9 ( I H , d d , 
J = 1 0 . 2 6 , 2 . 2 0 , H E - 1 0 ' ) , 4 . 9 7 ( I H , d d , J = 1 7 . 2 1 , 2 . 2 0 , H z - 1 0 ' ) , 8 . 1 9 ( 2 H , d, 
J = 8 . 7 9 , H - A r ' - 2 , 6 ) , 7 . 6 1 ( 2 H , d , J = 8 . 7 9 , H - A r ' - 3 , 5 ) , 7 . 4 1 ( 2 H , d , J = 8 . 6 1 , H -
A r " - 2 , 6 ) , 7 . 5 6 ( 2 H , d, J = 8 . 6 1 , H - A r " - 3 , 5 ) . 
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' ^C -NMR (100 MHz, acetone-rfe): 6c 156.09 (C-9), 170.18 (C-7), 143.05 (C-
4), 38.42 (C-3), 53.72 (C-2), 25.55 (C-T), 27.36 (C-2'), 29.20-30.40 (C-3'-7'), 
34.42 (C-8'), 139.83 (C-9'), 114.63 (C-10'), 130.44 (C-Ar '-2,6) , 129.67 (C-
Ar'-3. 5), 130.03 (C-Ar"-2,6), 129.39 (C-Ar"-3,5), 142.31 (C-Ar"-1), 134.24 
(C-Ar ' - l ) , 138.81 (C-Ar'-4), 134.39 (C-Ar"-4). 
D C I - M S (NH3): m/z (%) 512 ( M ^ 6.2), 513 [ ( M + l ) ^ 100.0], 514 (40.7), 515 
(72.1), 516 (25.2), 517 (18.2), 518 (5.4), 273 (3.9), 274 (23.7). 275 (7.4). 276 
(54.3), 277 (12.6), 278 (27.8), 279 (6.7), 280 (6.8), 238 (3.9). 239 (3.7). 240 
(28.6), 241 (7.4), 242 (5.7), 128 (5.1), 1 15 (7.9), 1 17 (5.1), 102 (9.0), 93 
(6.4). 
l,3-Bis(2-thienyl)-3-l3-(9-decenyl)-4-amino-5-thio-l,2,4-triazolyl]propan-l-
one FTCA (9) [Reaction of the s-triazole (1) with l ,3-bis(2-thienyl) 
propen- l -one (8)]* 
*[This reaction failed to yield the desired product 2,4-bis(2-thienyl)-7-(9-
decenyl)-2,3-dihydro-l ,2,4-triazolo[3,4-b] [1,3,4]thiadiazepine]. 
A mixture of the 1,2,4-triazole (1) (500 mg, 1.96 mmol) and l ,3-bis(2-
th ienyl )propen- l -one (20) (432 mg, 1.96 mmol) in dry benzene (20 ml) was 
ref luxed for 28 h in presence of catalytic amount of p - T s O H (5 mg). The 
reaction mixture on TLC examination (silica gel G, pet .e ther-EtOAc, 8:2 v/v) 
showed the presence of only one spot even by prolonging the reaction. The 
products on column chromatography (silica gel, pet. e ther-EtOAc, 8:2 v/v) 
afforded FTCA aa pale yellow oily liquid, 640 mg (68.6%), Rt 0.69 (pet. 
ether-EtOAc, 8:2 v/v). 
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Spectral data of FTCA (9) 
^H-NMR (400 MHz, acetone-^/^): 5h 5.21 (2H, s, NH2), 6 .79 ( I H , dd, J=9.01, 
5 . 8 0 , H - 3 ) , 3 . 8 2 ( I H , d d , J = 1 6 . 9 4 , 5 . 8 0 , H - 2 ) , 4 . 2 5 ( I H , d d , J = 1 6 . 9 4 , 9 . 0 1 , H -
2) , 2 . 7 1 ( I H , t, J = 7 . 4 7 , H - L " ) , 1 . 6 8 ( 2 H , b r p , J ~ 7 . 3 2 , H - 2 " ) , 1 . 2 8 (LOH, b r s, 
H - 3 " - 7 " ) , 2 . 0 2 ( 2 H , m , H - 8 " ) , 5 . 8 1 ( I H , t d d , J - 6 . 7 2 , 1 0 . 2 3 , 1 7 . 0 9 , H - 9 " ) , 4 . 9 1 
( I H , d d , J = 1 0 . 2 2 , 2 . 2 9 . H E - 1 0 " ) , 4 . 9 9 ( I H , d d , J = 1 7 . 2 4 , 2 . 2 9 , H ^ - I O " ) , 7 . 9 0 
( I H , d d , J = 4 . 8 9 , 1 . 2 2 , H - A r ' - 5 ) , 7 . 2 4 ( I H , d d , J = 4 . 8 8 , 3 . 8 1 H - A r ' - 3 ) . 8 . 0 3 
( I H , d d , J = 3 . 8 1 . 1 . 2 2 , H - A r ' - 3 ) 7 . 2 2 ( I H , d d , J = 3 . 5 1 , 1 . 2 2 . H - A r - 5 ) 6 . 9 7 ( I H . 
d d , J = 5 . 0 3 , 3 . 5 1 , H - A r - 4 ) , 7 . 3 6 ( I H , d d , J = 5 . 0 3 , 1 . 2 2 , H - A r - 3 ) . 
'^C-NMR (100 MHz, acetone-rf^): 5c 152.51 (C-3'), 167.48 (C-5'), 54.03 (C-3). 
44.25 (C-2), 189.06 (C-1), 25.18 (C- l" ) , 26.6 (C-2"), 29.20-30.40 (C-3"-7"), 
34.45 (C-8"), 139.89 (C-9") 114.64 (C-10"), 126.30-144.78 (Ar + Ar') . 
D C I - M S (NH3): m/z (%) 475 ( M ^ 12.5), 476 (4.4), 254 (6.8), 255 (67.1), 256 
(11.9). 257 (4.1), 220 (11.5), 221 (100.0), 222 (15.3), 223 (1 1.3), 137 (3.6), 130 
(5.7). I l l (32.0). 
1,11 11 






The work included in this chapter deals with the reaction of 4-amino-3-(9-
decenyl)-5-mercapto-l,2,4-triazole (1 ) with : 
i) E-3-(4-Chlorobenzylidene)-4'-chloroflavanone (10) which yielded an 
adduct, 2-(4-chlorophenyl)-3-[4-amino-2-(9-decenyl)-5-(4-chlorobenzyl-
thio)-! ,2,4-triazolyl]-2,3-dihydro-4-benzopyrone (11) and a novel 
compoundj2,3-bis(4-chlorophenyl)-1 l-(9-decenyl)-2a, 3-dihydro[l]benzo-
pyranof3,4-e]-2,2a-dihydro-l,2,4-triazolo[3,4-b][1,3.4Jthiadiazepine (12). 
ii) E-3-Benzylidene flavanone (13) which afforded an adduct 2-(phenyl)-3-
[4-amino-3-(9-decenyl)-5-(benzylthio)-1,2,4-triazolyl]-2.3-dihydr0'4-hen-
zopyrone (14) and an analogous new compound, 2.3-bis(phenyl)-J I-(9-
decenyl)-2a,3-dihydro[I]benzopyrano[3,4-e]-2.2a-dihydro-l.2.4-lriazuh) 
[3,4-b][},3.4]thiadiazepine (15) 
I N T R O D U C T I O N 
As part of our programme in search of biologically active compounds 
with sulphur and nitrogen containing heterocycles, we have synthesised two 
novel compounds, 2-(4-chlorophenyl)-4-[2-(4-chlorophenyl)ethenyl]-7-(9-
decenyl)-2 ,3-dihydro- l ,2 ,4- t r iazolo[3,4-b][ l ,3 ,4] thiadiazepine (4) and 2.4-
bis(4-chlorophenyl)-7-(9-decenyl)-2,3-dihydro-l ,2 ,4-tr iazolo[3.4-bJ[1.3.4]thi-
adiazepine (7) by the reaction of 3-(9-decenyl)-4-amino-5-mercapto-1,2,4-
triazole (1) with l ,5-bis(4-chlorophenyl)pent- l ,4-dien-3-one and 4,4'-
dichlorochalcone (described in Chapter 1). In continuation of the above 
mentioned work, we extended our work on the reaction with exocyclic 
^./^-unsaturated enone systems and synthesised two novel compounds, (i) 2,3-
bis(4-chlorophenyl)- l l - (9-decenyl) -2a ,3-dihydro[ l ]benzopyrano[3,4-e]-2 ,2a-
7 0 
dihydro-l ,2 ,4- t r iazolo[3,4-b][ l ,3 ,4] thiadiazepine (12) and (ii) 2,3-bis(phenyl) 
-1 l - (9-decenyl)-2a,3-dihydro[ l ]benzopyrano[3,4-e]-2 ,2a-dihydro- l ,2 ,4- t r iaz-
olo[3,4-b][ l ,3 ,4] thiadiazepine (15) by the reaction of 4-amino-3-(9-decenyl)-
5-mercapto- l ,2 ,4- t r iazole (1) with (i) £ '-3-(4-chlorobenzylidene)-4 '-chloro-
f lavanone (10) and (ii) £-3-benzyl idene f lavanone (13) in dry benzene using 
p - T s O H as catalyst. An adduct, 2-(4-chIorophenyI)-3-[3-(9-decenyl)-4-amino-
5-(4-chlorobenzyl thio)- l ,2 ,4- t r iazolyl]-2,3-dihydro-4-benzopyrone (11) in the 
former and 2-(phenyi)-3-[3-(9-decenyl)-4-amino-5-(benzylthio)-1,2,4-
tr iazolyl]-2,3-dihydro-4-benzopyrone (14) in the latter was also obtained in 
good yields. £'-3-Benzylidene flavanones have been prepared by the reported 
procedure^^ and their stereochemistry discussed. 
3-Benzylidene flavanones, often formed as co-products during the 
preparat ion of flavanones or chalcones^° have structural similarities with 
natural homo isoflavonoids, Eucomin and Eucomol isolated f rom Eucomis 
bicolor (Liliaceae)^' and they have been the focuss of attention for their 
methods of preparation and stereochemical implications during the past few 
years^^. Although the reactions of various substi tuted/unsubsti tuted 
benzyl idene f lavanones with 2-aminobenzenethiols to form the corresponding 
1,5-benzothiazepine have been described^^'^'', no report on the reaction of 
benzyl idene f lavanones with 4-amino-5-mercapto- l ,2 ,4- t r iazoles has 
appeared in the literature. 
Structural assignment, stereochemistry and biological assay are 
discussed. Screening results of the compound (12) is summarised for 
anticancer activity against 3-cell lines of three types of human cancers: lung, 
breast and CNS (details in Chapter 6). 
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4 .R ' 
O H 
(10) , (13) 
(11), (14) 
(12) , (15) 
(10) , (11) , ( 1 2 ) : R = R ' = CI 
(13) , (14) , ( 1 5 ) : R = R ' = H 
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R E S U L T S A N D D I S C U S S I O N 
£-3-Benzyl idene flavanones, AF2 (10) and AFj (13) were first prepared 
fol lowing the literature procedure '^ and their structures alongwith the 
stereochemistry determined by IR, 'H-NMR and '^C-NMR spectra. IR spectra 
(KBr) showed characterist ic bands corresponding to ( C = 0 ) , (C=C, phenyl) 
and (C-O-C). The ' H - N M R and '^C-NMR spectral signals were assigned on 
the basis of chemical shif t values, coupling constants and by comparison with 
the spectral data reported in the literature^^. The absorpt ion of the vinyl 
proton (H-y^ (H-1'") at very low field, 5 8.09/8.03 indicated that it is due to 
deshielding effect arising from the diamagnetic anisotropy of the carbonyl 
group (being in close proximity) which is consistent with the trans 
configuration^^ (£ - fo rm) (H cis and Ph trans to the carbonyl group) (in the 
cis isomer, the vinyl proton appears at 5 6.65^^). Thus, benzylidene 
f lavanones here exhibit ^-conf igurat ion. The conf igura t ion at C-2 was 
decided by the inspection of models. Models showed that ^ -S-benzyl idene 
f lavanones adopt strainless stable conformation only, when the 2-Ph is axial 
and 2-H equatorial as the 2-Ph equatorial in another possible conformer 
nearly overlaps with ^ - P - P h causing severe non-bonded interaction. Such an 
interaction is not present in the former conformer. It is well known that in 
cyclohexanes and other related compounds, a large group normal ly adopts the 
equatorial position to avoid 1,3-diaxial interaction. However , in our case, 
there are no such axial groups to interact with an axial 2-Ph group. The 
preferred conformat ion of £'-3 benzylidene f lavanones (10a and 13a) would 
therefore, be (10b and 13b). 
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lOa. R=R' = C1 
13a. R = R' = H 
10b. R=R' = C1 
13b. R=R' = H 
The title compounds FF2C (12) and FTZX5 (15) were then synthesised 
by ref luxing 4-amino-3-(9-decenyl)-5-mercapto- l ,2 ,4- t r iazole FTZ (1) with 
£ '-3-(4-chIorobenzylidene)-4 '-chloroflavanone AF2 (10) and £-3-benzyl idene 
f lavanone AFi (13) in dry benzene using />-TsOH as catalyst. In above 
reaction, a Michael adduct FF2A (11)/ FFjA (14) was also obtained in good 
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(10) R = R' = C1 
(13) R = R' = H 
Molar ratio (1:1) 
Dry benzene 
Reflux 38/32 h 
(11) R = R' = C1 
(14) R = R' = H 
N N 
(12) R = R ' - C 1 




2,2a-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine FF2C (12) alongwith 
the adduct, 2-(4-chlorophenyl)-3-[4-amino-3-(9-decenyl)-5-(4-chlorobenzyl-
thio)-l,2,4-triazolyl]-2,3-dihydro-4-benzopyrone FF2A (11). [Reaction of the 
5-triazole FTZ (1) with £'-3-(4-chlorobenzyIidene)-4'-chloroflavanone AF2 (10)] 
A solut ion of the 1,2,4-triazole (1) and £ ' -3- (4-chlorobenzyl idene)-4 ' -
ch lo ro f lavanone (10) (molar ratio, 1:1) in dry benzene was re f luxed for 38 h 
in the presence of a catalyt ic amount o f /7 -TsOH, moni to r ing the progress of 
the react ion by TLC. The react ion mixture revealed the p resence of two spots, 
labelled as FF2A (11) and FF2C (12). The res idue left a f te r usual work up 
was chromatographed over a silica gel column using pet. e ther -EtOAc, (7:3 
v/v) as eluent . Elut ion first y ie lded a colourless glassy f lakes , FF2A (40.5%). 
Further e lut ion of the column using pet. e ther -EtOAc, (1:1 v/v) y ie lded a pale 
yel low solid, FF2C which was recrystal l ised (pe t . e the r -E tOAc) as white 
crystal l ine needles in 44 .72% yield. 
N N 
N H 2 
F T Z (1) Dry benzene//?-TsOH AF2(10) 
Reflux 38h 
F F 2 A ( 1 1 ) F F 2 C ( 1 2 ) 
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Structure Eluc idat ion of FF7A (11) 
It was a colourless glassy flakes, m.p 93 °C. The structure of FF2A has 
been established by DCI-MS, 'H-NMR, and '^C-NMR spectra. The DCI-MS 
spectrum (Fig. 6a) displayed a set of [M+1]"^ peaks at m/z 635/637/639 
showing its molecular weight 634/636/638 [C34H36N4O2SCI2], which is equal 
to the sum of the molecular weights of the 1,2,4-triazole (1) (254) and £-3-(4-
ch]orobenzylidene)-4 ' -chloroflavanone (10) (380). This suggested that FF2A 
is an adduct of the two compounds. The retro-Michael addit ion fragment ion 
peaks were observed at m/z 255 [(M+l)-C22Hi4Cl202]^ as the base peak and 
at m/z 381/383/385 [(M+l)-Ci2H22N4S]^. The retro-Diels Alder f ragment ions 
were formed at m/z 121 and m/z 259/261/263. The f ragment ion peaks at m/z 
130 and 143 were arised by the cleavage on the long alkyl side chain at and 
/-posit ionsto the triazole ring as shown in Chart 6. 
All the signals in 'H-NMR and '^C-NMR spectra (Fig. 6b and 6c) were 
assigned to individual H and C-atoms (Table 7) on the basis of 5 values, 
mult ipl ici ty and by comparison with the previously established structures of 
similar adducts. The absence of vinylic proton (H- l ' " ) signal at 5 8.03 and 
thiol proton signal at 5 12.25 and the appearance of new signals at 5 5.65 as 
doublet for H - l ' " and 5 6.42 also as doublet for H-2 in the ' H - N M R spectrum 
of FF2A suggested the addition of thiol group to C=C double bond of the 
enone systems of £-3-benzyl idene flavanone. This is also supported by the 
shifts of the vinylic carbons at 5 138.28 (C- l" ' ) and 133.28 (C-3) to higher 
fields 5 60.01 and 5 79.04. The other 'H- and '^C-NMR signals were found 
almost identical to that of £'-3-benzylidene f lavanone and tr iazole moieties. 
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N-^  "SH 
NH2 
m/z 143(6.0) 
m/z 255 (100.0) 
P-cleavage 
H 
N N • 
i 1] 
^ N - ^ S H 
NH2 
m/z 130 (9.4) 
m/z 381/383/385 (22.6/14.7/3.2) 
retro-Diels Alder fission 
m/z 121 (12.4) 
m/z 259/261/263 (14.3/6.8) 
CHART 6 
The large coupl ing constants of C-2 and C-3 pro tons of f l avanone 
moiety (JH-2»H-3 11-14) conf i rmed that the two ad jacen t hydrogen a toms are in 
axial disposi t ion. This showed that the proton of thiol g roup has been added 
s tereoselect ively to C-3 of C=C bond f rom the axial s ide. A plausible 
explanat ion may be of fe red for this s tereoselect ivi ty . The addi t ion of thiol 
group of (1) to the exocycl ic a,y^-unsaturated carbonyl sys tem of E-3-{4-
chlorobenzyl idene) -4 ' -ch lorof lavanone (10) fo l lowing nuc leoph i l i c path '^ 
( S c h e m e 3) leads to the fo rmat ion of a s tereoselect ive t rans adduct probably 
8 2 
by in t ramolecular proton t ransfer of the 1,4-addition moie ty f rom the axial 
side at C-3, assuming the bigger group adopts equatorial pos i t ion . Thus, the 
conf igura t ions , of all the three s tereocentres (C-2, C-3 and C - l ' " ) could be 
settled f rom the coupl ing constants of protons at C-2, 6 6.42 ( I H , d, 
J2ax,3axl l . l4) , C-3, 5 4.37 ( I H , dd, J3ax,23x11-14, J3ax ,1'" 2 .75) and C - l ' " , 5 
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Structure Elucidat ion of FF^C (12) 
It was a white needle shaped crystalline solid, m.p 182 °C. The 
structure of FFjC has been established by DCI-MS, ' H - N M R and '^C-NMR 
spectra. The DCI-MS spectrum (Fig. 7a) showed a set of [M+1]"^ peaks as the 
base peak at m/z 617/619/621 confirming its molecular weight 616/618/620 
[ C 3 4 H 3 4 N 4 O S C I 2 ] which is equal to the molecular weight of (11) 
(634/636/638) minus one molecule of water. This indicated that 
cyclocondensat ion has occurred between the amino group of t r iazole moiety 
and carbonyl group of benzopyrone moiety forming th iadiazepine ring. The 
peak at m/z 492/494 was obtained by the cleavage on 9-decenyl side chain at 
the y^-position to the 5-triazole ring. The peaks at m/z 380/382/384 [(M+1)-
C,2H2iN3S]^ and at m/z 240 [M-C25HigN4SCl2]^ are the diagnost ic f ragment 
ion peaks arised by the cleavage of 3-4 and 1-7 bonds of thiadiazepine ring 
as shown in Chart 7. 
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[M+1 ]m/z 61 lie 19/621 (100.0/82.9/22.4) 
1-7 and 3-4 cleavage m/z 492/494 (5.4/4.8) 
iWz 240 (4.3) 
m/z 380/382/384 (23 4/14 2/4 4) 
CHART 7 
All the signals in ' H - N M R and '^C-NMR spectra (Fig. 7b and 7c) have 
been ass igned (Table 8) on the basis of 5 and J va lues and also by 
compar ison with the spectra of ( l l ) ( T a b l e 7). The absence of signals 
cor responding to amino protons at 5 5.22 and carbonyl g roup at 6 189.69 in 
the spectra of FF2C and in place, the appearance of C-4 signal at higher 
f ields, 5 156.24 (C-8b) in ' ^C-NMR spectrum is s trongly in agreement with 
the fo rmat ion of a thiadiazepine ring by the cyclocondensation of NH2 group with 
the carbonyl group. The chemical shifts of H- and C-atoms generally go to higher 
fields in the formation of the ring. The same trend was observed in this case also. 
The shifts of C-2 and C-3 protons to higher fields from 5 6.42 to 5 5.90 and from 
6 4.37 to 5 4.14 in the 'H-NMR spectrum and also from 6 79.04 to 6 76.98 and 6 
55.08 to 5 45.22 in '^C-NMR spectrum showed that these positions are 
8 6 
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involved in ring formation. Also the shift of carbonyl group f rom 5 189.69 to 
6 156.24 confirmed that intramolecular cyclocondensat ion has occurred 
between the NH2 group of triazole and > C = 0 group of pyrone forming 
thiadiazepine ring. The other signals corresponding to tr iazole and 
benzopyrone moieties appeared as in (11). 
On the basis of above spectral evidence, FF2C was character ised as 
2,3-bis(4-chlorophenyl)-l l-(9-decenyl)-2a,3-dihydro[l]benzopyrano[3,4-e]-
2, 2a-dihydro-l, 2,4-triazolo[3,4-b][ 1,3,4]thiadiazepine (12). 
FF2C (12) 
Mechanism of the formation of FF,A (11) and FF^C (12) 
The reaction occurred via nucleophilic attack of thiol group to the 
vinyl carbon of 3-benzylidene flavanone which resulted in the format ion of 
Michael adduct (11). This was followed by int ramolecular dehydrat ive 
cyclocondensat ion between the amino group and the carbonyl group forming 















triazolo-2,2a-dihydro[3,4-b][l,3,4]ihiadiazepine FTZXg (15) along with the 
adduct, 2-(phenyl)-3-[4-amino-3-(9-decenyl)-5-(benzylthio)-l,2,4-triazolyl]-
2,3-dihydro-4-benzopyrone FFjA (14) [Reaction of the s - t r iazo ie (1) with 
E-3-ben2yl idene f lavanone (13)] 
A solut ion of 1,2,4-triazole (1) and ^ - S - b e n z y l i d e n e f l avanone (13) 
(molar ratio, 1:1) in dry benzene was re f luxed for 35 h in presence of a 
catalyt ic amount of / )-TsOH. The products on pur i f i ca t ion by column 
chromatography (sil ica gel, pet. e ther-EtOAc, 8:2 v/v) a f f o r d e d F F , A (14) 
(39 .10%) as pale yel low oily liquid. Further e lut ion of the c o l u m n (pet. ether-
EtOAc. 7:3 v/v) gave white solid mass which on recrys ta l l i sa t ion (benzene-




F T Z (1) 
O (13) 
(i) /7-TsOH/dry benzene 
Reflux 35 h 
FF,A(14) FTZX5 (15) 
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Structure Elucidat ion of FFjiA (14) 
It was a pale yellow oily liquid. The structure of F F i A has been 
established by FTIR, EI-MS and 'H-NMR spectra. The FTIR spectrum 
displayed characteristic signals at 3402.9 (NH), 2927.0 (CH), 1694.5 (C=0) , 
1630.8 (C=C), 1607.2 (C=N), 1578.0 (phenyl) and 1495.1 (C-S) cm"'. 
EI-MS spectrum of F F i A showed a [M+l]"" peak at m/z 567 confirming its 
molecular weight 566 [C35 H38N4O2S], which is equal to the sum of the 
molecular weights of the 5-triazole (1) (254) and £-3-benzyl idene f lavanone 
(13) (312). This indicated the Michael addition of thiol group to the 
or,/?-unsaturated exocyclic system of £-3-benzyl idene f lavanone. The 
fragmentat ion pattern was found to be similar to that of FF2A (11). The 
characterist ic retro-Michael addition fragment ion peaks were observed at 
m/z 313 [M-C25H2oN4S]^ and m/z 255 [M-CnHj iN jS ] " . It also showed the 
retro-Diels Alder fragment ions at m/z 191 and m/z 121 in addition to the 
common ion peaks as in (11) at m/z 255,143 and 130 as shown in Chart 8. 
The 'H-NMR signals (Fig. 8) have been assigned (Table 9) to 
individual hydrogen atoms by comparing with the spectra of a previously 
described compound (11) (Table 7). The absence of signals corresponding to 
thiol proton at 6 12.25 of the triazole and the vinyl proton of the £ -3 -
benzyl idene f lavanone at 5 8.09 and appearance of this proton as doublet at 
higher f ield 5 5.52 confirmed the addition of thiol group to a,/?-unsaturated 
exocyclic system of £'-3-benzylidene f lavanone. As in (11), the large coupling 
constants of protons at C-2 and C-3 positions (12,3 11.40) revealed that the 
hydrogen atoms are oriented at the axial disposition. In addit ion, the signals 
9 3 
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corresponding to i^-S-benzylidene f lavanone and tr iazole moiet ies also 







m/z 255 (100.0) 





N N I 11 
^ N - ^ S H 
NH2 
m/z 130(12.5) 
m/z567( 7.2)[ M+V 
retro-Michael 
addition 




m/z 121 (13.3) 
m/z 193 (12.2) 
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NH2 5.02 2H s 
1"' 5.52 IH d J,... 3 1.80 
2 6.38 IH d J2,3 11.40 
3 4.38 IH dd h a 11-40,13.9 1-80 
5 7.38 IH dd J5,6 7.80, J w 1-65 
6 6.95 IH dd J6,7 7.80, J6 5 7.50 
7 7.55 IH dd J7,e7.50J7 8 7.20 
8 7.16 IH dd Jg,7 7.20, J8 6 1.09 
1" 2.76 2H t J i " , 2 " 7 . 2 0 
2" 1.73 2H br p J « 7 . 1 8 
3"-7" 1.22 5x2H br s 
8" 1.99 2H m 
9" 5.79 IH tdd J9..8.. 6.68, J9",he 10.20. Jg-.Hz 17.06 
He-10" 4.92 IH dd J h e , 9 " 10.20, Jhe. h z 2.29 
Hz-10" 4.95 IH dd J h z , 9 " 17.06, J h z , . i e 2.29 
Ar'+Ar" 7.17-7.29 2x5H m 




Structure Elucidation of FTZX^dS) 
It was a needle shaped white crystalline solid, m.p 167 °C. The 
structure of FTZXg has been fully established by IR, DCI-MS, 'H-NMR, 
'^C-NMR and further by COSY and HETCOR spectra. IR spectrum displayed 
characterist ic absorption bands at 2900 (CH), 1630 (C=C), 1600 (phenyl), 
1580 ( C - N ) and 1450 (S-C) cm"'. The DCI-MS spectrum displayed a [M+1]" 
peak as the base peak at m/z 549 showing its molecular weight 548 
[C34H36N4OS], which is equal to the molecular weight of (14) (566) minus 
one molecule of water, indicating the formation of thiadiazepine ring by the 
intramolecular cyclocondensat ion between the NH2 and > C = 0 groups of (14). 
A less intense peak at m/z 424 [M-CgHp]"^' was obtained by the y9-cleavage 
on the 9-decenyl side chain to the triazole ring. The peaks at m/z 310 [m/z 
424-C2|H,6N0]^ and m/z 115 [m/z 424-C3H5N3S]^-, arised by the cleavage of 
1-7 and 3-4-bonds are the diagnostic peaks of the thiadiazepine r ing obtained 
by f ragment ing the ions at m/z 424. The retro-Diels Alder f ragment ion peaks 
were observed at m/z 191 and m/z 121 as shown in Chart 9. 
All the signals in 'H-NMR and '^C-NMR spectra (Fig. 9a and 9b) were 
assigned to individual H and C atoms (Tables 10a and 10b) on the basis of 
chemical shifts , multiplicity, relative integrations and by compar ison with the 
spectra of a previously established compound FF2C (12) (Table 8). The 
absence of the signals corresponding to NH2 protons at 5 5.02 and carbonyl 
carbon at 5 189.69 in the 'H- and '^C-NMR spectra and the appearance of C-4 
signal at higher field 5 156.09 indicated that the intramolecular 
cyclocondensat ion between the two groups has occurred, forming the 
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Table 10b: ^^C-NMR and HETCOR data of FTZXj (15) 




8a 119.03 H-8 
8 125.88 H-7 
7 122.40 H-6 
6 136.00 H-5 
5 118.59 
4a 144.45 H-3 
3 77.47 
2a 45.36 H-2 
2 60.35 
r 25.45 H - r 
2' 27.67 H-2' 
y-7 29.20-30.40 H-3' - T 




Ar'-2,6 130.11 H-Ar'-2,6 
Ar'-3,5 128.72 H-Ar'-3,5 
Ar'-4 129.85 H-Ar'-4 
Ar" 126.72-128.86 Ar" 
' Assignment may be interchanged 
i n i 
f ields f rom 6 6.38 to 5 5.83 and f rom 5 4.38 to 6 4 .07 in the 'H -NMR 
spect rum conf i rmed the format ion of the ring. The other s ignals appeared as 
in the adduct (14). Also in '^C-NMR spectrum, the s ignals appeared were 
ass igned as 5 157.47 (C-11), 156.09 (C-8b), 77.47 (C-3), 45 .36 (C-2a) , 60.35 
(C-2) and 164.43 (C-13a) in addit ion to the signals of a romat ic carbons and 
9-decenyl s ide chain as shown in Table 10b. 
H 
\ 
N N N N 
^ ^ ^ ^ P-cleavage^ N ^ . 
[ M + l f m / z 549 (100.0) m/z 494 (8.7) 






m/z 115 (16.0) 
m/z 310 (11.8) 
retro-Diels Alder fission 
m/z 121 (5.5) 
m/z 193 (6.0) 
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The ass ignments of ' H - N M R and '^C-NMR signals (Tables 10a and 
10b) and the coupl ing of the protons were fur ther con f i rmed by a ' H - ' H 
COSY and a H E T C O R spectra. In ' H - ' H C O S Y spec t rum (Fig. 9c), the 
double doublet at 5 7.06 (J=8.16, 8.42, H-7) showed two cross peaks each 
with a double doublet at 8 7.41 ( J - 8 . 4 2 , 8.24, H-6) and 5 8.16 (J=8.16, 1.65, 
H-8) indicat ing the coupl ing of H-7 proton wi th both H-6 and H-8 protons. 
Similar ly, the signal at 5 7.41 (H-6) showed two cross peak mult iple ts at 
5 7.06 (H-7) and 5 6.54 (J=8.42, 1.10, H-5) , indicat ing the coupl ing of H-6 
proton with both H-5 and H-7 protons . The double doublet at 5 4 .07 (J=5.86. 
1.10. H-2a) showed a cross peak with the signals at 5 5.83. 5.87 (H-3. H-2), 
indicat ing the coupling between them. The signals for the terminal olefenic 
methylene protons appeared as two double double ts at 5 4 .90 (J= 10.26. 2.20, 
HE-10') and 5 4.98 (J=17.22, 2.20, H^-10') which were found to be coupled 
with each other and also with the ad jacen t meth ine p ro ton at 6 5.80. The 
signals appeared as triplet double doublet at 5 5.80 (J=6.70 , 10.26, 17.22) 
were due to the coupl ing of the methine proton (CH-, H-9 ' ) with the protons 
at H-8' and HE-10', H^-IO'. In addit ion, COSY spect rum also showed the cross 
peaks cor responding to the other s ignals of 9-decenyl side chain and aromatic 
protons (Table 10a). 
In H E T C O R spectrum (Fig . 9d , T a b l e 10b) the ' H - N M R signal at 
5h 8.16 (H-8) is correlated to 6c 125.88 (C-8) , 5h 7.06 (H-7) to 8c 122.40 
(C-7), 8h 7.41 (H-6) to 8c 136.0 (C-6), 8h 6 .54 (H-5) to 8c 118.59 (C-5), 8h 
5.83 (H-3) to 8c 77.47 (C-3) and 8h 5.87 (H-2) to 8c 60.35 (C-2) . In addition, 
it also showed the cross correlat ion peaks of 9-decenyl s ide chain and the 
aromat ic rings. 
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1 0 7 
On the basis of the above discussion, F T Z X 5 was characterised as 2,3-
bis(phenyl)-l l-(9-decenyl)-2a, 3-dihydro[ 1 JbenzopyranofS, 4-e]-2,2a-dihydro 
-1,2,4-triazolo[3,4-b][ 1,3,4]thiadiazepine (15) 
F T Z X 5 (15) 

1 0 8 
EXPERIMENTAL 
4-Amino-3-(9-decenyl)-5-mercapto-l,2,4-triazole (1) was prepared 
following a literature procedure and spectral studies performed as described in 
Chapter 1. 
E-3-(4-Chlorobenzylidene)-4'-chloroflavanone AF2 (10). 
It was prepared according to a published procedure^^ To a mixture of 
2-hydroxyacetophenone (2.0 g, 0.0147 mol) and jf?-chlorobenzaldehyde (6.0 g, 
0.0441 mol), a warm solution (45 °C) of KOH (15%) in aqueous-methanol 
(1:1) was gradually added with stirring. A clear solution resulted in after the 
addition of 23 ml of this solution. Turbidity was removed by adding 1 ml of 
methanol on cooling to room temperature. The reaction mixture was then kept 
s toppered for 4 days with occasional shaking. The solid mass appeared was 
filtered and washed with excess of water fol lowed by 10 ml of alcohol. It was 
then recrystal l ised from chloroform-acetone to give AF2 (10) as yellow 
crystall ine needles, 3.40 g (61%), m.p. 224-226 °C, Rf 0.66 (pet. ether-
benzene, 8:2 v/v). 
Spectral data of AF7 (10) 
IR (KBr): v^ax 2850 (C-H), 1665 ( > C = 0 ) , 1605, 1550 (C=C, phenyl) , 1130, 
( C - O - C ) , 1095, 1080, 1005, 950, 905, 875, 845, 805, 740 cm"'. 
' H - N M R (400 MHz, CDCI3): 6h 6.52 ( IH, s, H-2), 8.03 ( I H , s, H-1'"), 7.85 
( IH , dd, J = 7.93, 1.68, H-5), 6.98 ( IH, ddd, J= 7.93, 7.17, 168, H-6), 7.43 
( IH , ddd, , J= 7.17, 8.39, 1.68, H-7), 6.95 ( IH , dd, J = 8.39, 1.68, H-8), 7.24-
7.48 (8H, br m, H-Ar '+H-Ar") . 
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'^C-NMR (CDCI3, 75 MHz,): 5c 76.86 (C-2), 133.28 (C-3), 182.08 (C-4), 
138.28 (C-1'"), 122.65 (C-4a), 127.64 (C-Ar-5), 122.10 (C-Ar-6), 136.33 (C-
Ar-7), 118.58 (C-Ar-8), 121.92 (C-8a), 129.16 (C-Ar'-2,6), 131.05 (C-Ar'-
3,5), 128.93 (C-Ar"-2,6), 129.21 (C-Ar"-3,5), 132.37 (C-Ar '-4) , 132.25 (C-
Ar"-4), 136.30 (C-Ar ' - l ) , 134.86 (C-Ar"-1). 
E-3-Benzylidene flavanone AFJ (13) 
To a mixture of 2-hydroxyacetophenone (5.0 g, 0.0367 mol) and 
benzaldehyde (11.70 g, 0.1103 mol), a warm solution (45 °C) of KOH (15%) 
in aqueous-methanol (1:1) was gradually added with stirring. A clear solution 
resulted in after the addition of 44 ml of this solution. On cooling to room 
temperature the reaction mixture became turbid and 1.5 ml of methanol was 
added to remove the turbidity. The reaction mixture was then kept at room 
temperature. After Ca 3-4 h, an oily liquid began to deposit at the bottom and 
the reaction mixture gradually turned into dark green. The reaction mixture 
was then kept stoppered for 5 days with occasional shaking. The progress of 
reaction was closely monitored by TLC (silica gel G, pet. ether-benzene, 8:2 
v/v). The liquid that separated was changed into a semi solid mass, which 
showed a mixture of three components (TLC). The reaction mixture was then 
extracted with ethyl acetate, washed successively with water to make the 
solution neutral and dried over anhydrous sodium sulphate overnight. The 
solvent was then distilled off under reduced pressure. The product obtained 
was separated and purified by column chromatography (silica gel, pet. ether-
benzene, 8:2 v/v) to give a greenish yellow mass which on crystallisation 
(pet. ether-chloroform) yielded £'-3-benzylidene f lavanone (13), 8.0 g (67%), 
m.p 104-106 °C, Rf 0.73 (pet. ether-benzene, 8:2 v/v).The other two 
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components, corresponding to chalcone and flavanone were also obtained in 
very low yields on further elution of the column. 
Spectral data of AFj^  (13) 
IR (KBr): Vn,ax 2900 (C-H), 1710 (>C=0) , 1625, 1590 (C=C, phenyl), 1110 
( C - O - C ) , 1005, 940, 860, 805, 720 cm-'. 
'H-NMR (400 MHz, CDCI3,):5h 6.65 ( IH, s, H-2), 8.09 ( IH , s, H-1'"), 7.92 
( IH. dd, J = 8.24, 1.83, H-Ar-5), 6.95 ( IH, ddd, J=8.24, 7.14, 1.10, H-Ar-6). 
7.47 ( IH, ddd, J=7.14, 7.33, 1.83, H-Ar-7), 6.92 ( IH, dd, J=7.33, 1.10. H-Ar-
8), 7.02-7.43 (lOH, br m, H-Ar' + H-Ar"). 
'^C-NMR (100 MHz, CDCI3): 5c 77.69 (C-2), 133.28 (C-3). 182.65 (C-4). 
l21.63(C-4a), 126.17 (C-Ar-5), 121.75 (C-Ar-6), 136.05 (C-Ar-7), 118.65 (C-
Ar-8). 158.97 (C-8a), 139.32 (C-1'"), 128.63 (C-Ar'-2,6) 129.94 (C-Ar'-3.5), 
127.64 (C-Ar"-2,6), 128.85 (C-Ar"-3,5), 129.70 (C-Ar'-4), 128.63 (C-Ar"-4), 
138.18 (C-Ar ' - l ) , 134.17 (C-Ar"-1). 
2,3-Bis(4-chlorophenyl)-ll-(9-decenyl)-2a,3-dihydro[l]benzopyrano[3,4-e]-
2,2a-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine FF2C (12) alongwith 
the adduct, 2~(4-chlorophenyl)-3-[4-amino-3-(9-decenyl)-S-(4-chlorobenzyl-
thio)-l,2,4-triazolyl]-2,3-dihydro-4-benzopyrone FF2A (11). [Reaction of 
the 5-triazole (1) with £'-3-(4-chlorobenzylidene)-4'-chloroflavanone (10)) 
A mixture of ^-triazole (1) (500 mg, 1.96 mmol) and £-3-(4-chloro-
benzylidene)-4'-chloroflavanone (10) (744 mg, 1.96 mmol) in dry benzene 
(20 ml) containing catalytic amount of/7-TsOH (5 mg) was ref luxed for 38 h, 
% 
monitoring the progress of the reaction by TLC (silica gel G, pet. ether-
EtOAc, 8:2 v/v). After completion, the reaction mixture on TLC examination 
showed two spots, labelled as FF2A (11) (upper) and FF2C (12) (lower) 
I l l 
which on usual work up and column chromatography (si l ica gel, pet. ether-
EtOAc, 8:2 v/v) afforded F F j A (11) as glassy flakes, 504 mg. (40.5%), m.p. 
93 °C, Rf 0.65 (pet. ether-EtOAc, 8:2 v/v). Further elut ion of the column 
using pet . ether-EtOAc, (6:4 v/v) as eluent yielded a white solid mass which 
on crystal l isat ion (benzene-EtOAc) afforded FF2C (12) as whi te crystalline 
needles, 530 mg (44.72%), m.p. 182 °C, RfO.29 (pet. e ther -EtOAc, 6:4 v/v). 
Spectral data of FF7A (11) 
IR (KBr): 2900 (C-H), 1630, 1600 (C=C, phenyl) , 1580 (C=N), 1560, 
1500, 1490, 1450 (S-C), 1420, 1340, 1270, 1200, 1 140, 1 1 10, 1050, 990, 900, 
850, 750 cm"' 
'H-NMR (400 MHz, acetone-Jg): 5h 5.22 (2H,s, NH2), 5.65 ( I H , d, J=2.75, 
H-1'") , 4.37 ( IH , dd, J=10.98, 2.75, H-3), 6.42 ( IH , d, J=10.98, H-2), 7.22 
( IH , dd, J=8.39, 1.07, H-8), 7.67 ( IH, ddd, J=8.85, 8.39, 1.68, H-7), 7.06 
( IH, ddd, J=8.24, 8.85, 1.07, H-6), 7.51 ( I H , dd, J=8.24, 1.68, H-5), 7.28 -
7.36 (2x4H, m, Ar+Ar') , 2.84 (2H, t, J=7.48, H-1"), 1.83 (2H, br p, J~ 7.43, 
H-2"), 1.26 (lOH, br s, H-3'-7'), 2.01 (2H, m, H-8"), 5.81 ( I H , tdd, J=6.71, 
10.22, 17.09, H-9"), 4.91 ( IH, dd, J=10.22, 2.29, 10"-HE), 4.99 ( I H , dd, 
J=17.09, 2.29, Hz-lO"). 
'^C-NMR (100 MHz, ncetone-ds): 5c 153.73 (C-3'), 168.72 (C-5') , 25.31 
(C-1"), 26.54 (C-2"), 29.20-30.40 (C-3"-7"), 34.44 (C-8") , 139.85 (C-9"), 
114.65 (C-10"), 60.01 (C-1"'), 55.08 (C-3), 79.04 (C-2) , 160.10_ (C-8a), 
119.00 (C-8), 137.84 (C-7), 122.76 (C-6), 127.46 (C-5), 121.74 (C-4a), 
189.69 (C-4), 137.39 (C-Ar"-1), 130.89 (C-Ar"-2,6) , 129.13 (C-Ar"-3,5), 
134.66 (C-Ar"-4) , 136.05 (C-Ar ' - l ) , 129.57 (C-Ar'-2,6), 128.85 (C-Ar'-3,5), 
134.45 (C-Ar '-4) . 
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DCI-MS (NHj) : m/z (%) 635 (5.4), 636 (2.5), 637 (4.1), 638 (2.4), 380 (8.4), 
381 (22.6), 382 (10.3), 383 (14.7), 384 (4.3), 301 (4.5), 295 (13.4), 254 (5.0), 
255 (100.0), 256 (17.6), 257 (26.6), 258 (5.1), 259 (14.3), 261 (6.8), 225 
(6.0), 189 (5.0), 149 (4.7), 143 (6.0), 130 (9.4), 121 (12.4), 94 (4.8). 
Spectral data of FF^C (12) 
' H - N M R (400 MHz, acetone-«f^); 5h 5.90 ( IH, d, 1.07, H-3), 4.14 ( IH, dd, 
J=6.41, 1.07, H-2a), 5.92 ( IH, d, J=6.41, H-2), 8.15 ( IH , dd, J=7.94, 1.68, H-
8), 7.10 ( IH, ddd, J=8.85, 7.94, 1.07, H-7), 6.62 ( IH, dd, J=8.39, 1.07, H-5), 
5.92 ( IH, d, J=6.4L H-2), 7.17 (2H, d, J=8.69, H-Ar-2,6), 7.50 (H-Ar'-2,6), 
7.28-7.29 (4H, m, H-Ar'-3,5, H-Ar'-3,5), 2.76 (2H, t, J=7.48, H-1'), 1.45 (2H, 
br p, J~7.47,H-2'), 1.23 (lOH, br s, H-3'-7'), 2.00 (2H, m, H-8'), 5.79 ( IH, 
tdd, J=6.71,10.22, 17.09 H-9'), 4.89 ( IH, dd, J=10.22, 2.29, HE-IO'), 4.97 
( IH, J=17.09, 2.29, Hz-10'). 
' ^C-NMR (100 MHz, acetone-^/^): 5h 157.07 (C-11), 156.24 (C-8b), 118.94 
(C-8a), 126.02 (C-8), 122.82 (C-7), 136.30 (C-6), 118.56 (C-5), 144.17 
(C-4a), 76.98 (C-3), 45.22 (C-2a), 59.39 (C-2), 160.83 (C-13a), 138.63 (C-
Ar-1), 131. 77 (C-Ar-2,6), 128.75a (C-Ar-3,5), 135.42 (C-Ar-4), 134.41 (C-
Ar ' - l ) , 129.61 (C-Ar'-2,6), 128.59 (C-Ar'-3,5), 135.29 (C-Ar'-4), 25.48 (C-1'), 
27.81 (C-2'), 29.20-30.40 (C-3'-7'), 34.46 (C-8'), 139.89 (C-9'), 114.63 
(C-10'). 
D C I - M S (NHs): m/z (%) 616[M^ 5.4], 617 (100.0), 618 (50.8), 619 (82.5), 
620 (38.2), 621 (22.4), 622 (7.6), 583 (2.6), 585 (2.8), 492 (5.4), 494 (3.8), 
378 (7.1), 380 (23.4), 381 (8.1), 382 (14.2), 383 (4.3), 240 (4.3), 199 (3.8), 
149 (3.8). 
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2,3-Bis(phenyl)-ll-(9-decenyl)-2a,3-dihydro[lJbenzopyrano[3,4-e]-2,2a-
dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazepine FTZXg (15) alongwith the 
adduct, 2-(phenyl)-3-[3-(9-decenyl)-4-amino-S-(benzylthio)-l,2,4-triazolyl]-
2,3-dihydro-4-benzopyrone FF,A (14) [Reaction of the s-triazole (1) with 
E-3-benzyIidene flavanone (13)] 
A mixture of the 5-triazole (1) (500 mg, 1.96 mmol) and £ -3 -
benzylidene f lavanone (13) (610 mg, 1.96 mmol) in dry benzene (20 ml) was 
ref luxed with stirring on an oil bath at 80 °C using a Dean Stark apparatus for 
35 h in presence of a catalytic amount of jtP-TsOH (5 mg). TLC examination 
(silica gel G, pet. e ther-EtOAc, 8:2 v/v) of the reaction mixture revealed the 
presence of two spots, labelled as FFjA (14) (upper) and FTZX5 (15) (lower). 
The solvent was distilled off in vacuum and the residue thus obtained was 
dissolved in EtOAc, washed several times with water and the organic phase 
dried over anhydrous Na2S04. The solvent was removed under reduced 
pressure and the residue left was chromatographed over a silica gel column 
using pet. e ther-EtOAc (8: 2 v/v) as eluent which a f forded FF ,A (14) as an 
oily liquid, 434 mg (39.10%), Rf 0.66 (pet. ether-EtOAc, 8:2 v/v). Further 
elution of the column (pet. ether-EtOAc, 7:3 v/v) yielded FTZXg (14) as a 
white solid compound which on recrystallisation (EtOAc-benzene) as white 
crystall ine needles, 498 mg (46.36%), m .p . l67 °C, R, 0.31 (pet. ether-EtOAc, 
8:2 v/v) 
Spectral data of FFj^ A (14) 
FTIR (KBr): v^ax 3402.9, 3068.2 ( N H 2 ) , 3032.9, 2927.0, 2853.9(CH), 
2362.6, 1694.5(C=0) , 1630.8 (C=C), 1607.2 (C=N), 1578.1(phenyl) , 1495.1, 
1460.5, 1420.1, 1357.6, 1296.0, 1210.7 cm-' 
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' H - N M R (300 MHz, acetone-f/g): 5h 5.02 (2H, s, NH2), 5 .52 ( I H , d, J=1.80, 
H-1'") , 6 .38 ( I H , d, J=11.40, H-2), 4.38 ( IH , dd, J=1 1.40, 1.80, H-3) , 7.16 
( IH , dd, J=7.50, 1.09, H-8), 7.55 ( I H , ddd, J=7.50, 7.20, 1.65, H-7) , 6.95 
( IH , dd, J=7.80, 7.20, H-6) , 7.38 ( l H , d d , 7.80,1.65, H-5) , 2 .76 (2H, t, J=7.20, 
H-1 ' ) , 1.73 (2H, br p, J=7.18, H-2") , 1.22 ( lOH, brs, H-3" -7" ) , 1.99 (2H, m, 
H-8") , 5 .79 ( I H , tdd, J=, 6.68, 10.20, 17.06 H-9") , 4 .92 ( I H , d, J=10.20, He-
10"), 4.95 ( I H , d, J=17.06, H^-IO"), 7.17- 7.29 ( lOH, m, 2xAr) . 
E I - M S (NH3): m/z (%) 567 [(M+1), 7.2], 568 (3.1), 312 (6.7) , 313 (18.4), 
314 (4.5), 254 (6.3), 255 (100.0), 256 (19.8), 191 (12.2) , 192 (5.8), 193 
(12.2), 143 (10.6), 144 (2.9), 130 (12.5), 131 (4.1), 121 (13.3) , 122 (3.7) 
Spectral data of F T Z X S (15) 
' H - N M R (400 MHz, acetone-rf^): 5 h 5.83 ( I H , d, J= poor ly resolved, H-3) , 
4.07 ( I H , dd, J=5.86, 1.10, H-2a) , 5.87 ( IH , d, J=poor ly reso lved , H-2) , 8.16 
( I H , dd, J=8.16 , 1.65, H-8) , 7.06 ( I H , dd, J=8.16, 8.42, 1.29, H-7) , 7.41 ( I H , 
dd, J=8 .42 , 8.24, 1.65, H-6) , 6.54 ( I H , dd, J=8.24, 1.10, H-5) , 7.48 (2H, d, 
J=7.88, H-Ar ' -2 ,6) , 7.14 (2H, dd, J=7.88, 7.32, H-Ar ' -3 ,5 ) , 7.26 ( I H , d, 
J=7.32, H-Ar ' -4) , 7.19-7.24 (5H, m, H-Ar") , 2.76 (2H, t, J=7 .47 , H-1 ' ) , 1.45 
(2H, br p, J~7.37, H-2') , 1.24 ( lOH, brs, H-3 '-7 ' ) , 2.01 (2H, m, H-8 ' ) , 5.80 
( I H , tdd, J=17.22, 10.25, 6.78, H-9') , 4.90 ( I H , dd, J=10 .25 , 2 .20, HE-10'), 
4.98 ( I H , dd, J=17.22, 2.20, Hz-lO') . 
'^C-NMR (100 MHz, acetone-^/^): 5c 157.47 (C-11) , 156.09 (C-8b) , 119.03 
(C-8a) , 125.88 (C-8), 122.40 (C-7), 136.00 (C-6) , 118.59 (C-5) , 144.45 
(C-4a) , 77.47 (C-3), 45.36 (C-2a), 60.35 (C-2) , 164.43 (C-13a) , 136.46 
( C - A r ' - l ) , 130.11 (C-Ar ' -2 ,6) , 129.85 (C-Ar '-4) , 126.72-128.86 (C-Ar"-1 , C-
Ar"-2,6 , C-Ar"-3 ,5 , C-Ar"-4) . 
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D C I - M S (NH3): m/z (%) 549 [(M+1), 100.0], 550 (50.0), 551 (17.9), 424 
(8.7), 425 (6.9), 310 (11.8), 312 (38.8), 313 (14.3), 314 (8.7), 208 (5.0), 191 
(4.6), 193 (6.0), 121 (5.5), 115 (6.0), 91 (12.8). 
b l . 
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DISCUSSION 
SUMMARY 
The work described in this chapter includes the reaction of 4-amino-3-(9-
decenyl)-5-mercapto-l,2,4-triazole (1) with: 
(i) p-Anisaldehyde which yielded 4-(N-4-methoxybenzylidene amino)-3-(9-
decenyl)-5-mercapto-J,2,4-triazole (16) and 2'(4-methoxyphenyl)-5-(9-
decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazole (17) 
(ii) p-Chlorobenzaldehyde which afforded 4-(N-4-chlorobenzylidene amino)-
3-(9-decenyl)-5-mercapto-l,2,4-triazole (18) and 2-(4-chlorophenyl)-5-
(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadiazole (19). 
(Hi) Thiophen-2-aldehyde which furnished 4-(N-2-thienylidene amino)-3-{9-
decenyl)'5-mercapto-l,2,4-triazole (20) and 2-(2-thienyl)-5-(9-decenyl)-
2.3-dihydro-l,2,4-triazolo[3,4-b][l,3,4] thiadiazole (21). 
(iv) Furfur aldehyde which gave 4-(N-2-furfurylidene amino)-3-(9-decenyl)-5-
mercapto-1,2,4'lriazole (22) as the sole product 
INTRODUCTION 
1,2,4-Triazole and its derivatives have been found to play vital role in 
medicine, agriculture and industry^^"^^. The fused ring systems such as 
i-- tr iazolo[3,4-b][l ,3,4]thiadiazoles have varied range of biological activities 
as antibacterial^'•^^ antifungaP^'^®, a n t i i n f l a m m a t o r y ^ a n t i h y p e r t e n s i v e ^ ^ ' ^ ^ 
a n a l g e s i c " and anthelmintic^'"^^ agents. The 5-tr iazolo-thiadiazole system can 
be viewed as a cyclic analogue of two very important components . 
thiosemicarbazide^° and biguanide^' which often display diverse biological 
activities probably due to the presence of -N=C-S group responsible for their 
activities. Also, the Schiff bases and their complexes prepared by the 
condensat ion of various aldehydes and ketones with substi tuted or 
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unsubsti tuted 1,2,4-triazoles have been found to be potential biologically 
active agents^^'^^ as well as substrates for the syntheses of various 
heterocycles of medicinal importance^^. These f indings have tempted us to 
undertake this problem. It consists of the syntheses of three new compounds, 
(i) 2-(4-methoxyphenyl)-5-(9-decenyI)-2,3-dihydro-l ,2 ,4- t r iazolo[3,4-b] 
[ l ,3 ,4] thiadiazole (17) (ii) 2-(4-chlorophenyl)-5-(9-decenyl)-2,3-dihydro-
1.2,4-tr iazolol3,4-b][ l ,3 ,4]thiadiazole (19) and (iii) 2-(2-thienyl)-5-(9-
decenyl)-2 ,3-dihydro- l ,2 ,4- t r iazolo[3,4-b][ l ,3 ,4] thiadiazole (21) from (i) 
p-anisaldehyde (ii) /?-chlorobenzaldehyde and (iii) th iophen-2-aldehyde 
respectively using 4-amino-3-(9-decenyl)-5-mercapto-1.2,4-tr iazole (1) in 
the presence of a catalytic amount of p -TsOH. In each reaction, the 
corresponding Schiff bases (16), (18), and (20) have also been obtained. The 
reaction of fur fura ldehyde with the triazole (1) yielded only the Schiff base 
(22). no cyclised product could be isolated due to the decomposi t ion of the 
products. 
Structural assignment and biological assay are discussed. Screening 
results of the compounds (16), (17), (20), (21) and (22) are summarised for 
the anticancer activity against 3-cell lines of three types of human cancers: 
lung, breast and CNS (details in chapter 6) 
(1) 
1 1 8 
(16) R = 0CH3 
( 1 8 ) R = C1 
( 1 7 ) R = 0 C H 3 
( 1 9 ) R = C1 
( 2 0 ) X - S 
( 2 2 ) X = 0 
( 2 1 ) X = S 
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RESULTS AND DISCUSSION 
The synthesis of compounds (17), (19) and (21) was carried out by 
reacting the triazole (1) (obtained by fusing 10-undecenoic acid with 
thiocarbohydrazide) with /?-anisaldehyde, /7-chlorobenzaldehyde and 
thiophen-2-aldehyde respectively in dry benzene using p - T s O H as catalyst. It 
is believed that the corresponding Schiff base is first formed which undergoes 
intramolecular cyclocondensation to give the desired product alongwith the 
uncyclised Schiff base in each case (Scheme 4). In the reaction of triazole 
with furfural , only the Schiff base could be isolated from the products as on 
prolonging the reaction, the product underwent decomposi t ion. 
N N 
(16) R = 0CH3 
(18) R = C1 
+ 
N N 
(20) X = S 
(22) X = 0 
(17) R = 0CH3 
(19) R = CI 
(21) X = S 
SCHEME 4 
1 2 0 
2-(4-Methoxyphenyl)-5-(9-decenyl)-2,3-(iihydro-l,2,4-triazolo[3,4-b][1,3,4] 
thiadiazole FTZX' (17) along with the Schiff base, 4-(N-4-
methoxybenzylidene amino)-3-(9-decenyl)-5-mercapto-l,2,4-triazole FTZX 
(16) [Reaction of the 5-triazoIe (1) with p-anisaldehyde in presence of 
/j-TsOH] 
A solution of the 1,2,4-triazole (1) and p-anisaldehyde (molar ratio. 
1:1) in dry benzene was refluxed with stirring for 5 h with catalytic amount of 
jD-T s OH. T L C examination of the reaction mixture revealed the presence of 
two spots, labelled as FTZX (16) and FTZX' (17). The products on column 
chromatography (pet. ether-EtOAc, 9:1 v/v) as eluent first afforded a pale 
yellow crystalline solid, FTZX (18%) and then a colourless oily liquid. 


















FTZX' (17) Q 
'0CH3 
structure Elucidation of FTZX (16) 
It was a pale yellow needle shaped crystalline solid, m.p. 66 °C. The 
structure of FTZX has been established by IR, DCI-MS, 'H-NMR and '^C-
NMR spectra. The IR spectrum (KBr) exhibited characteristic peaks at 2900 
(CH), 2350 (SH), 1630 (C=C), 1600 (C=N), 1580 (phenyl) and 1480 (S-C) cm"'. 
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The DCI-MS spectrum of FTZX (Fig. 10 a) showed a [M+1]^ peak at m/z 
373 confirming its molecular weight 372 [C20H28N4OS], which is equal to the 
sum of the molecular weights of the ^-triazole (1) (254) and /p-anisaldehyde 
(136) minus one molecule of water. This indicated the format ion of the Schiff 
base by the condensation of/7-anisaldehyde with ^-triazole (1). The prominent 
fragment ion peak at m/z 133 (base peak) [(M+l)-Ci2H2iN3S]"'' and a less 
intense peak at m/z 240 [(M+l)-C8H8NO]'^ were arised by the exocyciic N-N 
bond cleavage. The peak at m/z 206 [m/z 239-SHj'^ and another peak at m/z 
115 [m/z 239-C9Hi6]'^' were obtained from the f ragment ion m/z 239 as 




N = C H — / ( ^ N — O C H 3 
m/z 373 (84.1)[M+1] 
exocyciic 










NEC- o -OCH, 
m/z 133(100.0) 
m/z 115 (26.0) 
CHART 10 
1 2 3 
All the signals in ' H - N M R and '^C-NMR spect ra (Fig . lOb and 10c) 
were ass igned to specif ic H- and C- atoms (Table 11a and l i b ) f rom their 
typical chemical shif t values, mult ipl ici ty, relat ive in tegra t ions and also by 
compar ing with the spectra of F T Z (1). The absence of NHa pro tons at 6 5.18 
in ' H - N M R spectrum of F T Z X and appearance of new s ignals at 5 10.16 and 
at 5 162.51 for benzyl idene proton and benzyl idene ca rbon conf i rmed the 
format ion of the Schif f base. The other signals for p ro tons and carbons 
appeared as in F T Z spectra as shown in Table 11a and l i b . 
Table l ib : Comparison of the "C-NMR spectral data of 
FTZX (16) with that of FTZ (1) 
FTZX (16) FTZ (1) 
C-nr 8(ppm) C-nr 5(ppm) 
3 152.85 3 153.34 
5 164.22 5 168.26 
6 162.51 
1' 25 .62 1' 25 .40 
2' 26 .73 2' 26 .68 
y-T 2 9 . 2 3 - 3 0 . 3 8 y-T 29.40-30.20 
8' 34 .43 8' 34 .40 
9' 139.85 9' 139.82 
10' 114.63 10' 114.61 
Ar -1 126.36 
A r - 2 , 6 131.24 
Ar -3 ,5 115.45 
A r - 4 163.73 
OCH3 55 .98 
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1 2 7 
Based on the above evidence, the structure of FTZX was characterised 
as 4-(N-4-methoxybenzylidene amino)-3-(9-deceny l)-5-mercapto-1,2,4-
triazole (16). 
FTZX (16) OCHi 
Structure Elucidation of FTZX' (17) 
It was a colourless oily liquid. The consti tution of FTZX' has been 
fully established by DCI-MS, 'H-NMR and '^C-NMR spectra. The DCI-MS 
spectrum of FTZX' (Fig. 11) showed [M+1]^ peak at m/z 373 as the base 
peak corresponding with the molecular formula [C20H28N4OS], indicating thai 
the compound FTZX' is different from FTZX (16) in stability but same in 
molecular weight. The prominent fragment ion peak at m/z 240 [(M+1)-
CgHyNO]^ and another peak at m/z 133 [(M+l)-C,2H2iN3S]^- were arised by 
the cleavage of 3-4 and 1-5 bonds of the thiadiazole ring. The peak at m/z 151 
[ M - C i 2 H 2 o N 4 ] ^ obtained by the cleavage of 1-2 and 4-5 bonds of the fused 
ring [which was absent in the non-cyclised adduct (16)] is the diagnostic peak 
of a ^•-triazolo-thiadiazole ring^^. In addit ion, it also showed the usual 
/^-cleavage f ragment ion peak at m/z 115 (Chart 11). 
1 2 8 
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m/z373 (100.0)[M+H] 
1-5 and 3-4 bond 
cleavage 
1-2 and 4-5 bond 
cleavage 
N N 
N = C OCH3 
H 
SH 
m/z 133(85.2) m/z240 (42.1) 
P-cleavag 




m/z 115(11 .4) 
C H A R T 1 1 
S = C - O -0CH3 
m/z 151 (35.2) 
The 'H-NMR and '^C-NMR spectra showed signals as assigned (Table 
12). The assignments of all signals to individual H- and C- a toms were made 
on the basis of chemical shifts, multiplicity, relative integrations and by a 
comparison with the spectral data of the uncyclised Schiff base FTZX (16) 
(Tables 11a and l i b ) . The signal corresponding to thiol proton at 6 12.40 of 
the Schiff base was found to be absent in the ' H - N M R spectrum of FTZX', 
showing that thiol group is involved in the newly formed ring. Also, the 
benzylidene proton and carbon signals shifted upfield f rom 6 10.16 to 6 8.60 
and f rom 5 162.51 to 5 70.18, confirming the formation of thiadiazole ring. In 
addition, both the spectra showed H- and C- signals of aromatic protons, 
5-triazole ring and 9-decenyl side chain as shown in Table 12. 
Table 12. ^H-NMR and ^^C-NMR spectral data of FTZX' (17) 
1 3 0 
H-nr 5(ppm) Integ-ration 
Multip-
licity J (Hz) C-nr 5(ppm) 
6 8.60 IH S 3 151.71 
NH - 6 70.18 
R 2.83 2H t h\T 7.32 7a 164.33 
2' 1.75 2H br p J « 7.36 R 25.54 
y-T 1.30 5x2H br s 2' 26.65 









J9.HZ 17.09, J9'.HB 10.23, 
J9',8' 6.72 






l O ' - H z 4.97 IH dd W 17.09, JHE, Hz 2.29 10' 114.49 
Ar-2,6 7.43 2H d J A r - 2 , 6 , A r - 3 , 5 8 . 8 5 Ar-1 126.70 
Ar-3,5 6.97 2H d J A r - 2 , 6 5 A r - 3 , 5 8.85 Ar-2,6 131.04 
O C H 3 3.83 3H s Ar-3,5 
Ar-4 




1 3 1 
Based on the above facts, the compound FTZX' was assigned the 
structure as 2-(4-methoxyphenyl)-5-(9-decenyl)-2,3-dihydro-l ,2,4-triazolo 
[3,4-b][ 1,2,4]thiadiazole (17). 
FTZX' (17) 
2-(4-Clilorophenyl)-5-(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4] 
thiadiazole FTZY' (19) along with the Schiff base, 4-(N-4-
chlorobenzylidene amino)-3-(9-decenyl)-5-mercapto-l,2,4-triazole FTZY 
(18) [Reaction of the 5-triazole (1) with p-chlorobenzaldehyde in presence of 
p-TsOH] 
A solution of j-triazole (1) and /?-chlorobenzaldehyde (molar ratio, 
1:1) in dry benzene was refluxed with stirring for 12 h in presence of 
catalytic quantity of p-TsOH. TLC examination revealed the presence of two 
spots, labelled as FTZY (18) and FTZY' (19). The products on column 
chromatography (silica gel, pet. ether-EtOAc, 8:2 v/v) as eluent first 
furnished a white solid, FTZY which was recrystall ized (benzene-acetone) 
as white crystalline needles in 59% yield. Further elution of the column 
yielded a colourless oily liquid, FTZY' in 27% yield. The react ion sequence 
is as follows. 





















Structure Eiucidation of FTZY (18) 
It was a white needle shaped crystalline solid, m.p. 102 °C. The IR 
spectrum (KBr) displayed characteristic absorption bands at 2850 (CH), 2400 
(SH), 1640 (C=C), 1620 (C=N), 1570 (phenyl) and 1480 (S-C) cm' ' . The 
DCI-MS spectrum showed a set of [M+1]"^ peaks at m/z 377/379 confirming 
its molecular weight 376/378 [ C 1 9 H 2 5 N 4 S C I ] which is equal to the sum of the 
molecular weights of the 5-triazole (1) (254) and p-chlorobenzaldehyde (140) 
minus one molecule of water, suggesting the formation of the Schiff base. All 
the signals in the 'H-NMR and '^C-NMR spectra have been assigned to 
individual H- and C- atoms (Table 13) by comparing with the spectral data of 
a previously established structure of compound (16) (Table 11a and l i b ) . In 
'H-NMR spectrum, the absence of NH2 signals at 5 5.18 and appearance of 
new signals at 5 10.49 and 5 160.28 for benzyl idene proton and carbon, 
conf i rmed the formation of Schiff base. In addition, both the 'H- and '^C-
N M R spectra gave usual signals for the 9-decenyl side chain and A2B2 signals 
of /7-chlorophenyl ring as shown in Table 13. 
Table 12. ^ H - N M R and ^ ^C-NMR spectral data of FTZX' (17) 
1 3 3 
H-nr 5(ppm) Integ-ration 
Multip-
licity J (Hz) C-nr 5(ppm) 
SH 12.50 IH brs 3 153.08 
6 10.49 IH s 5 163.78 
1' 2.84 2H t h ' T 7.32 6 160.28 
2' 1.78 2H br p J « 7.46 1' 25.58 
y-T 1.31 5x2H br s 2' 26.74 
8' 2.01 2H m 3'-7' 29.23-30.39 




10'-HE 4.90 IH dd JHE,9'10.25,JHE, Hz 2.38 9' 139.85 
1 
lO'-Hz 4.98 IH dd JHZ,9' 17.21, JHE, HZ 2.38 10' 114.64 
Ar-2,6 7.96 2H d JAr-2,6>Ar-3,5 8-42 Ar-1 132.87 






1 3 4 
Based on the above discussion, compound FTZY was character ised as 4-
(N-4-chlorobenzylidene amino)-3-(9-decenyl)-5-mercapto-l,2,4-triazole (18). 
FTZY (18) 
Structure Elucidation of FTZY' (19) 
It was a pale yellow oily liquid. The DCI-MS spectrum of FTZY' showed a 
set of [M+l]"^ peaks as the base peak at m/z 377/379 confirming its molecular weight 
376/378 [C19H25N4SCI]. The fragment ion peaksat m/z 240 [(M+1)-C7H4NC1] ^ and at 
m/z 137/139 [(M+O-CuHaiNBS]""' were obtained by the cleavage of 3-4 and 1-5 
bonds of the thiadiazole ring. The set of peaks at m/z 155/157 [M-C|2H2oN4]^ was 
obtained by the cleavage of 1-2 and 4-5 bonds of the thiadiazole ring as shown in 
Chart 12. 
N- -N 
\ ^ 5 • 
HN— 
m/z 377/379 (100.0/47.3) 
N-
N = C- C1 + 






S = C -< -CI 
m/z 137/139 (43.7/21.2) 
SH H 
m/z 240 (28.3) 








m/z 115 (9.3) 
CHART 12 
1 3 5 
All the signals in the and '^C-NMR spectra have been assigned 
(Table 14). The assignments have been made on the basis of chemical shifts, 
multiplicity, relative integrations and by comparison with the spectra of the 
uncyclised Schiff base FTZY (18) (Table 13). The absence of signal 
corresponding to the thiol proton at 5 12.50 and the shif t of benzylidene 
proton (H-6) to higher field from 5 10.49 to S 8.84 suggested the formation of 
thiadiazole ring. In '^C-NMR spectrum, the benzylidene carbon also shifted to 
higher field f rom 5 160.28 to 5 69.23, confirming the format ion of the ring. In 
addition, other signals for j:7-chlorophenyl ring and 9-decenyl side chain 
appeared as usual as shown in Table 14. 
Based on the above spectral evidence, FTZY' was characterised as 2-(4-
chlorophenyl)-5-(9-decenyl)-2,3-dihydro-l, 2,4-triazolo[3,4-b ] [1 ,S,4]thiad-
iazole (19) 
FTZY' (19) 
Table 12. ^H-NMR and ^^C-NMR spectral data of FTZX' (17) 





licity J (Hz) C-nr 5(ppm) 
6 8.84 IH S 3 151.78 
r 2.86 2H t J,. 2. 7.33 6 69.23 
2' 1.76 2H br p J=«7.35 7a 163.69 
y-T 1.31 5x2H br s r 25.56 
8' 2.01 2H m 2' 26.62 
9' 5.79 IH tdd J9.8.6.72, J9.,HE 10.23, y-T 29.22-30.37 
J9.HZ 17.06 
10'-HE 4.90 IH dd Jhe,9'10.23,JHE, HZ 2.28 8' 34.42 
l O ' - H z 4.97 IH dd W 17.06, JHE, Hz 2.28 9' 139.83 
Ar-2,6 7.54 2H d JAr-2,Ar-3,5 8.35 10' 114.51 




1 3 7 
2-(2-Thienyl)-5-(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4Jthm^^ 
azole FT' (21) along with the Schiff base, 4-(N-2-thienylidene amino)-3-(9-
decenyl)-5-mercapto-l,2,4-triazole FT (20) [Reaction of the s-triazole (1) 
with thiophen-2-aldehyde] 
A solution of the 5-triazole (1) and thiophen-2-aldehyde (molar ratio, 
1:1) in dry benzene was ref luxed with stirring for 8 h with catalytic amount of 
/?-TsOH. TLC examination of the reaction mixture revealed the formation of a 
major and a minor components, labelled as FT (20) and FT' (21). The 
products on column chromatography over silica gel using pet. e ther-EtOAc 
(9:1 v/v) as eluent yielded a pink crystalline solid, FT (16%) and a colourless 











Reflux, 8 h 
N N 
FT' (21) I 
Structure Elucidation of FT (20) 
It was a globule shaped pink crystalline solid, m.p. 74 °C. The IR 
spectrum (KBr) of the compound displayed characteristic bands at 2800 (CH), 
2300 (SH), 1640 (C=N) and 1580 (C=C) cm"'. The DCI-MS spectrum showed 
a [M+1]"^ peak as the base peak at m/z 349, showing its molecular weight 348 
1 3 8 
[C17H24N4S2] which is equal to the sum of the molecu la r weights of the 
5-tr iazole (1) (254) and thiophen-2-aldehyde (112) minus one molecule of 
water. This indicated the format ion of the Shif f base. The other f ragment ion 
peaks were observed at m/z 240 [(M+1)-C5H4NS]^-, m/z 206 [m/z 239-SH] ^ 
and m/z 115 [m/z 239-C9Hi6]^'^in addition to the peak at m/z 109 [(M+1)-
C,2H2iN3S]^- as shown in Chart 13. 
m/z349(100.0)[M+H] 





m/z 240 (4.3) 
m/z 109(5.2) 








The ' H - N M R and '^C-NMR spectra (Fig. 12a and 12b) of FT showed 
signals as ass igned (Table 15). The absence of the signal for amino proton at 
5 5.18 and appearance of a sharp singlet for the benzy l idene proton at 5 10.60 
indicated the format ion of Schiff base. In ' ^C-NMR spec t rum a signal for the 
benzyl idene carbon at 5 155.88 due to the format ion of C=N bond appeared. 
1 3 9 
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licity J (Hz) C-nr 5(ppm) 
SH 12.50 IH brs 3 152.82 
6 10.60 IH s 5 163.73 
1' 1.19 2H t h 'T 7.33 6 155.88 
2' 1.77 2H br p J « 7.45 1' 25.57 
y-T 1.32 5x2H br s 2' 26.72 
8' 2.02 2H m 3'-7' 29.22-30.38 
9' 5.80 IH tdd J9.,8'6.59,, J9.,he 10.26, 
J9. Hz 17.03 
8' 34.41 
10'-He 4.90 IH dd JHE,9' 10.26, JHE, HZ 2.38 9' 139.83 
lO'-Hz 4.98 IH dd JHZ,9' 17.03, JHE; HZ 2.38 10' 114.61 
Ar-3 7.83 IH d J Ar-3) Ar-4 4.94 Ar-1 138.45 
Ar-4 7.25 IH dd Jat-S,Ar-4 4 . 9 4 , JAr-4,Ar-5 3 . 6 6 Ar-3 132.53 




1 4 2 
support ing the formation of the Schiff base. In addition, both spectra showed 
the signals corresponding to 9-decenyl side chain and thiophene ring as 
shown in Table 15. 
Based on the above facts, compound FT was characterised as 4-(N-2-
thienylidene amino)-3-(9-decenyl)-5-mercapto-l,2,4-triazole (20). 
FT (20) 
Structure Elucidation of FT' (21) 
It was a colourless oily liquid. The DCI-MS spectrum of FT' showed a 
[M+l]"" peak as the base peak at m/z 349 confi rming its molecular weight 348 
[C17H24N4S2]. The fragment ion peaks at m/z 128 [M-Ci2H2oN4]'^' was arised 
by the cleavage of 1-2 and 4-5 bonds of the thiadizole ring. The peaks at m/z 
240 [ (M+O-CsHjNS]^ and m/z 109 [(M+1)-C,2H2,N3S]^- were obtained by the 
cleavage of 1-5 and 3-4 bonds as shown in Chart 14. 
All the signals in the 'H-NMR and '^C-NMR spectra have been 
assigned to individual H- and C- atoms (Table 16) by compar ing the spectral 
data with the previously established compounds FTZX' (16) and FTZY' (18) 
(Tables 12 and 14). Both the spectra fully conf i rmed the formation of the 
thiadiazole ring. In 'H-NMR spectrum, the absence of signal for thiol proton 
at 5 12.50 and the shift of benzylidene proton signal to up f ield f rom 5 10.60 
to S 8.93 indicated the formation of the thiadiazole ring. Also in '^C-NMR 
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spectrum, the shift of benzylidene carbon signal to higher f ield f rom 5 155.88 
to 5 66.37, supported the formation of the ring. Both the spectra also showed 
the signals for thiophene ring and 9-decenyl side chain as shown in Table 15. 
N N 
m/z 349(100.0)[M+1] 
] -5 and 3-4 bond 
cleavage 




N + H ^SH 
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Table 12. ^ H - N M R and ^^C-NMR spectral data of FTZX' (17) 
1 4 4 
H-nr 5(ppm) Integ-ration 
Multip-
licity J (Hz) C-nr S(ppm) 
6 8.93 IH s 3 151.93 
r 2.81 2H t Jr,2' 7.32 6 66.37 
2' 1.77 2H br p J « 7.36 7a 163.48 
y-T 1.31 5x2H br s 1' 25.53 
8' 2.01 2H m 2' 26.58 
j 
9' 5.80 IH tdd J9.8'6.71, J9.,HH 10.22, 
J9-,Hz 17.09, 
y-T 29.22-30.37 
10'-HE 4.90 I H dd W 10.22, Jhe, Hz 2.29 8' 34.46 
lO'-Hz 4.97 IH dd JHZ,9' 17.09, JHE, HZ2.29 9' 139.85 
Ar-3 7.60 I H d JAr-3»Ar-4 5.19 10' 114.66 
Ar-4 7.07 I H dd JAR-3,AR-4 5.19 , JAR-4,AR-5 3-67 Ar-1 135.77 
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4-(N-2-furfuryUdene amino)-3-(9-decenyl)-5-mercapto-l,2,4-triazole F F 
(22). [Reaction of the 5-triazoIe (1) with furfuraldehyde]* 
*[This react ion failed to yield the desired product, 5-(9-decenyl)-2-(2-furyl)-
2,3-dihydro-l, 2,4-triazolo[3,4-b][ 1,3,4] thaidiazole. ] 
A solution of the 5-triazole (1) and fur fura ldehyde (molar ratio, 1:1) 
was ref luxed in dry benzene containing a catalytic amount of p -TsOH. The 
progress of the reaction was monitored by TLC, which revealed the presence 
of only one spot labelled as FF. The refluxing continued for fur ther 5 h. but 
no progress in the reaction was observed and the solution gradually changed 
into dark brown in colour. The products on purif icat ion by column 
chromatography (pet. ether-EtOAc, 9:1 v/v) yielded a grey coloured 





N H , 
N N 
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Reflux, 11 h 
N N 
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Structure Elucidation of FF (22) 
It was a globular shaped grey crystalline solid, m.p. 98 °C. The 
structure of FF has been fully established by IR, DCI-MS, 'H-NMR and 
'^C-NMR spectra. The IR spectrum (KBr) showed characteris t ic peaks at 
2850 (SH), 1640 ( C - C ) and 1610 (C=N) cm''. The DCI -MS spectrum 
displayed [M+1]"^ peak as the base peak at m/z 333 conf i rming its molecular 
weight [ C 1 7 H 2 4 N 4 O S ] , which is equal to the sum of the molecular weights of 
the 5-triazole (1) (254) and furfura ldehyde (96) minus one molecule of water. 
This indicated the formation of the Schiff base. Other prominent f ragment ion 
peaks were observed at m/z 240 [(M+1)-C5H4NS]\ m/z 206 [m/z 239-SH]" 
and m/z 115 [m/z 239-C9H,6]^; in addition to the peak at m/z 93 [(M+1)-
CnH.iNsS] ' ' - as shown in Chart 15. 
N N 
'SH 
N = C H - i ) 
m/z333(100.0)[M+l] O 
Exocyclic 
N —N bond cleavage 
m/z 206 (4.8) H^ 
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All the signals in 'H- and '^C-NMR spectra have been assigned to 
individual H-and C-atoms (Table 17) by comparing the spectra with a 
previously established compound FT (20) (Table 15). The absence of NH2 
proton signal at 5 5.18 in 'H-NMR spectrum and appearance of new signal at 
6 10.35 for CH=N proton confirmed the formation of the Schiff base. This is 
also supported by the appearance of carbon signal for C H - N at 5 150.11 in 
'^C-NMR spectrum. In addition, both the spectra showed characterist ic peaks 
of furan ring and 9-decenyl side chain as shown in Table 17. 
Based on the above facts, compound FF was characterised as 4-(N-2-
fwfurylidene amino)-S-(9-decenyl)-5-mercapto-l,2,4-triazole (22). 
FF (22) 
Table 12. ^H-NMR and ^^C-NMR spectral data of FTZX' (17) 
1 4 8 
H-nr 5(ppm) Integ-ration 
Multip-
licity J (Hz) C-nr 5(ppm) 
SH 12.52 IH brs 3 153.03 
6 10.35 IH s 5 163.62 
V 2.79 2H t J,. 2' 7.32 6 150.11 
2' 1.77 2H br p J « 7.46 r 25.52 
y-T 1.32 5x2H br s 2' 26.61 
8' 2.02 2H m y-T 29.22-30.38 
9' 5.80 IH tdd J9'8'6.59, J9',HE 10.25, 
Hz 17.21, 
8' 34.42 
lO'-H,: 4.90 IH dd JHE ,9' 10.25, JHE, HZ 2.38 9' 139.85 
l O ' - H z 4.98 IH dd Jh2,9' 17.21, JHC, HZ 2.38 10' 114.62 
Ar-3 7.90 IH d JAr-3>Ar-4 1-83 Ar-1 149.40 
Ar-4 6.73 IH dd JAr-3!Ar-4 3.48 , Jam,Ar-5 1-83 Ar-3 148.03 





1 4 9 
EXPERIMENTAL 
4-Amino-3-(9-decenyl)-5-mercapto-l,2,4-triazole FTZ (1): 
It was prepared according to the literature method^^ as described in Chapter 1. 
2-(4-Methoxyphenyl)r5-(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4] 
thiadiazole FTZX' (17) along with the Schiff base FTZX (16) [Reaction of 
the 5-triazoie (1) with p-anisaldehyde in presence of /7-TsOH] 
A solution of i - t r iazole (1) (SOOmg, 1.96 mmol) and jO-anisaldehyde 
(266 mg, 1.96 mmol) in dry benzene (20 ml) containing p - T s O H (5mg) as 
catalyst was refluxed with stirring on an oil bath at 80 °C for 5 h using an 
azeotropic water collector. The progress of the reaction was monitored by 
TLC (silica gel G, pet. ether-EtOAc, 8:2 v/v) which revealed the presence of 
two spots, one minor (upper) and another major (lower), labelled as FTZX 
and FTZX'. The reaction mixture was then concentrated under reduced 
pressure, extracted with diethyl ether and washed several t imes with water 
until the solution was neutral. The ethereal solution was then kept over 
anhydrous Na2S04. The solvent was evaporated under reduced pressure and 
the residue left was chromatographed over a silica gel column using 
(pet .ether-EtOAc, 9.5:0.5v/v as eluent). Elution of the column first afforded a 
yellow solid which on crystallisation from pet .e ther-benzene yielded FTZX 
as pale yellow crystalline globules, 130 mg (18.2%), m.p. 66 °C, Rf 0.76 (pet. 
e ther-EtOAc, 9:1 v/v). Further elution of the column yielded a colourless oily 
liquid which was further purif ied by repeated column chromatography using 
pet. ether-diethyl ether (8:2 v/v) as eluent to yield FTZX', 518 mg (71.0%), 
Rf 0.42 (pet. ether-EtOAc, 9:1 v/v). 
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Spectral data ofFTZX (16) 
IR (KBr): 2900 (CH str), 2350 (SH), 1630 (C=C) 1600 (C-N) , 1580, 1480 
(phenyl), 1500, 1460, 1410, 1290, 1250, 1150, 1000, 950, 820 cm-'. 
'H-NMR (400 MHz, acetone-rf^): 6h 12.40 ( IH, br s, SH), 10.16 ( IH, s, 
H - 6 ) , 2 . 8 1 ( 2 H , t , J = 7 . 3 3 , H - 1 ' ) , 1 . 7 7 ( 2 H , b r p , J « 7 . 3 1 , H - 2 ' ) , 1 . 3 2 (LOH, b r s, 
H - 3 ' - 7 ' ) , 2 . 0 1 ( 2 H , m , H - 8 ' ) , 5 . 8 0 ( I H , t d d , J = 6 . 6 0 , 1 0 . 2 5 , 1 7 . 2 1 , H - 9 ' ) , 4 . 9 0 
( I H , d d , J = 1 0 . 2 6 , 2 . 3 9 , H E - 1 0 ' ) , 4 . 9 8 ( I H , d d , J = 1 7 . 2 I ; 2 . 3 9 , H , - 1 0 ' ) , 7 . 8 9 
( 2 H , d , J = 8 . 9 8 , H - A r - 2 , 6 ) , 7 . 1 0 ( 2 H , d , J = 8 . 9 8 , H - A r - 3 , 5 ) , 3 . 9 1 ( 3 H , s, 
O C H 3 ) . 
'^C-NMR (100 MHz, acetone-rf^): 5c 152.85 (C-3), 164.22 (C-5), 162.51 
(C-6), 25.62 ( C - r ) , 26.73 (C-2'), 29.23-30.38 (C-3'-7'), 34.43 (C-8'), 139.85 
(C-9'), 114.63 (C-10'), 126.36 (C-Ar-1), 131.24 (C-Ar-2,6), 115.45 (C-Ar-
3,5), 163.73 (C-Ar-4). 
DCI-MS (NH3): m/z (%) 373 (84.), 374 (28.8), 375 (9.8), 239 (4.9), 240 
(5.0), 21 1 (1 1.7), 206 (6.9), 133 (100.0), 13 (12.7), 135(7.6). 
Spectral data o f F T Z X ' (17) 
^H-NMR (400 MHz, acetone-rfg): 6 h 8 . 6 0 ( I H , s, H - 2 ) , 2 . 8 3 ( 2 H , t, J = 7 . 3 2 , 
H - 1 ' ) , 1 . 7 5 ( 2 H , b r p , J = 7 . 3 6 , H - 2 ' ) , 1 . 3 0 (LOH, b r s, H - 3 ' - 7 ' ) , 2 . 0 1 ( 2 H , m , H -
8 ' ) , 5 . 7 9 ( I H , t d d , J = 6 . 7 2 , 1 7 . 0 9 , 1 0 . 2 3 , H - 9 ' ) , 4 . 9 0 ( I H , d d , J = 1 0 . 2 3 , 2 . 2 9 , 
H E - 1 0 ' ) , 4 . 9 7 ( I H , d d , J = 1 7 . 0 9 , 2 . 2 9 , H , - I O ' ) , 7 . 4 3 ( 2 H , d , J = 8 . 8 5 , H - A r - 2 , 6 ) , 
6 . 9 7 ( 2 H , d, J = 8 . 8 5 , H - A r - 3 , 5 ) , 3 . 8 3 ( 3 H , s, O C H 3 ) . 
'^C-NMR (100 MHz, acetone-rf^): 5c 151.71 (C-5), 70.18 (C-2), 164.33 
(C-7a), 25.54 (C-1'), 26.65 (C-2'), 29.22-30.37 (C-3'-7'), 34.45 (C-8'), 139.82 
(C-9'), 114.49 (C-10'), 126.70 (C-Ar-1), 131.04 (C-Ar-2,6), 114.65 (C-Ar-
3,5), 161.19 (C-Ar-4,) 55.67 ( O C H 3 ) . 
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DCI-MS (NH3): m/z (%) 372 (100.0), 373 (29.5), 374 (9.7), 341 (5.7), 239 
(7.6), 240 (42.1), 241 (6.8), 206 (8.3), 151 (35.2), 152 (5.4), 153 (8.0), 133 
(85.2), 134 (11.6), 135 (8.6), 136 (50.2), 137 (5.5), 128 (9.1), 115 (11.4), 80 
(8.1). 
2-(4-Chlorophenyl)-5-(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4] 
thiadiazole FTZY'(19) along with the Schiff base FTZY (18) [Reaction of 
the 5-triazoIe (1) with p-chlorobenzaldehyde in presence of /7-TsOH] 
A solution of the 1,2,4-triazole (1) (500 mg, 1.96 mmol) and /?-chloro-
benzaldehyde (274 mg. 1.96 mmol) in dry benzene (20 mi) containing 
catalytic amount o f / ' - T s O H (5mg) was refluxed with stirring on an oil bath at 
80°C for 12 h using an azeotropic water collector. The products on usual 
work up gave a light yellow coloured oily residue. On examinat ion by TLC 
(silica gel G, pet. ether-EtOAc, 8:2 v/v), it was found to be a mixture of two 
compounds labelled as FTZY (18) (minor, upper) and FTZY' (19) (major, 
lower). The oily residue was then chromatographed over a silica gel column 
using pet. ether - EtOAc, 8:2 v/v as eluent. Elution of the column first 
furnished a white solid, FTZY' which was crystallized f rom benzene-acetone 
as white crystall ine needles, 440 mg (59.1%), m.p. 102 °C, Rf 0.68 (pet. 
e ther-EtOAc, 8:2 v/v). Further elution of the column yielded a colourless oily 
liquid, FTZY', 203 mg (27.3%), Rf 0.37 (pet. e ther-EtOAc, 8:2 v/v). 
Spectral data of FTZY (18) 
IR (KBr): 2850 (CH str.), 2400 (SH), 1640 (C=C), 1620 (C=N), 1570, 1480 
(phenyl), 1450, 1410, 1320, 1240, 1160, 980, 910, 820, 750 cm"'. 
'H-NMR (400 MHz, acetone-rfg): 1250 ( IH, s, SH), 10.49 ( I H , s, H-6), 2.84 
(2H, t, J=7.32, H - r ) , 2.84 (2H, br p, J«7.46, H-2'), 1.31 ( lOH, br s, H-3'-7') , 
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2 . 0 1 ( 2 H , m , H - 8 ' ) , 5 . 8 0 ( I H , t d d , J = 6 . 7 8 , 1 0 . 2 5 , 1 7 . 0 3 , H - 9 ' ) , 4 . 9 0 ( I H , d d , 
J = 1 0 . 2 5 , 2 . 3 8 , H E - 1 0 ' ) , 4 . 9 8 ( I H , d d , J - 1 7 . 2 1 , 2 . 3 8 , H , - 1 0 ' ) , 7 . 9 6 ( 2 H , d , 
J = 8 . 4 2 , H - A r - 2 , 6 ) , 7 . 5 9 ( 2 H , d , J = 8 . 4 2 , H - A r - 3 , 5 ) . 
'^C-NMR (100 MHz, acetone-rf,): 6c 153.08 (C-3), 163.78 (C-5), 160.28 (C-
6), 25.58 ( C - r ) , 26.74 (C-2'), 29.23-30.39 (C-3'-7'), 34.43 (C-8'), 139.85 (C-
9'), 114.64 (C-10'), 132.87 (C-Ar-1), 130.82 (C-Ar-2,6), 130.21 (C-Ar-3,5), 
138.60 (C-Ar-4). 
DCI-MS (NH3): m/z (%): 3 7 7 ( 1 0 0 . 0 ) , 3 7 8 ( 2 9 . 2 ) , 3 7 9 ( 4 1 . 9 ) , 3 8 0 (1 1 .1) , 
2 3 9 ( 4 . 3 ) , 2 4 0 ( 4 . 1 ) , 2 0 6 ( 1 1 . 6 ) , 1 1 5 ( 3 . 6 ) . 
Spectral data of FTZY'(19) 
'H-NMR (400 MHz, acetone-^/^): 5h 8.84 (IH, s, H-2), 2.86 (2H, t, J=7.33, H-l'), 
1.756 (2H, br p, J= 7.35, H-2'), 1.31 (lOH, br s, H-3'-7'), 2.01 (2H, m, H-8'), 5.80 
(IH, tdd, J= 6.72, 10.23,17.06, H-9'), 4.97 (IH, dd, J=17.06, 2.29, H,-10'), 7.54 (2H, 
d, J=8.35, H-Ar-2,6), 7.37 (2H, d, J-8.35, H-Ar-3,5). 
'^C-NMR (100 MHz, acetone-^): 5c 151.78 (C-5), 69.23 (C-2), 163.69 (C-7a), 
25.56 (C-r), 26.62 (C-2'), 29.22-30.37 (C-3'-7'), 34.42 (C-8'), 139.83 (C-9'), 114.51 
(C-IC), 130.12 (C-Ar-1), 127.25 (C-Ar-2,6), 129.14 (C-Ar-3,5), 134.58 (C-Ar-4,) 
DCI-MS (NH3): m/z (%) 377 (100.0), 378 (29.7), 379 (51.5), 240 (28.3), 241 (5.6), 
155 (16.4), 157 (6.8), 137 (43.7), 138 (40.8), 139 (21.2). 
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2-(2-Thienyl)-5-(9-decenyl)-2,3-dihydro-l,2,4-triazolo[3,4-b][l,3,4]thiadi-
azole FT' (21) along with the Schiff base FT (20) [Reaction of the 
s-triazole (1) with thiophen-2-aldehyde] 
A mixture of 1,2,4-triazole (1) (500 mg, 1.96 mmol) and thiophen-2-
aldehyde (247 mg, 1.96 mmol) in dry benzene (20 ml) containing catalytic 
amount of p -TsOH (5mg) was refluxed with stirring on an oil bath at SO'^ C for 
8 h using an azeotropic water collector. The progress of the reaction was 
monitored by TLC (pet. ether-EtOAc, 8:2 v/v), which revealed the formation 
of one minor (upper) and another major (lower) spot labelled as FT (20) and 
FT ' (21). The products on usual work up and column chromatography (silica 
gel, pet. ether-EtOAc, 9:1, v/v) first afforded a pink coloured solid, FT 
which was recrystallized from pet.ether-benzene as pink crystalline globules, 
115 mg (16.3%), m.p. 74°C, Rf 0.82 (pet. ether-EtOAc, 8:2 v/v). Further 
elution of the column using (pet. ether-EtOAc, 8:2 v/v), yielded FT' as a 
colourless oily liquid, 548 mg (77.2%), Rf 0.44 (pet. ether-EtOAc, 8:2 v/v). 
Spectral data of FT (20) 
IR (KBr) :2800 (CH str), 2300 (SH), 1640 (C=C), 1690 (C=N), 1580, 1490 
(phenyl), 1420, 1400, 1350, 1270, 1200, 1150,1 100, 1040, 980, 890, 830, 
800, 750, 700 cm"'. 
'H-NMR (400 MHz, acetone-RF^): 5h 12.50 ( IH, s, SH), 10.60 ( I H , s, H-6), 
2 . 7 9 ( 2 H , t , J = 7 . 3 3 , H - 1 ' ) , 1 . 7 7 ( 2 H , b r p , J « 7 . 4 5 , H - 2 ' ) , 1 . 3 2 ( L O H , b r s , H - 3 ' -
7 ' ) , 2 . 0 2 ( 2 H , m , H - 8 ' ) , 5 . 8 0 ( I H , t d d , J = 6 . 5 9 , 1 0 . 2 6 , 1 7 . 0 3 , H - 9 ' ) , 4 . 9 0 ( I H , 
d d , J - 1 0 . 2 6 , 2 . 3 8 , H E - 1 0 ' ) , 4 . 9 8 ( I H , d d , J = 1 7 . 0 3 , 2 . 3 8 , H , - 1 0 ' ) , 7 . 8 3 ( I H , d , 
J = 4 . 9 4 , H - A r - 3 ) , 7 . 2 5 ( I H , d d , J = 4 . 9 4 , 3 . 6 6 , H - A r - 4 ) , 7 . 7 3 ( I H , d , J = 3 . 6 6 , H -
Ar-5). 
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'^C-NMR (100 MHz, acetone-cffi): 5c 152.82 (C-3), 163.73 (C-5), 155.88 
(C-6), 25.57 ( C - r ) , 26.72 (C-2'), 29.22-30.38 (C-3'-7'), 34.41 (C-8'), 139.83 
(C-9'), 114.61 (C-IC) , 138.45 (C-Ar-1), 132.53 (C-Ar-3), 129.12 (C-Ar-4), 
135.28 (C-Ar-5). 
D C I - M S (NHj) : m/z (%) 349 (100.0), 350 (26.2), 351 (13.2), 240 (4.3), 206 
(8.5), 128 (6.7), 115 (11.6). 
Spectral data of FT'(21) 
• H - N M R (400 MHz, acetone-rf^): 5h 8.93 ( IH, s, H-2), 2.81 (2H, t, J=7.32, 
H-1'), 1.77 (2H, br p, J= 7.36, H-2'), 1.31 (lOH, br s, H-3'-7') , 2.01 (2H, m, 
H-8'), 5.80 ( IH, tdd, J=6.71,10.22, 17.09 H-9'), 4.90(1H, dd, J= 10.22, 2.29, 
HE-10'), 4.97 ( IH, dd, J=17.09, 2.29, H,-10'), 7.60 ( IH, d, J=5.19, H-Ar-3), 
7.07 ( IH, dd, 1=5.19,3.67, H-Ar-4) 7.39 ( IH, d, J=5.19, H-Ar-5). 
' ' C - N M R (100 MHz, acetone-^/,): 6c 151.93 (C-5), 66.37 (C-2), 163.48 (C-
7a). 25.53 (C-1'), 26.58 (C-2'), 29.22-30.37 (C-3'-7'), 34.46 (C-8'), 139.85 (C-
9'), 114.66 (C-10'), 135.77 (C-Ar-1), 129.06 (C-Ar-3), 127.02 (C-Ar-4), 
130.08 (C-Ar-5) 
DCI -MS (NH3): m/z (%) 349 (100.0), 350 (25.4), 351(12.5), 334 (7.8), 239 
(4.4), 240 (12.7), 206 (11.7), 129 (5.5), 128 (8.7), 1 15 (11.1), 1 12 (9.1), 109 
(13.9). 
4-(2-N-furfurylidene amino)-3-(9-decenyl)-5-mercapto-l,2,4-triazole, FF 
(22). [Reaction of the 5-triazole (1) with furfuraldehyde] 
A solution of 1,2,4-triazoIe (1) (500 mg, 1.96 mmol) and 
furfuraldehyde (188 mg. 1.96 mmol) in dry benzene (20 ml) containing 
catalytic amount of /?-TsOH (5mg) was refluxed with stirring on an oil bath at 
80 °C for 6 h using an azeotropic water collector as described above. The 
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progress of the reaction was monitored by TLC (pet. ether-EtOAc, 8:2 v/v) at 
every 15 min. TLC revealed the formation of only one spot, labelled as FF. 
So, the refluxing continued for further 5 h to see the development of another 
spot but no progress in the reaction was observed and the colour of the 
solution gradually changed into dark brown and a black precipitate started 
depositing on the sides of the round bottom flask. This may be due to the 
decomposition of the furfural moiety in presence of strong acid (p-TsOH). 
The reaction was stopped and the colour of the solution was removed by 
passing through the activated charcoal. It was worked up as usual and the 
brown oily residue thus obtained was chromatographed over a silica gel 
column using pet. ether-EtOAc, 9:1, v/v as eluent which furnished a grey 
coloured crystalline solid, FF (22). it was recrystallized from pet. ether-
benzene as grey crystalline globules, 371 mg (57.0%), m.p. 98°C, Rf 0.69 
(pet. ether-EtOAc, 8:2 v/v). 
Spectral data of FF (22) 
IR (KBr): 2850 (CH str.), 2250 (SH), 1640 (C=C), 1610 (C=N), 1580, 1490 
(phenyl), 1460, 1400, 1320, 1260, 1220, 1150, 1100, 1070, 1020, 980. 820, 
750 cm"'. 
'H-NMR (400 MHz, acetone-^/^): 5h 12.52 ( IH, s, SH), 10.35 ( IH, s, H-6). 
2 . 7 9 ( 2 H , t , J = 7 . 3 2 , H - T ) , 1 . 7 7 ( 2 H , b r p , J « 7 . 4 6 , H - 2 ' ) , 1 . 3 2 (LOH, b r s , H - 3 ' -
T ) , 2 . 0 2 ( 2 H , m , H - 8 ' ) , 5 . 8 0 ( I H , t d d , 1 = 6 . 5 9 , 1 0 . 2 5 , 1 7 . 2 1 , H - 9 ' ) , 4 . 9 0 ( I H , 
d d , J = 1 7 . 2 . 1 , 2 . 3 8 , H E - 1 0 ' ) , 4 . 9 8 ( I H , d d , J = 1 0 . 2 5 , 2 . 3 8 , H ^ - I O ' ) , 7 . 9 0 ( I H , d , 
J = 1 . 8 3 , H - A r - 3 ) , 6 . 7 3 ( I H , d d , J = 3 . 4 8 , 1 . 8 3 , H - A r - 4 ) , 7 . 2 4 ( I H , d , J = 3 . 4 8 , H -
Ar-5). 
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' ^C-NMR (100 MHz, acetone-rfg): 5c 153.03 (C-3), 163.62 (C-5), 150.11 
(C-6), 25.52 ( C - r ) , 26.61 (C-2'), 29.22-30.38 (C-3'-7'), 34.42 (C-8'), 139.85 
(C-9'), 114.62 (C-10'), 149.40 (C-Ar-1), 148.03 (C-Ar-3), 113.50 (C-Ar-4), 
118.84 (C-Ar-5). 
DCI-MS (NHa): m/z (%) 333 (100.0), 334 (23.9), 335(8.3), 240 (3.2), 206 
(4.8), 128 (8.4), 115 (14.7), 96 (12.5), 93 (7.0). 
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2,3-DISUBSTITUTED THIAZOLIDIN-
4-ONES/THIAZAN-4-ONES 
OAni 11 J r , 
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THEORETICAL 
4-Thiazolidinones and tetrahydro-l,3-thiazin-4-ones (called as 4-
Thiazanones) are two important classes of biologically active five and six 
membered sulphur and nitrogen containing heterocyclic compounds with a 
carbonyl group in the 4-position (I) and (II). 
3 4 0 
H N — f 
3 4 0 3 
HN ^ HN 
I III V 
0 0 0 
3 IJ4 3 





II IV VI 
0 , (2,4-thiazolidine-dione / th iazan-2,4-dione) 
V B / V I B , X = S, (2-thiono-4-thiazolidinone or rhodanine /2- th iono-4- th iazanone) 
V C / V I C , X = NR, (2- immo-4-thiazol idinone or pseudoth iohydantom / 2- imino-4- th iazanone) R 
V D / V I D , X = N - N = C ^ (2-hydrazmo-4- th iazol id inone/2-hydraz ino-4- th iazanone) 
Substituents in the 2, 3 and 5-positions may be varied, but the greatest 
difference in structures and properties is exerted by the group attached to the 
carbon atom in the 2-position (Rj and R2 in formula II I , IV and X in formula 
V, VI). Variations in the substituents attached to the nitrogen atom and the 
methylene carbon atom are possible for the structures represented by 
formulas III , IV, V and VI. 
4-Thiazolidinones have been the subject of extensive study in the 
recent past. Numerous reports in the form of chemical reviews''^ and review 
articles^'"''^ have appeared in the literature which highlight their chemistry and 
1 6 6 
use, especially syntheses, reactions and biological activity. 4-Thiazolidinone 
derivatives have been found to be associated with diverse biological activities 
such as bactericidal^"'", fungicidal^"'", insecticidal"" '^, pesticidal''*, 
herbicidal '^ ' '^ antitubercular'^"'^, antiinflammatory^""^^ antitumor^'', 
antipsychotic^^"^^, antiviral^^"^", anti-convulsant^'"^'*, anthelmintic^^'^^ 
respiratory activity^^'^^ antidiarrhoeal^^ and antiarthritic^^. A number of 
thiazolidinone derivatives has also been found to exhibit highly potent anti-
anti-histaminic'^^"'''', antidiabetic'^^''"', oxygenase inhibitory^^, calcium 
antagonist'^^ potassium inhibitory"^', PPAR agonist '", cardioprotect ive ' ' , 
antiischemic activity" ' '^ and as promising agent for treating Alzheimer 
disease'^^, cancer^'* and viral diseases like AIDS^^'^"'^"' and hepatitis-B^'. 
Although 4-thiazolidinones have established chemistry, there is only 
sporadic reports on the anaologous 4-thiazanones. They are also associated 
with wide range of biological activities such as treatment of cardiac 
arrhythmia''^, tranquilizer^^ anticoagulant^^, treating peptic u lcer '^ 
antimicrobial^^"^', antiarthritic®^, anti-rheumatic^^, pesticidal activity'"'' 
immunoregulatory agent^^ and for treating occular inflammation^®. 
Several methods for the preparation of 4-thiazolidinones and 4-
thiazanones have been reported in the literature which are based mainly on 
the reaction of: 
1. a/p-mercaptoalkanoic acids with 
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(e) alkali thiocynates 
a/p-Mercaptoalkanoic acids have been extensively used for the 
syntheses of 4-thiazolidinones/4-thiazanones. The substituted and 
unsubstituted a/p-mercaptoalkanoic acids react conveniently with Schiff 
bases of aromatic or heterocyclic aldehydes or ketones and aliphatic or 























R = alkyl, aryl or heterocyclic Rj = H, alkyl, aryl or heterocyclic 
R2 = alkyl, aryl or heterocyclic R3 = H, alkyl 
R4 = H, alkyl 
Hydrazones of aldehydes or ketones react with substituted or 
unsubstituted a/p-mercaptoalkanoic acids to form 2-substituted or 2,2-
disubstituted 4-thiazolidinones (IX) '^^ "'®'^  or 4-thiazanones (X)®'. 
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- H 2 O 
R 

















R = alkyl, aryl or heterocyclic 
R2 = alkyl, aryl or heterocyclic 
Ri = H, alkyl, aryl or heterocyclic 
R3 = H, alkyl 
R4 = H, alkyl 
a-Mercaptoacetic acid or p-mercaptopropionic acid reacts with the 
aldehyde or ketone in the presence of ammonium salts such as ammonium 
carbonate or acetate in inert solvent. The reaction seems to proceed by the 
formation of an aldimine or a ketimine intermediate followed by the 
cyclisation with a-mercaptoacetic/p-mercaptopropionic acid to form 2,2 
disubstituted-4-thiazolidinones (XI)^''^^-^^/4-thiazanones (XII) 




HS CH2 CH2COOH/NH3 
-H2O 





R,^  ^S-^ R3 
XII 
R = Her alkyl Rj-a lkyl or aryl 
a-Mercaptoacetamide reacts with the carbonyl function of aldehydes in 
the presence of catalytic amounts of p-toluenesulphonic acid or 
1 6 9 
borontrifluoride ethereate in inert solvent to give 2-substituted-4-










R = alkyl, aryl 
a-Mercaptothiocarboxylic acids can also be used for the synthesis of 4-





-"2S Ri "S' 
XIV 
R = alkyl or aryl Ri = H or alkyl R2 = alkyl or aryl 
A number of spiro-4-thiazolidinones (XV, XVII ) and 4-thiazanones 
(XVI, XVII I ) have been prepared by the reaction of cyclic ketones with 
a-mercaptoacet ic acid or P-mercaptopropionic acid in presence of ammonium 









XV, XVI: R = H 
XVII, XVIII: R = alkyl or aryl 
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Substituted and unsubstituted a/p-mercaptoalkanoic acids, their esters 
react smoothly with the compounds containing activated nitrile groups in the 
presence of an equivalent amount of alcoholate to give 4-thiazolidinones 
(XIX)^^ or 4-thiazanones (XX)^^ 




















H N ' " 
XX 
R = Alky], 
R3 = H or aryl , 
Ri = H or alkyl, R2 = H or alky! or aryl 
R4 = COOEt, CONH2, CN, Pyridyl, Indoyl or Ph 
Monforte et al.^^ have synthesized 4-thiazolidinones by reacting 
carbodiimides with a-mercaptopropanoic acid. The acid reacts with one of the 
two carbodiimidic C=N groups to give 3-substi tuted-2-imino-5-methyl-4-
thiazolidinones (XXI). 
c„, 
H S — C H - C O O H 
R - N = C = N - R — 
-H2O R _ N ' ^s" 
R = alkyl or aryl 
XXI 
Substituted 2-imino-4-thiazolidinones (XXII) or 2-imino-4-thiazanones 
(XXIII) are obtained in good yields by the reaction of symmetrical and 
unsymmetrical thioureas with various substituted and unsubsti tuted a /p -
1 7 1 
haloalkanoic acids, their esters, acid chlorides, amides and carbamates. The 
reaction proceeds via the intermediate isothiourea which cyclise in the 
presence of sodium acetate or pyridine^^''°^ 
R - N H - C - N H R , 
SH 
I 
R ^ N H - C = N R , 
X - C - C O Y 
I 
R3 
- H X 
O 
N H 
R , N 
^s-' 'R2 
XXII 
X - C H - C H 2 - C O Y 
o 
- H X , - H Y 
R i N ^ S ' 
XXIII 
R = alkyl, aryl or heterocycHc 
R2 = H or alkyl 
R] = alkyi, aryl 
R3= H or alkyl 
A number of fused thiazolidin-4-ones (XXIV) or fused thiazan-4-ones 
(XXV) have been prepared by the reaction of cyclic thioureas with various 
substituted a//?-haloalkalnoic acids and their derivatives^^"^' '®'*"'®'. 
X-CH2-C0Y 
HN NH 
R = H or alky! 
X = Halo-
Y = CI or OR 









X X V 
.0 
2-Imino-4-oxo-5-thiazolidinoneacetic acid (XXVI) can be conveniently 
prepared from dicarboxylic acids'"^. a-Bromosuccinic acid on treatment with 
thioureas in the presence of sodium acetate in methanol gives 2-imino-4-oxo-
S-thiazoUdinoneacetic acid. 
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HN ^ " 
XXVI 
R = H, alkyl or aryl 
Recently, Madhukar S. Chande et have synthesized 3-amino-2 
alkyl/arylimino-5-carbethoxymethyl thiazolidin-4-one (XXVII) by the 
reaction of diethylbromomalonate (DBM) with 4-arylsubstituted 
thiosemicarbazide in ethanol in the presence of pyridine. 
H2N 
RNH-C-NHNH2+H5C200C"^~CH2COOC2H5 I \ 
XXVII 
R = H or aryl 
Thioureas add to the unsaturated carbon-carbon linkage of maleic, 
fumaric, citraconic acids, their esters, imides and anhydrides probably by a 
Michael type reaction and cyclisation to give a 2-imino-4-oxo-5-




R N H - C - N H 2 + H O O C - C H = C H ^ O O H ~ = Y 2 0 
RN/ X g X ^CHjCOOH 
R = H, alkyl 
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Dimethyl acetylenedicarboxylate (DMAD) reacts readily with 
substituted thioureas, thiosemicarbazides and thiosemicarbazones to give 4-
thiazolidinones (XXIX)"" 
R N H - C - N H R + H3COOC - C = C -COOCH3 
R=H, C H 3 , C g H j C H j or C ^ H j 
C H C O O C H , 
Dihydro-l,3-thiazin-4-one derivatives (XXX) and (XXXII) are formed 
when alkyl propiolates were added to thioureas and dithiocarbamic acids 
respect ively"^ In the latter case, it is necessary to cyclize the initial products 
(XXXI) with acetic anhydride. 
o 
R i - C = C — C O O E t -
R2NRCS.NHR2 
- E t O H 
NHt.CS2H 
Ri - alkyl 
NR2 
Ri^  ^ S ' ^ N R z 
XXX 
[ - E t O H 





When the thiosemicarbazone of aldehyde or ketone is allowed to react 
with substituted or unsubstituted a-haloalkanoic acids, their esters, amides in 
the presence of sodium ethoxide or sodium acetate, the product formed is 
aldehyde or ketone derivative of 2-hydrazino-4-thiazoiidinone (XXXIII)"^'"^ 






R - N H - C = : N - N 
R2 
R = H or aryl 
R2 = alkyl or aryl 
X-CH-COY Ri 
- H X , - H Y R2 
\ 
X-CH,-CH,-COY 
-HX, - H Y RI 
R] = H, alkyl or aryl 
R3 = H, alkyl or aryl 
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R. .0 
•N-







A number of exonuclear thiazolidin-4-ones (XXXV) have been 
prepared by the reaction of thiosemicarbazones of cyclic ketones with 
substituted and unsubstituted a-haloalkanoic acids in the presence of sodium 
acetate or sodiumethoxide"^"'^". 
S R2 ^ 
II r - H X A A 
N - N H - C — N H ~ R I + X - C H - C O Y — ^ ( C H J ) , , J = 
Rlx 
O 
N - N Rj 
Ri=H,Aiyl, alkyl 
R2 = H, alkyl, aiyl XXXV 
When a,p-unsaturated acyl isothiocynates were reacted with alkyl 
amines or aromatic amnes, it gave the corresponding thioureas (XXXVI) 
which on intramolecular cyclization under different conditions (BF3, NaOEt 
etc.) yielded the l,3-thiazin-4-one^^'- '" (XXXVII) 
o 








R = Alkyl, aryl, heterocyclic Ri = H, alkyl, aryl 
R2 = Alkyl, aryl R3 = H, alkyl, aryl 
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A.F.S. Ahmad'^'^ et al. have reported that the reaction of cinnamoyl 
isothiocyanate with 4-pyridine carbohydrazide yielded N-cinnamoyl triazole 
(XXXIX) presumably via the non-isolable thiosemicarbazide (XXXVIII ) . 
Base induced cyclization of (XXXIX) resulted in the intramolecular 

















A number of 2-pyridyl/aryl substituted 4-thiazolidinones (XLI) have 
been synthesized by Tanabe et al" '^ in 1995 following the method of surrey^^ 
by condensing a-mercaptoalkanoic acids with aldehydes and primary amines 
or with corresponding Schif f s bases in refluxing benzene or toluene with 
continuous removal of water being formed and found to exhibit highly potent 
and selective anti-Platelet Activating Factor activity both in vitro and in vivo. 
Me H Ri 
I 
R — C H = N - M e HS.CH.COOH 
0 Me 
XLI 
R = 3-pyridyl, 4-CI.C6H4, 4-N02 C6H4, 4-MeO.C6H4 
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S.M. Osman and coworkers have prepared some long alkyl chain 
substituted thiazoIidin-4-ones and thiazan-4-ones from modified fatty acids as 
part of their programme of preparing fatty acid derivatives^^"^^ They^^ have 
reported the synthesis of long alkyl chain substituted thiazolidin-4-ones 
(XLII) and thiazan-4-ones (XLIII) by reacting 10-oxoundecanoic acid and 
12-oxooctadecanoic acid with mercaptoacetic acid and 3-mercaptopropionic 








H N ^ ^ S 
O 
HS .(CH2)2 .C00H 
XLII 
R ^ R , 
H N ^ ^ S 
(NH4)2C03 /benzene 
O' 
XLIII R =CH3, CH3(CH2)8,CH3 (CH2),6 
Ri = (CH2)g.COOCH3, (CH2)7.C00CH3 
Similar reaction of 9,10-dioxooctadecanoic acid with mercaptoacetic 
acid or 3-mercaptopropionic acid and ammonium carbonate gave two 
isomeric thiazolidin-4-ones (XLIVa) and (XLIVb)^^'^"' or thiazan-4-ones 
(XLVa) and (XLVb). 
0 
R i 





R - X 





H S . ( C H 2 ) 2 . C 0 0 H 
RI 
(NH4)2C03 /benzene 0 ' 
XLVa XLVb 
R = C H 3 ( C H 2 ) 7 
R i = ( C H 2 ) 7 . C 0 0 C H 3 
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J. Mustafa and S.M. Osman^^ have reported the preparation of a mixture 
of isomeric thiazan-4-ones (XLVIa) and (XLVIb) by reacting a,P-
unsaturated fatty acid, (£')-methyl-4-oxooctadec-2-enoate with 3-




A r , 
H 
R=CH3(CH2),3 




They have also prepared a mixture of thiazolidinedione (XLVII) and a 
thiazole (XLVIII) by heating a solution of (£)-methyl-4-oxooctadec-2-enoate 







dil. HCI, reflux 
R=CH3(CH2)I3 
















W.H. Ansari and co-workers^®"^^ have synthesised two novel 
compounds 2-[3-carboxyethylthio-2-(phenyl)ethyl]-2-(4-chlorophenyl)tetra-
hydro-l,3-thiazin-4-one^^ (XLIX) and 2-[2-carboxymethylthio-2-(4-chloro-
1 7 8 
phenyl)ethyl]-2-(4-chlorophenyl)thiazolidin-4-one^^''' ' ' (L) as two novel 
compounds from 4,4'-dichlorochalcone using 3-mercaptopropionic acid/ 
mercaptoacetic acid in presence of ammonium carbonate. In 2002, they have 
synthesised a new compound, 2-[2,2-bis(4-chlorophenyl)ethyl]-2-(4-
Q n 
chlorophenyl)thiazolidin-4-one (LI) from 4,4'-dichlorochalcone via 1,3,3-
tris(4-chlorophenyl)propan-l-one using mercaptoacetic acid in presence of 
ammonium carbonate in dry benzene. Compounds (L) and (LI) were studied C 7K B B 
for cyctotoxic activity ' against 60 cell lines of nine types of human 
cancers. Noteworthy results were obtained in the case of melanoma, colon 
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S U M M A R Y 
The work described in this chapter includes the reaction of 
m-nitrobenzaldehyde-10-undecenohydrazone (24) with: 
(i) Mercaptoacetic acid in dry benzene which furnished an adduct, m-nitro-
benzaldehyde-1 l-(carboxymethylthio)undecanohydrazone (25) and a 
novel compound, 2-(3-nitrophenyl)-3-[ll-(carboxymethylthio)undecana-
mido]thiazolidin-4-one (26). 
(ii) 2-Mercaptopropiomc acid in dry benzene which yielded two novel 
compounds, 2-(3-nitrophenyl)-5-methyl-2-(10-undecenamido)thiazolidin-4-
one (27) and 2-(3-nitrophenyl)-5-(methyl)-3-[l l~{(l-carboxy)ethylthio} 
undecanamido]thiazolidin-4-one (28). 
(iii) 3-Mercaptopropionic acid in dry benzene which afforded an adduct, 
m-nitrobenzaldehyde-11 -(2-carboxyethylthio)undecanohydrazone (29) and 
a novel compound, 2-(3-nitrophenyl)-3-[ll-(2-carboxyethyl-thio)undecan-
amido]thiazan-4-one (30). 
The hydrazone (24) as a substrate was prepared from 10-undecenoicacid 
by treatment with hydrazine hydrate in the presence of MeOH and acid to give 
10-undecenoacid hydrazide (23) which on condensation with m-nitro-
benzaldehyde yielded the hydrazone (24) as yellow globules in 87% yield. It was 
found to exist in two stereoisomeric forms as synperiplanar (major) and 
antiperiplanar (minor) as are evident from its stereochemical studies. 
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INTRODUCTION 
A survey of literature revealed that in recent years attention has been 
focussed on the synthesis of analogs of naturally occurring long alkyl chain 
substituted heterocycles'^^""® and the interest in substituted thiazolidin-4-ones 
and thiazan-4-ones in particular for medical application is increasing 
strongly. The compound, (-) 2-(5-carboxypentyl)-4-thiazolidinone known as 
actithiazic acid is an antibiotic which was isolated'^^®'*' from the culture broth 
of a strain of streptomyces and found to show highly specific in vitro activity 
against Mycobacterium tuberculosis. Another compound, 2-(4-chlorophenyl)-
3-methyl-4-thiazanone-l,l-dioxide, known by the generic name 
chlormezanone, is an important pharmaceutical compound and is widely used 
as a tranquilizer^^ which is effective in the treatment of anxiety and tension 
states. It has also been claimed to be of beneficial in muscle spasm"' and 
effective as anticoagulant^^. 
CI 
Q 
o,s ' N - M e 
O 
Actithiazic acid Chlormezanone 
During the past few years, several 2-sbustituted thiazolidin-4-ones and 
thiazan-4-ones have been synthesized and found to possess anticonvulsant^'*, 
antidiarrhoeal^^, antihistaminic'*^''*'', antimicrobial^"'®'^^ oxygenase 
inhibitory''^, calcium antagonist'*^ and K"^  channel inhibitory activity'*^ 
Recently, a number of 2-pyridyl substituted 4-thiazolidinones has been 
synthesized'*' and found to exhibit highly potent and selective anti-Platelet 
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Activating Factor activity both in vitro and in vivo. Although a large number 
of reports''^ are available for the aromatic and heterocyclic substituted 
thiazolidin-4-ones and thiazan-4-ones, there is only sporadic reports on long 
alky] chain substituted thiazolidin-4-ones and thiazan-4-ones^^'^^ Also a 
number of long chain alkyl thioethers have been reported for their 
b a c t e r i c i d a l f u n g i c i d a l ' ^ ^ \ tranquilizer'^^, anti-cholestermic'^^ 
analgesic'^® and antidepressant'^® activities. 
As part of our programme in search of biologically active compounds 
with sulphur and nitrogen containing heterocycles, we have synthesised 2-[2-
carboxymethylthio-2-(4-chlorophenyl)ethyl]thiazolidin-4-one as a novel 
compound^^. Because 4-thiazolidinones substituted in the 2-position were 
proven to be biologically very potent and selective"" and in anticipation that 
by incorporating a long chain alkylthioether moiety to thiazolidin-4-one ring, 
the biological activity may be enhanced due to lipophilization of the resulting 
molecule, we have undertaken this problem. It consists of the synthesis of the 
following four novel compounds, (i) 2-(3-nitrophenyl)-3-[l l-(carboxy-
methylthio)undecanamido]thiazolidin-4-one (26), (ii) 2-(3-nitrophenyl)-5-
(methyl)-3-(10-undecenamido)thiazolidin-4-one (27) and 2-(3-nitrophenyl)-5-
(methyl)-3-[l l-{(l-carboxy)ethylthio}undecanamido]thiazolidin-4-one (28), 
(iii) 2-(3-nitrophenyl)-3-[l l-(2-carboxyethylthio)undecanamido]thiazan-4-
one (30) from m-nitrbenzaldehyde-lO-undecenohydrazone (24) using 
mercaptoacetic acid in (i), 2-mercaptopropionic acid in (ii) and 
3-mercaptopropionic acid in (iii) in dry benzene. An adduct, 
m-nitrobenzaldehyde-ll-(carboxymethylthio)undecanohydrazone (25) in the 
former and w-nitrobenzaldehyde-11-(2-carboxyethylthio)undecanohydrazone 
(29) in the latter was also obtained in good yields. 
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The hydrazone (24) as a substrate has been prepared by the reaction of 
10-undecenoacid hydrazide (23) with w-nitrobenzaldehyde and its 
stereostructure discussed. Structural assignment, stereochemistry and 
biological assay are discussed. Screening results of the compounds (24), (26), 
(27), (28) and (30) are summarised for cytotoxic activity against 3-cell lines 
of three types of human cancers: lung, breast, CNS and then 60 cell lines of 
nine types of human cancers: leukaemia, lung, colon, CNS, melanoma, 
ovarian, renal, prostate and breast. Screening results of the above compounds 
are also summarised for antimicrobial activity against four bacteria, 
Escherichia coli. Bacillus subtilis, Staphylococcus aureus, Pseudomonas 
aeruginosa and one fungi Candida albicans (details in Chapter 6) 
(24) 
1 8 3 
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RESULTS AND DISCUSSION 
The syntheses of compounds, (25)-(30) have been performed in two 
steps (Scheme 1). The hydrazone FB (24) was first prepared following a 
published procedure^ by refluxing a solution of 10-undecenoacid hydrazide 
(23) in dry benzene with w-nitrobenzaldehyde (molar ratio, 1:1), as yellow 
crystalline needles in 87% yield. The hydrazone FB (24) was then reacted 
with (i) mercaptoacetic acid, (ii) 2-mercaptopropionic acid and (iii) 
3-mercaptopropionic acid (molar ratio, 1:3) in dry benzene. The products on 
column chromatography over silica gel using pet. ether-diethyl ether as eluent 
yielded compounds FBX,B (25) and FBX,C (26) in (i); F B X 3 A (27) and 
F B X 3 B (28) in (ii), and FBX^B (29) and FBX2C (30) in (iii). In the reaction 
of (24) with 2-mercaptopropionic acid, it was observed (TLC examination) 
that condensation competes addition, yielding (27) as the first product and 
then (28). The increased nucleophilicity of the thio group in 2-mercapto-
propionic acid probably facilitates condensation. 
1 8 5 
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m-Nitrobenzaldehyde-lO-undecenohydrazone FB (24) 
The outl ine of its synthesis is as fol lows 
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O O 
MeOH/H"" 
'OH NH2.NH2.H2O ^NH-NH2 (23) 
dry benzene 
Reflux, 5 h 
O 
N07 
s tructura l Elucidation of FB (24) 
It was a yellow globule shaped crystalline solid, m.p. 128 °C. The 
structure of FB has been fully confirmed by IR, DCI-MS. 'H-NMR, NOE, 
'^C-NMR and HETCOR spectra. IR spectrum exhibited characteristic bands at 
3100 (N-H), 2950, 2850 (C-H), 1660, 1640 (C=0) , 1580 (phenyl), 1550 
(C=N), 1510 (NO2, asym. str) and 1330 (NO2, sym. str) cm"'. The DCI-MS 
spectrum showed a [M+l]'^ signal as the base peak at m/z 332 conforming its 
molecular weight 331 which corresponded with the molecular formula 
[C18H25N3O3]. It is equal to the sum of the molecular weights of (24) (349) 
and m-nitrobenzaldehyde (151) minus one molecule of water. This suggested 
that the formation of a Schiff base has occurred by the condensation of 
10-undecenoacid hydrazide (23) with m-nitrobenzaldehyde. 
The 'H-NMR and '^C-NMR spectra (Fig. l a and l b ) dissolved in 
acetone-<i^ showed signals as assigned (Table la) . The assignments of all 
signals to specific H- and C-atoms have been performed on the basis of 
typical 5-values, multiplicity, relative integrations, a HETCOR spectra and 
also by comparing the spectra with reference spectra (SDBS) '^ ' of 








O — TJ n 
10 ^ ^ 
i n N u o o 
t n • • M o £ g 
c ^ T> O 
o o a j a 
•O Xt n c €* 
ai 
"Sg 
o> O I 
0 — zz\ » « 
K ? : g i it ^ K £ 
_ ° S Sr!. . 
a S c o o t - - ' • 
H - o c u w ^ o ^ c 
a s ; 
lO - -
« 40 • 3 
i D O l — m o r v i - ^ c n o 
It) m (O — 













r^ o — (\ j — rv PI — f ^ o 

























c^  o 
X X i X 
(N in NO 1 w k. 
































' vO • vP 
^ ^ l O 
rf m in 
— (N —' (N 
v-i N® r- N° oo o^  o 
in (N ^ fS 
ON R-
o " ^ O . ^ in o r^  o t— Ti- j ; 
m o ~ ro 
in 
• (N i 
Os <N 
ON oo o <N NO 00 o (N oo in NO 00 m ON ^ ON r-' ON d ND rr m (N (N 
' — ' 
r- <N 
cc 1—' (N 
























t^ r^  o ^ ~ T 
- Si o 
c ^ K -




r o o o ON 
o o OO r- On 
— r-- — 
r. 
On o o ON OS O S r ^ 
II II II II 
'—) •—1 ) 
S Q 
Cl vi 
u •M X) 
•o •a T3 "O 
-o -o •a •o •o T 3 
I s bJO S 01 




E E a: K X X 
s 
c. a. w to 
l i 00 
„ N? f-^  ON .-H in 
m c- ^ 
Tt ^ r^  o^  ON • in r^  m NO ^ • 
1 (N 00 00 ND Os (N — rM O oo On OJ ' — ' 







o b CN 
w N V-. i-






1 9 0 
10-undecenoic acid, 10-undecenamide and w-nitrobenzaldehyde. The 'H-
NMR and '^C-NMR spectra dissolved in acetone-iig showed several double 
signals, especially of NH, H-7 and H-2' in the 'H-NMR spectrum and of C-7, 
C - r , C-2', C-3', C-2 and C-6 in the '^C-NMR spectrum which indicated that 
this molecule is present in two different forms. The two forms were found to 
be in the ratio ( -3 :1) as calculated from the integration values of the N-H and 
H-2' signals in the 'H-NMR spectrum. This can be thought of about the 
geometrical {E/Z) isomers of the C=N bond or stabile conformers around 
single bond such as in the CO-NH group. Irradiation of the NH protons (Fig. 
Ic) resulted in a NOE-enhancement of H-7 (both signals), showing that the 
N-H proton and H-7 (in both forms) are very near to each other. This can only 
be the case in ^-isomer. Further, in case of H-2' signals, a NOE enhancement 
was observed only for the largest H-2' signal ( -75%) and absolutely no NOE 
enhancement was seen for the small H-2' signal ( -25%) (Table la). This 
showed that only in the major form, the H-2' protons are near to the NH-
proton. It was therefore, concluded that both forms of m-nitrobenzaldehyde-
10-undecenohydrazone (24) are due to a major synperiplanar CO-NH 
conformation (~75%>) and a minor antiperiplanar CO-NH conformation 
( -25%) which are in equilibrium with each other as presented in (Fig.l) . An 
additional evidence for this conclusion is the fact that in the 'H-NMR 
spectrum of this compound dissolved in DMSO-t/g (Table lb) , again two 
forms are observed but in a (~ 4:6) ratio. This observation again is an 
indication that the two forms are stabile conformers which are in equilibrium 
with each other, an equilibrium which is dependent on the polarity of the 
solvent. 
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Table l b : 'H-NMR spectral data of FB (24) in DMSO-t/g 





7 8.09, 8.50 
( -60%, 40%) 
IH s 
NH 11.41, 11.54 
(60%,40%) 
IH s 
2' 2 . 22 , 2 .64 
( 4 0 % , 6 0 % ) 
2H t J r j ' 7.30, 7.41 
3' 1.60 2H br p J~7.35 
4'-8' 1.28 5x2H br s 
9' 2.00 2H m 
10' 5.76 IH tdd 
J,o..9' 6.77, J,O',hz10.26, Jio'.Hz 17.22, 
HE 4.93 IH dd Jhe,io' 10.26, JHE, HZ 2.01 
Hz 5.00 IH dd 
1 
J H , I O ' 17.22, Jhe, Hz 2.01 
Ar-2 8.47 IH dd J - 2.03, 2.02 
Ar-4 8.26 IH dd J= 8.23, 2.02 
Ar-5 7.72 IH dd J= 8.23, 7.51 
Ar-6 8.09 IH d J= 7.51 
The assignments of the protonated carbons in (Table l a ) was further 
confirmed by HETCOR spectra (Fig. Id). It was found that 5h signals are 
correlated with 5c signals at 6h 8.17, 8.46 ( -75%, 25%; H-7) to 5c 140.79, 
144.53 ( -75%, 25%; C-7); 6h2.74, 2.33 ( -75%, 25%; H-2') to 6c 33.09, 35.55 
( -75%, 25%; C-2'); 6h 1.69 (H-3'), to 5c 25.41, 26.07 ( - 7 5 % , 25%; C-3'); 5h 
1.31 (H-4'-8') to 6c 29.41-30.38 (C-4'-8'); 6h2.02 (H-9') to 6c 34.42 (C-9'); 6h 
5.78 (H-10') to 5c 139.81 (C-10'), two signals at 5h 4.88 (He-1 1') and 5h 4.96 
( H z - l l ' ) to 5 c 114.59 (C-IV). In aromatic region, the signals at 5 h 8.49 














y - nn 
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(H-Ar-2) correlated to 5c 121.80 (C-Ar-2); 6h 8.22 (H-Ar-4) to 5c 124.56 
(C-Ar-4); 6h 7.71 (H-Ar-5) to 6c 130.98 (C-Ar-5) and 6h 8.12 (H-Ar-6) to 
5c 133.30 (C-Ar-6) as shown in Table la. 
On the basis of these spectral evidence, the structure of compound FB 
formulated as m-nitrobenzaldehyde-lO-undecenohydrazone (24) was deduced 
to be in its two forms, synperiplanar (major) and antiperiplanar (minor) as 
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m-Nitrobenzaldehyde-ll-(carboxymethylthio)undecanohydrazone FBX,B 
(25) and 2-(3-nitrophenyl)-3-[ll-(carboxymethylthio)undecanamido]thia-
zolidin-4-one FBXjC (26) [Reaction of the hydrazone (24) with 
mercaptoacetic acid] 
A solution of the hydrazone (24) in dry benzene was refluxed with 
mercaptoacetic acid (molar ratio, 1:3) for 16 h collecting the generated water 
in an azeotropic water collector. The solvent was distilled off under reduced 
pressure and the orange oily residue left was chromatographed over a silica 
gel column using (pet.ether-diethylether, 1:1 v/v) as eluent which yielded the 
two products, FBX,B (25) as crystalline yellow globules (EtOH) in 31.2% 





"NO2 dry benzene, 







O O N02 
0 NH —N S 
FBX,C(26) 
Structure Elucidat ion of FBX^B (25) 
It was a yellow globule shaped crystalline solid, m.p. 120 The 
structure of FBXjB has been established by IR, DIC-MS, 'H-NMR and 
'^C-NMR spectra. IR spectrum (KBr) showed characteristic bands at 3250 
(NH), 3075 (OH), 2900, 2850 (C-H), 1725 (COOH), 1645 (CO), 1610 
(phenyl), 1555 (C=N), 1520 (NO2, asym str), 1350 (NO2, sym str) and 1465 
( S - C H 2 ) cm' ' . The DIC-MS spectrum showed a [M+1]^ peak at m/z 424 
confirming its molecular weight 423 [C20H29N3O5S], which is equal to the 
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sum of the molecular weights of (24) (331) and mercaptoacetic acid (92) 
suggesting that (25) is an adduct of (24) and mercaptoacetic acid. The peak 
appeared at m/z 164 [M-C13H23O2S]'' was due to the cleavage of CO-NH 
bond. The base peak at m/z 148 [M-Ci3H25N03S]"^ arised by the cleavage of 
N-NH bond and other peaks at m/z 134 [M-Ci5H2oN303]^ and at m/z 118 [M-
C i 6 H 2 3 N 3 0 3 ] ^ formed by the cleavage of 8'-9' bond and 9'-10' bond of the long 
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m/z 148 (100.0) 
CHART 1 
The signals in 'H-NMR and '^C-NMR spectra dissolved in DMSO-c?^ 
were assigned to individual H and C atoms (Table 2a) by comparing with the 
spectra of (24) (Table la) . The 'H-NMR spectrum dissolved in acetone-ii?^ 
showed clearly that this compound was formed by the addition of 
mercaptoacetic acid to terminal C=C double bond of compound (24) as the 
signals for the terminal olefmic protons at 5 4.88 (Hg-l 1') and 5 4.96 (H^-l 1') 
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in (24) have disappeared and a new pealc corresponding lo the methylene 
protons at C- I" of the terminal thioether moiety appeared as a singlet at 
5 3.22. The signals for H-10' appeared as a broad pentet nt 5 1.69 (J~7.28) 
and for H-11' appeared as a triplet at 5 2.64 (J=7.32). This was further 
confirmed by '^C-NMR spectrum which also showed the disappearance of the 
signal corresponding to the olefmic carbons at 5114.59 (C-1 1') and 6 139.81 
(C-10') in (24) and the appearance of the new signal corresponding to the 
methylene carbon of the terminal thioether moiety at 5 33.20. It also showed 
a signal for the carboxylic carbon (C-2") at 5 171.47. The 'H-NMR and 
'^C-NMR spectra dissolved in DMSO-^/^/acetone-c/^ showed several double 
signals indicating that this molecule is also present in two Ibrms. The signals 
corresponding to C-1, C- l ' , C-2' in '^C-NMR spectrum and that of NH, H-7 
and H-2' in the 'H-NMR spectrum dissolved in in DMSO-f^, the two forms 
were found to be in the ratio (--6:4). From the NH, H-7 and 11-2' signals in the 
'H-NMR spectrum in acetone-t/^, the two forms were found in the ratio of 
( -3:1) as in (24) (Table 2b). This observation again is an indication that the 
two forms are stabile conformcrs which are in equilibrium with each other as 
shown in Fig. 2, an equilibrium which is dependent on Ihc polarity of the 
solvent. 
On the basis of the above discussion, the compound FBXiB was 
characterized as m-nitrobenzaldehyde-1 l-(carboxymethylthio)undecano-
hydrazone (25) and its two forms deduced are shown in Fig. 2 




anti-periplanar ^ NO2 
Fig. 2 






7 8.18, 8.48 
( -75%, 25%) 
IH s 
NH 10.29, 10.66 
( -75%, 25%) 
IH s 
T 2.31, 2.74 
( -25%, 75%) 
2H t J2.,3' 7.30, 7.41 
y 1.59 2H brp U1.2S 
1.31 6x2H brs 
10' 1.69 2H brp J=^7.28 
i r 2.64 2H t J,,MO'7.32 
1" 3.22 2H s 
Ar-2 8.51 IH dd J= 1.98, 1.83 
Ar-4 8.24 IH dd J=7 .93 , 1.98 
Ar-5 7.73 IH dd J= 7.94, 7.93 
Ar-6 8.14 IH dd J= 7.94, 1.98 
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Structure Elucidation of FBXi^C (26) 
It was a yellow oily liquid. The structure of FBXjC has been 
confirmed by IR, DCI-MS, 'H-NMR, '^C-NMR and COSY spectra. IR 
spectrum gave characteristic peaks at 3250 (NH), 3050 (OH), 2900, 2850 (C-
H), 1725 (COOH), 1685 (CON) 1660 (CONH), 1610 (Phenyl), 1525 (NO2 
asym. str) 1355 (NO2 sym. str) and 1430 ( S - C H 2 ) cm-'. The DCI-MS 
spectrum (Fig. 3a) showed a [M+1]"^ peak at m/z 498 corresponding with the 
molecular formula [C22H31N3O6S2] which is equal to the sum of the molecular 
weights of compound (25) (423) plus mercaptoacetic acid (92) minus one 
molecule of water. This suggested that the formation of thiazolidinone ring 
has occurred by the cyclocondensation of (25) with mercaptoacetic acid. The 
mode of fragmentation is presented in Chart 2. The peak at m/z 452 was due 
to [M-COOH]"'. The other structure revealing fragment ion peak was 
observed at m/z 424 [(M+1)-C0CH2S]^ arised by the cleavage of 1-2 and 3-4 
bonds is the diagnostic peak of the thiazolidinone ring^^. Two a-cleavage 
fragments to the thiazolidinone ring on the long alkyl chain were observed at 
m/z 223 [M-C,3H24N03S]^ and m/z 276 [(M+1)-C9H7N203S]^ along with two 
y9-cleavage fragments at m/z 240 [(M+l)-Ci3H22 03S]^ and m/z 258 [M-
C9H9N303S]^ The base peak was observed at m/z 210 [(M+l)-Ci3H24N203S] 
arised by the cleavage of 2-3 and 3-4 bonds of the ring. The peaks at m/z 231 
[M-C8H9N302S]^ and m/z 215 [M-Ci4H26N03S]^ were formed by the cleavage 
of V-2' and 2'-3' bonds of the long alkyl chain. It also showed some common 
fragment ion peaks to that of (25) at m/z 166, 148, 134 and m/z 118. 
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m/z 240 (91 8) 
2 0 2 
m/z 1 18 (32 2) 
c 
I I I s 
Q 
m/z 223 (27 2) 
NO2 
m/z 166 (40 4) 
The signals in 'H-NMR and '^C-NMR spectra dissolved in acetone-^^^ 
(Fig. 3b and 3c) were assigned to individual H-and C-atoms (Table 3). The 
assignments were made from their typical chemical shift values, coupling 
constants, relative integrations and also by comparing with the spectra of 
FBXiB (25) (Table 2a and 2b). The 'H-NMR spectra are strongly in agreement 
with the formation of a thiazolidinone ring as the H-7 signal of (25) has shifted 
from 5 8.18, 8.48 ( -75%, 25%) to higher field 6 6.04 (H-2 in FBXiC) due to 
the disappearance of C=N double bond and the appearance of two 
diastereotopic hydrogen atoms of thiazolidinone ring in the form of double 
doublets by coupling with H-2 at 5 3.84 (Jjtrans.a 15.87, 1.68, H-5trans) and S 
3.75 ( Jsc.s,215.87, 0.92, H-5cis). Also, the '^C-NMR spectrum (acetone-J^) 
indicated the formation of a thiazolidinone ring as the C-7 signal of FBX ,A 
has shifted from 5 139.99, 143.24 (-60%, 40%) to 6 62.23 (C-2 in FBX,B). 
The assignment of signals as depicted in Table 3 and the coupling of the 
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protons were further confirmed by COSY spectra (Fig. 3d). The broad signal at 
5 6.04 (H-2) showed a weak cross peak with two double doublets at 5 3.75 
(J=15.87, 0.92, H-5c,s) and at 5 3.84 (J-15.87, 1.68, H-5trans) indicating the 
coupling of H-2 proton with both the ring methylene protons at C-5. In contrast 
to FB (24) and FBXjB (25), only one form of FBXjC (26) appeared in the 
spectra. 
Based on the above discussion, compound F B X , C was characterized as 
2-(3-Nitrophenyl)-3-[l l-(carboxymethylthio)undecanamido]thiazolidin-4-one. 
(26) and is represented as 
H 
2- . 1 , H , ... 
F B X i C ( 2 6 ) ° H H 
2-(3-Nitrophenyl)-5-(methyl)-3-(10-undecenamido)thiazolidin-4-one FBX3A 
(27) and 2-(3-nitrophenyl)-5-(methyl)-3-[ll-{(l-carboxy)ethylthio}undecan-
amido]thiazolidin-4-one FBX3B (28) [Reaction of the hydrazone (24) with 
2-mercaptopropionic acid] 
A solution of FB (24) in dry benzene was refluxed with 
2-mercaptopropionic acid (molar ratio, 1:3) in dry benzene for 22 h after 
which TLC examination revealed the presence of two spots labelled as 
FBX3A (27) (upper) and FBX3B (28) (lower). The products on usual work up 
and column chromatography yielded two liquid compounds, FBX3A (42.3%) 
as colourless oily liquid and FBX3B (34.5%) as a pale yel low oily liquid. The 
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"NO2 ''O' benzene, 
reflux, 22 h 
O H \ O x 
NH—N' "S 
M 
FBXjA (27) CH3 
Structure Elucidation of FBX^A (27) 
It was a colourless oily liquid. The structure of FBX3A has been fully 
established by DCI-MS, 'H-NMR, and '^C-NMR spectra. The DCI-MS 
spectrum (NH3 as a reagent gas) (Fig. 4a) showed [M+1]'^ peak at m/z 420 
and a less intense [M+18]"^ peak at m/z 437, confirming its molecular weight 
419 [C21H29N304S], which is equal to the sum of the molecular weights of 
compound (24) (331) and 2-mercaptopropionic acid (106) minus one 
molecule of water. This indicated that the thiazolidinone ring has been 
formed by the cyclocondensation of (24) with 2-mercaptopropionic acid but 
no addition of 2-mercaptopropionic acid to the terminal C=C double bond of 
the 10-undecenoyl side chain has occurred. The characteristic structure 
revealing fragment ion peak was observed at m/z 332 [(M+1)-C0CH(CH3)-
S]"^  arised by the cleavage of 1-2 and 3-4 bonds of the thiazolidinone ring. 
The a-cleavage fragment ion peaks to the ring were observed at m/z 237 
[(M+l)-CnH2oNO]^ and at m/z 184 [M^-C,oH9N303S]^ the /^-cleavage 
fragment ion peaks were observed at m/z 254 [(M+l)-CiiHi90]"^ and at m/z 
167 [ ( M + 1 ) - C i o H i ] N 3 0 3 S ] " ^ along with some lower mass ion peaks as shown 
in Chart 3, 
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N H ' 
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m/z 167 (60 5) 
CHART 3 
All the signals in the 'H-and '^C-NMR spectra dissolved in acetone-fig 
(Fig. 4b and 4c) have been assigned to specific H-and C-atoms (Table 4). 
The 'H-NMR spectrum is in strong agreement with the formation of a 
thaizolidin-4-one ring as the H-7 signal of (24) has shifted from 6 8.17, 8.46 
( -75%, 25%) to 5 6.01-6.04 (position 2 in F B X 3 A ) due to the disappearance 
of C=N double bond and formation of ring. Also the NH signal has shifted 
from 5 10.41, 10.76 ( -75%, 25%) to 5 9.28 due to the ring formation. The 
signal for the thaizolidin-4-one ring protons at C-5 appeared at 5 4.04 (IH, 
qd, J -6 .86 , 0.91, H-5cis) and 5 4.11 ( IH, qd, J=7.17, 1.53, H-5uans)- Also, in 
'^C-NMR spectrum, the C-7 signal of (24) has shifted f rom 8 140.79, 144.53 
( -75%, 25%) to 5 61.16. Contrary to FBXjC (26), the FBX3A (27) 'H-NMR 
spectrum showed signals for two terminal olefmic protons (=CH2) at 5 4.90 
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Hz-11') and the signal for olefinic methine proton (=CH-) at C-10' appeared 
at 5 5.81 ( IH, tdd, J = 6.72, 10.23, 17.09 H-10') indicating the presence of a 
C=C terminal double bond. This strongly suggested that the addition of 
2-mercaptopropionic acid to the terminal double bond has not occurred in this 
case. Also, in '^C-NMR spectrum, the signals of the o lefmic carbons appeared 
at 5c 139.88 (C-10') and 114.63 (C-11') further confirmed that addition has 
not occured. It is probably due to the increased nucleophilicity of the thio 
group in 2-mercaptopropionic acid which facilitated condensation rather than 
addition. Furher in 'H- and '^C-NMR spectra (Fig. 4a and 4b, Table 4), the 
signals corresponding to thiazolidinone ring protons/carbons at C-2, C-5, C-
5-CH3 indicated that this compound contained a mixture of isomers with cis 
and trans standing methyl and 3-nitrophenyl groups on the thaizolidin-4-one 
ring. However, it is not clear which isomer is the major and which one, the 
minor. 
Based on the above spectral evidence, compound F B X 3 A was 
characterized as 2-(3-Nitrophenyl)-5-(methyl)-3-(10-undecenamido)thiazo-




Structure Elucidation of FBXjB (28) 
It was a pale yellow oily liquid. The structure of F B X 3 B has been fully 
established by DCI-MS, 'H-NMR, and '^C-NMR spectra. The DCI-MS 
spectrum (Fig. 5a) showed a set of intense [M+1]"^ and a less intense [M+18]"^ 
peaks at m/z 526 and m/z 543 confirming the molecular weight 525 
[C24H35N3O6S2] which is equal to the sum of the molecular weights of 
compound F B X 3 A (419) and 2-mercaptopropionic acid (106). This suggested 
that compound F B X 3 B was formed by the addition of 2-mercaptopropionic 
acid to the terminal C=C double bond of F B X 3 A . The mode of fragmentation 
is presented in Chart 4. The peak at m/z 480 [M-COOH]"^ confirmed the 
presence of terminal thioether moiety in the compound. The peak at m/z 419 
was due to the loss of [M-HSCH(CH3)C00H]^. The peaks observed at m/z 
290 [(M+O-CioHgNjOsSJ^and at m/z 237 (base peak) [(M+1)-C,4H28N03S]^ 
were due to a-cleavage to the ring. The peaks at m/z 271 [M-CioHnN303S]^ 
and at m/z 254 [(M+l)-Ci4H25 03S]"' due to the y?-cleavage to the ring. The 
characteristic peak for thiazolidinone ring was obsereved at m/z 436 
[M-C0CH(CH3)S]^ as shown in Chart 4. 
All the signals in the 'H-NMR and '^C-NMR spectra dissolved in 
acetone-fig (Fig. 5b and 5c) could be easily assigned to specific H- and C-
atoms (Table 5) by comparison with the spectra of F B X 3 A (27) (Table 4). 
All the signals in both the spectra were found compatible with that of F B X 3 A 
(27) except H2C=CH- signals which didn' t appear here. In 'H-NMR spectrum, 
the signals at 6 4.90 (IH, dd, J=10.23, 2.13, HE - IT) and 6 4.98 ( IH, dd, 
J=17.09, 2.13, H z - l l ' ) of F B X 3 A disappeared and in place a new peak 
corresponding to H-1" of the terminal thioether moiety appeared as a quartet 
at 5 3.42 (J=7.02). This strongly supported that compound F B X 3 B has been 
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formed by the addition of 2-mercaptopropionic acid to the terminal C=C 
double bond of F B X 3 A . 
HO^  Y >-^ 0 NH2 
CH3 
m/z 289 (9 2) 
+H 
m/z 290 (33 1) 
m/z 147 (22 7) 
m/z 148 (10 3) m/z 237 (100 0) 
o K . CH3 
m/z 130(20 5) 
s 
N^O, 
m/z 166(15 5) 
CHART 4 
This was further confirmed by '^C-NMR spectrum which also showed the 
disappearance of the signals corresponding to the terminal C=C double bond 
at 6 114.63 ( C - i r ) and 6 139.88 (C-10') of F B X 3 A and the appearance of the 
new signals corresponding to the terminal thioether moiety at 6 41.35 (C-1"), 
174.33 (COOH) and 5 17.78 ( r ' - C H j ) indicating that the compound F B X 3 B 
contains both thiazolidinone and terminal thioether moieties. The signals of 
H-2, H-5, 5-CH3 in 'H-NMR spectrum and C-2, C-5, 5-CH3 in '^C-NMR 
spectrum (Table 5) again indicated that this compound also contains mixture 
of isomers with cis and trans standing methyl and 3-nitrophenyl group on the 










































G cs I—I u 
a m XI O O 
OO M CO ^ '—I ^ ^ m 00 
1—I r- ON ON o ^ CO m < fS 
(N 
fN) OO o 
o 
o cn 
(N Tf to ON 
CO •a T3 o lo <N NO 1—< OO m CO m OO m OO O to 
ON CO (N CO ^ to 













K b u r - H CN) 
U 1—N 1 ^ 1 1 - V-c 1 1 









NO r—< t> OO 00 CO 
to NO NO 
ON m I u 
ly-i 1 w-i 1 I 
lO 
o u-1 I 
"O Crt o o 
VI c ra u crt 
c. CO X I O (N tN O lAt u o (N 11 1—) >—1 1—1 1—> 1—1 
<N O (N O 
-o (U > 1 1 o s X c/) « 
rn K a: « O u 1—1 
CO ON fO ON 
OO ON ON <N 
o i 
rs rv 
00 On ON CO 
















T3 -o o^  cr T3 T3 00 
Ui 1- T3 cr 
T3 
K ffi ffi K K ffi ffi r^ r^ ^ 
X 
CN (N vo cs cs m K ffi ^ m —I 
-a •a -a 
•o 







IZI VH (U 
a 
c/l 
(U s Kl M 
(U > 
0 








ON 00 O CN NO <N 00 NO CO TO 
LO NO (N >—1 >O (N M NO CO CO CN R-- ON 











(N (N lO >/-) u-i 
X 
z 
ON u 1 CN 1 1 NO t 
. . J o ^ : CN CO —' ^ ^ < 
S-H < < < 
2 21 
On the basis of the above discussion, the deduced structure of F B X 3 B 
as 2-(3-nitrophenyl)-5(methyl)-3-[l l-{(l-carboxy)ethylthio}undecanamido] 





thiazan-4-one FBX2C (30) [Reaction of the hydrazone (24) with 
3-mercaptopropionic acid] 
A solution of the hydrazone FB (24) in dry benzene was refluxed with 
3-mercaptopropionic acid (molar ratio, 1:3) for 26 h, monitoring the reaction 
by TLC which showed it to be a mixture of two components, labelled as 
FBX2B (29) (major, upper) and FBXjC (30) (minor, lower). The products on 
purification By column chromatography (silica gel, pet. ether-diethyl ether. 
1:1 v/v) first yielded a yellow solid which on crystallisation (benzene-
acetone) furnished FBXjB (58.0%) as white crystalline globules and then a 
yellow oily liquid of FBX2C in (26.0%) yield. 
HS . (CH2)2 .C00H 
0 0 
NO2 dry benzene, ^ H i ^ n H ' 
reflux, 26 h 
F B X j B (29) 
NO2 
0 O 
H O H ^ - W ^ N H — N 
0 
FBX2C (30) 
N O , 
222 
Structure Elucidation of FBX7B (29) 
It was a white globule shaped crystalline solid, m.p. 98 °C. The 
structure of F B X j B has been fully established by IR, DCI-MS, 'H-NMR and 
'^C-NMR spectra. IR spectrum (KBr) showed characteristic peaks at 3175 
(N-H), 3040 (OH), 2900, 2800 (C-H), 1730 (COOH), 1645 (CONH), 1605 
(Phenyl), 1555 (C=N), 1520 (NO2, asym. str.), 1480 (S-CH2), and 1340 
(NO2, sym. str.). The DCI-MS spectrum strongly supported the structure 
which showed a [M+1]"^ peak at m/z 438 confirming its molecular weight 437 
[C21H31N3O5S]. This is equal to the sum of the molecular weights of (24) 
(331) and 3-mercaptopropionic acid (106). This indicated that FBX2B is an 
adduct of (24) and 3-mercaptopropionic acid. The base peak at m/z 134 
[(M+1)-Ci6H23N303]^ and another fragment ion peak at m/z 304 
[M-C5H902S]^ were formed by the cleavage of 9'-10' bond of the long alkyl 
chain. The peaks at m/z 218 [M-Ci2Hi302S]^ and at m/z 186 [M-C,2H,2N303]" 
were obtained by the cleavage of 3'-4' and 5'-6' bonds. It also showed some 
fragment ion peaks common to (25) at m/z 164, 166, 148, 118 and 119 as 
shown in Chart 5. 
o o 
m/z 438 [M+ 
O O 
HO' 




m/z 218 (76.1) 
NH ^ C H 
C" ^ NO2 
I I I 




All the signals in the 'H and '^C-NMR spectra have been assigned to 
individual H-and C-atoms (Tables 6a and 6b) by comparison with the NMR 
spectra of a previously established compound FB (24) (Tables l a and lb ) and 
FBX,B (25) (Tables 2a and 2b). The 'H-NMR spectrum dissolved in acetone-
di clearly showed that this compound was formed by the addition of 3-
mercaptopropionic acid to terminal C=C double bond of compound (24) as 
the olefmic proton signals of HE- l l ' - and Hz-11' of (24) at 6 4.88 ( IH, dd, 
J=10.22, 2.14, HE-11') and 5 4.96 ( IH, dd, J=17.09, 2.14, Hz-11') have 
disappeared and in place two additional triplets at 5 2.74 (J=6.87, H-1 ) and 5 
2.57 (J=6.87, H-2 ) corresponding to two methylene protons of the thioether 
moiety appeared. The triplet at 5 2.55 (J=7.33) was attributed to the 
methylene proton at C-11'. Also, in '^C-NMR spectrum (Table 6a), C-11' 
signal of (24) has shifted from 5 114.59 to 6 31.00 and an additional peak was 
observed at 5 178.50 for the carboxylic carbon at C-3". Here again, the 'H-
NMR and '^C-NMR spectra showed several double signals, the signals 
especially of C-7, C-l", C-2' in '^C-NMR spectrum and of NH, H-7 and H-2' in 
'H-NMR spectrum. This indicated that FBX2B is also present in two different 
forms as synperiplaner and antiperiplanar conformers of CONH bond in a 
55/45 ratio in DMS0-g?6 (Table 6a) and 85/15 ratio in acetone- d^ (Table 6b). 
Thus, the two forms are the stabile conformers in equilibrium with each other 
as in (24) and (25), and is dependent on the polarity of the solvent. 
224 
s a c. 
to 
CN li^  
(N ^ WO ^ 
r-^ " ^ ^ o^  
UO !>• UO .IT) —' in Tj-





CN I. N 1 0 0 00 ON 00 as m in 
0 0 m m m r — 1 <n — I M3 01 >0 






























'-H — (N m 







. — I 00 . — 1 00 0 00 0 
rsi (N 
r-- r\ ON m i n 00 
b ON 0 0 00 
— r — 1 06 00 
11 rNi I I I I I I I I 




D, CO Qi 










<N ^ cn ^ 
00 „ X© (N s p 
^ m >n pr, in 00 
' I 7 7 fN ^ 
06 w ^ w (N w 
ON >n ON m (N 00 <N m NO (N 0 




a\ I o (N 
(N tn ^ I I I I iH Vi Li < < < < 
225 
Table 6b: 'H-NMR spectral data of FBXjB (29) in acetone-rf<5 





7 8 .18 , 8 .48 I H s 
( - 8 5 % , 15%) 
NH 10.30,10.66 I H s 
( - 8 5 % , 15%) 
2' 2 .31,2.73 2H t J2.3. 7.31, 7.48 
( - 8 5 % , 15%) 
3' 1.56 2H br p J«7 .28 
4'-9' 1.31 6x2H br s 
10' 1.69 2H br p J^7 .25 
i r 2.55 2H t JnMO'7.33 
1" 2.74 2H t Jr . 2" 6 .87 
2" 2.57 2H t J2M" 6.87 
C O O H 12.20 IH br s 
Ar-2 8.51 IH dd J= 1.99, 1.82 
Ar-4 8.24 IH dd J= 8.08, 1.98 
Ar-5 7.73 IH dd J= 8.08, 7.94 
Ar-6 8.14 IH dd J= 7.94, 1.86 
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On the basis of the above spectral evidence, compound FBX2B which 
was characterized as m-nitrobenzaldehyde-1 l-(2-carboxyethylthio)undecano 




Structure Elucidation of FBX^C (30) 
It was a pale yellow oily liquid. The structure of FBX2C has been fully 
established by IR, DCI-MS, 'H-NMR and '^C-NMR spectra. IR spectrum 
(Neat) displayed characteristic absorption bands at 3200 (NH), 3050 (OH), 
2910, 2840 (CH), 1710 (COOH), 1680 (CON), 1650 (CONH), 1610 (Phenyl), 
1525 (NO2, asym. str), 1430 (S-CH2) and 1375 (NO2, sym. str) cm"'. The 
DCI-MS spectrum (Fig. 7a) showed a [M+1]^ peak at m/z 526 confirming its 
molecular weight 525 [C24H35N3O6S2] which is equal to the sum of the 
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molecular weights of FBX2B (437) and 3-mercaptopropionic acid (106) minus 
one molecule of water. This indicated that the cyclocondensation has 
occurred between FBX2B and 3-mercaptopropionic acid forming thiazanone 
ring. The base peak at m/z 341 [M-CgHgNOaS]"^ was resulted by the cleavage 
of 2-3 and 5-6 bonds of the thiazanone ring. The fragment ion peak at m/z 
438 [(M+1)-C0CH2CH2S]^ arised by the cleavage of the 1-2 and 3-4 bonds, is 
the diagnostic peak of a thiazanone ring®"^ . The fragment ion peaks at m/z 290 
[(M+O-CioHgNjOsS]^ and m/z 237 [M-CnHjeNOsS]^ were obtained by the a -
cleavage to the ring. The fragment ion peaks at m/z 273 [M-CioHjoNaOsS]^ 
and m/z 254 [M-Ci4H2503S]"^ were due to the /^-cleavage to the ring. These 
peaks strongly supported the formation of thiazanone ring. In addition to 
these, some peaks common to FBX2B appeared at m/z 220, 165, 121 as shown 
in Chart 6. 
m/z 438 (41 2) 
0 
m/z 220 (76 1) 
m h 148 
+2H 
^ m/z 150 (15 7) g 
C m/z 166 (23 1) 
N 
CHART 6 
m/z 231 a \ 4) 
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All the signals in the 'H-NMR and '^C-NMR spectra dissolved in 
acetone-<i6 (Fig. 7b and 7c) have been assigned to individual H-and C-atoms 
(Table 7) by comparison with the NMR spectra of FBXzB (Tables 6a and 6b). 
The 'H-NMR spectrum is in agreement with the formation of a thiazanone ring 
as the H-7 signal of FBXzB has shifted to higher field from 5 8.18, 8.48 (85%, 
15%) to 5 6.14 (position 2 in FBX2C) due to the disappearance of C=N double 
bond signal and also the NH signal has shifted to higher field from 5 10.30, 
10.66 (75%, 25%) to 5 9.12, due to the ring formation. It also showed two 
additional triplets for two ring methylene protons (-CH2-CH2-S-) at 5 2.94 
(J=6.71, H-5) and 5 3.10 (J=6.71, H-6). Also, in '^C-NMR spectrum, the C-7 
signal of FBXjB has shifted to higher field from 5 139.97, 143.22 ( -55%. 
45%) to 5 66.02 (position C-2 in F B X 2 C ) . It also showed an additional peak at 
6 173.14 for the carbonyl carbon at C-4. Here again, in both the NMR spectra, 
only one form of FBX2C appeared 
Based on the above spectral evidence, compound FBX2C was 




In conclusion, it is stated that the course of addition of mercaptoacetic 
acid, 2-mercaptopropionic acid and 3-mercaptopropionic acid to terminal 
olefinic bond followed anti-Markovnikov's rule which is attributed to the free 
radical mechanism^^. The increased nucieophilicity of thio group in 
2-mercaptopropionic acid facilitates condensation rather than addition thereby 
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lO-Undecenoicacid hydrazide (23) 
It was prepared from 10-undecenoic acid by a well known common 
procedure. A mixture of 10-undecenoic acid (10.Og, 0.0542 mol), methanol 
(40 ml) and sulphuric acid (1 ml) was refluxed on a water bath for 6 h. To 
this was added freshly distilled hydrazine hydrate (4.08g, 0.0813 mol) and 
refluxed for further 8 h. The reaction mixture was cooled, concentrated in 
vacuum and the solid residue left was extracted with ethylacetate, waslicd 
several times with water and the organic phase dried over anhydrous Na^SOj-
The solvent was distilled off under reduced pressure to a white solid residue 
which on crystallization from ethanol afforded (23) as white globules, 9.02 g 
(84%). m.p.88 °C, Rf 0.76 (benzene-diethyl ether, 6:4 v/v) 
IR (KBr): v,,, , 3300 (N-H), 2950, 2850 (C-H), 1630 (C=0) , 1600 (C-C) . 
1575, 1530, 1460, 1440, 1380, 1 190, 1160, 910 cm-1. 
m-Nitrobenzaldehyde-lO-undecenohydrazone, FB (24) 
It was prepared following the literature method®. A solution of 10-
undecenoacid hydrazide (23) (4.0g, 0.0202 mol) and m-nitrobenzaldehyde 
(3.052g, 0.0202 mol) in dry benzene (50 ml) was refluxed with stirring on an 
oil bath at 80 °C for 5 h, collecting the generated water in a Dean Stark 
apparatus. Progress of the reaction was monitored by TLC (silica gel G, pet. 
ether-diethyl ether, 6:4 v/v) at every 15 min. TLC examination showed the 
disappearance of the spot corresponding to the substrate and the appearance 
of a new spot corresponding to the product, labelled as FB (24). The solution 
was then cooled, washed several times with water, and the benzene layer was 
dried over Na2S04. The solvent was removed under reduced pressure and the 
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yellow solid residue was crystallized from ethanol to yield FB (24) as yellow 
crystalline globules, 5.81g (87%), m.p. 128 °C, Rf 0.70 (benzene-diethylether, 
6:4 v/v) 
IR ( K B r ) : v„ax 3100 (N-H), 2950, 2850 (C-H), 1660, 1640 (C=0) , 1580 
(phenyl, C=C), 1550 (C=N), 1510 (NO2, asym str), 1330 (NO2, sym. str), 
1420, 1255, 1225, 1150, 1100, 1055, 970, 935, 885 810,790, 715 cm"' 
' H - N M R (, 400 MHz, acetone-^/^): 5h 8.17, 8.46 ( - 7 5 % , 25%); IH, s, H-7), 
10.41, 10.76 ( -75%, 25%; IH, s, NH), 2.33, 2.74 ( - 2 5 % , 75%; 2H, t, J= 7.32, 
7.48, H-2'), 1.69 (2H, br p, J= 7.32, H-3'), 1.31 (5H, br s, H - 4 ' - 8 ' ) , 2.02 (2H, 
m, H-9) , 5.78 ( IH, tdd, J=| 6.72,10.22, 17.09 H-IO'), 4.88 ( I H , dd, J=10.22, 
2.14. H r - l l ), 4.96 ( IH, dd, J=17.09, 2.14, l l ' -Hz) , 8.49 ( IH , dd, J=1.99, 1.83 
Ar-2), 8.22 ( IH, dd, J=7.94, 1.83, Ar-4), 7.71 ( IH, dd, J=7.78, 7.94, Ar-5) 
8.12 ( IH , dd, J=7.78, 1.99, Ar-6). 
' H - N M R (400 MHz, DMS0-rf<5): 5h 8.09, 8.50 ( - 6 0 % . 40%; IH. s. H - 7 ) . 
1 1.41, 11.54 ( -60%, 40%; IH, s, NH), 2.22, 2.64 ( - 4 0 % , 60%; 2H, t, J= 7.30, 
7.41, H-2'), 1.60 (2H, br p, J=7.14, H-3'), 1.28 (lOH, br s, H-4'-8'), 2.00 (2H. 
td, J=7.14, 6.60, H-9') 5.76 ( IH, tdd, 1=6.77,10.26, 17.22, H-10'), 4.93 ( ]H, 
dd, J=10.26, 2.01, HE), 5.00 ( IH, dd, J=17.22, 2.01, Hz), 8.47 ( IH , dd, 
J=2.02. 2.03, Ar-2), 8.26 (IH, dd, J=8.23, 2.02, Ar-4), 7.72 ( I H , dd, J=7.51. 
8.23, Ar-5), 8.09 ( IH, d, J -7 .51 , Ar-6) 
'^C-NMR (100 MHz, acetone-rf^,): 5c 140.79, 144.53 ( - 7 5 % , 25%; C-7), 
170.07, 172.12 ( -75%, 25%; C-l ' ) , 33.09, 35.55 ( - 7 5 % , 25%; C-2'), 25.41, 
26.07 ( -75%, 25%; C-3'), 29.22-30.38 (C-4'-8'), 34.42 (C-9'), 139.81 (C-10) , 
114.59 (C- l l ' ) , 137.68 (Ar-C-1), 121.80 (Ar-C-2), 149.72 (Ar-C-3), 124.56 
(Ar-C-4), 130.98 (Ar-C-5), 133.30 (Ar-C-6). 
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DCI-MS (NH3): m/z 332 [(M+1), 100.0], 333 (48.0), 334 (19.0), 335 (7.0). 
316 (6.4), 317 (3.6), 165 (5.0), 149 (4.4), 118 (4.0), 59 (3.8) 
m-Nitrobenzaldehyde-ll-(carboxymethylthio)undecanoltydrazone FBXiB 
(25) and 2-(3-nitrophenyl)-3-[ll-(carboxymethylthio)undecanamido]thia-
zolidin-4-one FBX,C (26) [Reaction of the hydrazone (24) with 
mercaptoacetic acid] 
To a solution of the hydrazone (24) (1.20g, 0.0030 mol) in dry benzene 
(20 ml) was added mercaptoacetic acid (0.832g, 0.0090 mol) and refluxed 
with stirring on an oil bth at 80 °C for 16 h, collecting the generated water 
using a Dean Stark apparatus. The products on TLC examination (silicagel G, 
benzene-diethyl ether, 6:4 v/v) showed a major (lower) and a minor (upper) 
spot labelled as FBXiB (25) and FBXjC (26). The solution was cooled, 
washed several times with water to make the solution neutral and the organic 
phase dried over anhydrous Na2S04. The solvent was distilled off under 
reduced pressure and the orange oily residue left was chromatographed over a 
silica gel column using (pet.ether-diethylether, 1:1 v/v). Elution of the 
column first furnished a pale yellow solid FBXiB which was recrystallised 
from ethanol as crystalline yellow globules, 217 mg (31.2%), m.p 120 °C, Rf 
0.43 (benzene-diethyl ether, 6:4 v/v). Further elution of the column yielded 
FBXiC as a yellow oily liquid which was further purified by repeated column 
chromatography using the same solvent, 810 mg (54%), Rf 0.38 (benzene-
diethyl ether, 6:4 v/v). 
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Spectral data of FBX,B (25) 
IR (KBr): v^^a, 3250 (N-H), 3075 (OH), 2900,2850 (C-H), 1725 (COOH), 
1645 (CO), 1610 (Phenyl), 1555 (C=N), 1520 (NO2, asym str), 1350 (NO2, 
sym str) 1465 (S-CH2), 1400, 1380,1190 cm"'. 
^H-NMR (400 MHz, acetone-^/g,): 5h 8.18, 8.48 ( - 7 5 % , 25%; IH, s, H-7), 
10.29,10.66 ( -75%, 25%; IH, s, NH), 2.31, 2.74 ( - 2 5 % , 75%; 2H, t, J=7.30, 
7.47, H-2 ') , 1.59 (2H, br p, J «7.25, H-3') , 1.31 (12H, br s, H-4 ' -9 ' ) , 1.69 (2H, 
br p, J«7.28, H-10'), 2.64 (2H, t, J=7.32, H - l l ' ) , 3.22 (2H, s, H-1") , 8.51 
( IH, dd, 1.98, 1.83, Ar-2), 8.24 ( IH, dd, 7.93,1.98, Ar-4), 7.73 ( IH, dd, 
J=7.94, 7.93, Ar-5), 8.14 ( IH, dd, J=7.94, 1.98, Ar-6). 
' H - N M R (400 MHz, DMSO-^/fi,): 5H 8.07, 8.27 ( - 6 0 % , 40%; IH, s, H-7), 
11.39, 11.53 ( -60%, 40%; IH, s, NH), 2.21, 2.62 ( - 4 0 % , 60%; 2H, t, J=7.33, 
7.42, H-2') , 1.48 (2H, br p, J=7.37, H-3'), 1.58 (2H, br p J«7.22, H-10') , 1.25 
(12H, br s, H-4 ' -9 ' ) , 2.54 (2H, t, J -7 .34 , H - l l ' ) , 3.17 (2H, s, H-1") , 8.45 
( IH, dd, J=1.99, 1.83, Ar-2), 8.21 ( IH, dd, J= 8.05, 1.83, Ar-4), 7.70 ( IH, dd, 
J=8.05, 7.69, Ar-5), 8.07 ( IH, dd, J -7 .69 , 1.82, Ar-6). 
^^C-NMR (lOOMHz, DMSO-rf^,): 5c 139.99, 143.24 ( - 6 0 % , 40%; C-7), 
168.95, 174.57 ( -40%, 60%; C - l ' ) , 31.76, 34.12 ( - 6 0 % , 40%; C-2 ') , 24.17 
(C-3'), 28.04-28.79 (C-4'-10') 31.67 (C-11'), 171.47 (C-2") , 33.20 ( C - l " ) , 
136.18 (Ar-C-1), 120.51 (Ar-C-2), 148.18 (Ar-C-3), 123.70 (Ar-C-4), 130.30 
(Ar-C-5), 132.60 (Ar-C-6) 
DCI-MS (NH3): m/z (%): 424 [ ( M + l ) ^ 50.9] 425 (28.6), 426 (10.2), 336 
(10.6), 337 (4.2), 275 (3.8), 276 (52), 218 (5.8), 215 (4.3), 163 [ ( M > C , 3 
H23O2S, 11.8], 149 (36.7), 150 (10.2), 165 (9.4), 166 (10.0), 167 (4.8), 147 
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(11.0). 148 [ ( M > C , 3 H25 NO3S, 10.0], 149 (36.7), 150 (10.2), 136 (16.6), 
137 (5.3), 133 (9.8), 134 [(M+l)-C,5 H20 N3O3, 58.8], ,121 (9.5), 118 [M^-
C,6H23N303, 13.0], 119(6.3) . 
Spectral data of FBX^C (26) 
IR (Neat): v^ax 3250 (N-H), 3050(OH), 2900,2850 (C-H), 1725 (COOH), 
1685 (CON), 1660 (CONH), 1610 (phenyl), 1525 (NO2 asym str), 1355 (NO., 
sym str), 1430 (S-CH2), 1405, 1260, 1165 cm"' 
'H-NMR (400 MHz, acetone-c?^,): 5h 6.04 ( IH, s, H-2), 3.84 (IH, dd, 
J=15.87, 1.68, H-5 trans), 3.75 ( IH, dd, J=15.87, 0.92, H-5cis) , 2.10 (2H, t, 
J -7 .32 , H-2 ' ) , 1.50 (2H, br p, J=7.14, H-3 ' ) , 1.19 (12H, br s, H-4 ' -9 ' ) , 1.59 
(2H. brp, J=7.26, H-10 ' ) 2.64 (2H, t, J=7.33, H-11 ' ) , 3.22 ( IH , s. H-1"), 8.34 
( IH, dd, J=1.99, 1.98, Ar-2), 8.24 ( IH, dd, J=8.10, 2.23, Ar-2), 7.71 ( IH, 
J=8.10, 7.94, Ar-5), 7.95 ( IH, dd, J=7.94, 1.99, Ar-6). 
^^C-NMR (100 MHz, acetone-^/^,): 5c 62.23 (C-2), 172.17 (C-4), 34.09(C--5), 
171.71 ( C - r ) , 33.09 (C-2') , 25.97 (C-3') , 29.50-30.00 ( C - 4 ' - l l ' ) , 33.80 (C-
1"), 169.67(C-2"), 142.18 (Ar-C-1), 124.76 (Ar-C-2), 149.54 (Ar-C-3), 
123.63 (Ar-C-4), 131.01(Ar-C-5), 135.3l(Ar-C-6). 
D C I - M S (NH3): m/z (%) 498 [(M+1)^ 14.5], 499 (10.1), 452 [(M^)-C02H, 
10.2], 424 [(M+1)^-SCH2C0, 10.4], 425(4.8), 332(9.5), 273(10.4), 274 (7.6), 
275(13.6), 276[(M+1)^-C9H7N203S, 72.2], 277 (31.3), 278 (14.0), 258 
[(M+1)^-C9H9N303S, 10.0], 239 (7.2), 240 [(M+O^'-CoHssOsS, 91.8], 241 
(35.9), 242 (11.8), 230 (10.9), 231 [(M^)-C8H9N302S, 25.4], 232 (16.3), 223 
[(M^)-C,3H24N09S, 27.2], 224 (12.2), 210 [(M+1)^-C,3H24N203S, 39.5], 212 
(24.0), 213 (13.1) 214 (6.4), 215 [(M>CI3H24N03S, 47.7], 216 (22.2), 217 
(8.1), 218 (14.5), 193 (25.0), 194 (12.2), 195 (29.5), 196 (11.3), 176 (11.8), 
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178 (12.7), 162 (8.1), 163 (8.2), 164 (8.1), 165 (7.9), 166 (40.4), 148 (15.0), 
149 (10.0), 150 (9.0), 151 (15.4), 152 (16.3), 153 (7.5), 134 (42.2), 135 
(20.0), 136 (32.2), 137 (19.0), 138 (30.0), 139 (18.1), 1 18 (32.2), 1 19 (9.5), 
1 10 (8.2), 81 (13.1), 82 (9.0), 83 (14.5), 87(1 1.8), 89 (10.4), 91 (12.7), 93 
(13.6), 94 (29.0), 95 (17.7), 96 (8.4), 97 (8.6), 99 (20.0), 100 (9.5). 
2-(3-Nitrophenyl)-5-(meihyl)-3-(10-undecenaniido)thiazolidin-4-one F B X 3 A 
(27) and 2-(3-nitrophenyl)-5-(methyl)-3-[ll-{(l-carboxy)ethylthio}undecan-
amidoJthiazolidin-4-one F B X 3 B (28) [Reaction of the hydrazone (24) with 
2-mercaptopropionic acid] 
To a solution of the hydrazone (24) ( l .Olg , 0.0030 mol) in dry benzene 
(20ml) was added 2-mercaptopropionic acid (0 .96Ig, 0.0090 mol) and 
refluxed for 22 h as above, monitoring the progress of reaction by TLC (silica 
gel G, pet. ether-diethylether, 3:7 v/v) which revealed the presence of two 
spots labelled as F B X 3 A (27) (upper) and F B X 3 B (28) (lower) and then 
worked up as usual. The product on purification by column chromatography 
(silica gel, pet. ether-diethyl ether, 3:7 v/v) as eluent yielded F B X 3 A as a 
colourless oily liquid, 536 mg (42.3%), Rf 0.46 (benzene-diethyl ether, 6:4 
v/v). Further elution of the column using pet. ether-diethyl ether, 6:4 v/v 
afforded F B X 3 B as a pale yellow oily liquid, 528 mg (34.5%), Rf 0.32 
(benzene-diethyl ether, 6:4 v/v). 
Spectral data of FBX,A (27) 
'H-NMR (400 MHz, acetone-ds,): 5H 6.01 ( IH, d, J=0.91, H-2cis), 6.04 ( IH, 
d, J=1.53, H-2trans), 4.04 ( IH, qd, J=6.86, 0.91, H-5cis), 4.11 ( IH, qd, 
J=7.17, 1.53, H-5trans), 1.59 (3H, d, J=6.86, S-CHacis), 1.61 (3H, d, J=7.17, 
5-CH3trans), 9.28 ( IH, s, NH), 2.11 (2H, t, J=7.25, H-2'), 1.50 (2H, br p. 
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J = 7 . 0 5 , H - 3 ' ) , 1 .22 ( 1 2 H , b r s, H - 4 ' - 9 ' ) 5 . 8 1 ( I H , t d d , J = 6 . 7 2 , 1 0 . 2 3 , 1 7 . 0 9 , 
H - 1 0 ' ) , 4 . 9 0 ( J = 1 0 . 2 3 , 2 . 1 3 , H E - 1 1 ' ) , 4 . 9 8 ( I H , d d . J = 1 7 . 0 9 , 2 . 1 3 ) , 8 . 3 4 ( I H , 
d d , J = 1 . 9 9 , 1 .83 , A r - 2 ) , 8 . 2 6 ( I H , d d , J = 8 . 0 9 ; 1 . 9 9 , A r - 4 ) , 7 . 7 3 ( I H , d d , 
J = 8 . 0 9 , 7 . 9 3 , A r - 5 ) , 7 . 9 5 ( I H , d d , J = 7 . 9 3 , 2 . 2 8 , A r - 6 ) . 
'^C-NMR (ICQ MHz, acetone-</<j,): 5c 61.16 (Cc-2), 172.83 (C-4), 39.53 (C-
5cis), 39.82 (C-5tran), 19.46 (C-S-CHjcis), 20.60 (C-S-CHstran), 172.23 (C-
r ) , 34.30 {C-T), 25.98 (C-3'), 29.24-30.39 (C-4'-8'), 34.44 (C-9^), 139.88 
(C-10'), 114.63 ( C - i r ) , 141.59 (Ar-C-lcis) , 142.41 (Ar-C-l t rans) , 124.84 
(Ar-C-2), 149.55 (Ar-C-3), 123.82 (Ar-C-4), 131.05 (Ar-C-5). 
DCI-MS (NH3): m/z (%) 420 [ ( M + l ) \ C21H29N3O4S, 82.1], 421 (36.0), 422 
(26.9), 437 [(M+18)^ 6.6], 438 (3.7), 387 (9.1), 332 [(M+18)^-C3H40S, 8.7], 
313 (9.1), 266 (4.9), 254 [(M+1)^-C,,H ,90, 82.1], 255 (13.6), 256 (4.9), 237 
[(M+1)"-ChH2ONO, 100.0], 238 (20.7). 239 (7.8), 218 (4.1), 209 (3.3), 207 
(4.5), 184 (11.6), 185 (6.6), 186 (3.3), 165 (7.0), 166 (8.7), 167(60.5), 168 
(9.1), 169 (3.3), 147 (21.9), 148 (4.1), 149 (26.9), 150 (5.3), 151 (4.1), 137 
(4.5), 130 (16.5), 131 (3.7), 121 (6.2), 116 (4.5), 117 (3.3), 118 (7.8), ] 10 
(5.3), 105 (3.3), 107 (4.5), 95 (4.9), 94 (3.3), 93 (6.2), 91 (3.3), 89 (7.4), 87 
(7.4), 85 (24.0), 83 (6.2), 82 (3.3), 81 (14.9), 80 (3.7), 76 (31.1), 74 (21.1), 
72 (10.3), 71 (4.1). 
Spectral data of FBX^B (28) 
'H-NMR (400 MHz, acetone-dg): 5h 6.01 ( IH , d, J=0.91, H-2cis), 6.04 (IH, 
d, J=1.53, H-2trans), 4.05 ( IH, qd, J=6.86, 0.91, H-5cis), 4.11 ( IH, qd, 
J=7.17, 1.53, H-5trans), 1.59 (3H, d, J=6.87, 5-CH3cis), 1.61 (3H, d, J=7.]7 , 
5-CH3trans), 9.28 ( IH, s, NH), 2.11 (2H, t, J=7.25, H-2'), 1.50 (2H, brp, 
J~7.09, H-3'), 1.22 (12H, brs, H-4'-9'), 1.59 (2H, brp, J~poorly resolved, H-
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10'), 2.67 (2H, m, H-11 ' ) , 3.42 ( IH, q, J=7.02, H-1"), 1.60 (3H, d, J=7.02, 1"-
CH3), 8.34 ( IH, dd, J=1.98, 1.83, Ar-2), 8.26 ( IH, dd, J=8.09, 1.99, Ar-4), 
7.73 ( IH , dd, J=8.09, 7.93, Ar-5), 7.95 (IH, dd, J -7 .93 , 2.29, Ar-6). 
'^C-NMR (100 MHz, DMSO-rf^): 6c 61.16 (C-2), 172.83 (C-4), 39.53 (C-
5cis), 39.83 (C-5trans), 19.46 (C-S-CHscis), 20.61 (C-S-CHjuans), 172.22 (C-
r ) , 34.08 (C-2') , 25.97 (C-3'), 29.24-30.40 (C -4 ' -10 ' ) , 31.91 (C- IT) , 17.78 
(C-1"-CH3), 41.35 (C- l") , 174.33 (C-COOH), 141.57 (Ar -C - lc is) , 142.40 
(Ar-C-1 trans), 124.85 (Ar-C-2), 149.55 (Ar-C-3), 123.82 (Ar-C-4), 131.06 
(Ar-C-5). 
DCI-MS (NH3): m/z (%) 525 [ (M+l )^ C24H35N3O6S2, 22.0], 526 (98.6), 527 
(31.0), 524 (58.6), 543 [(M+18)", 31.7], 544 (8.9), 541 (8.9), 480 [ ( M > 
COOH, 15.0], 471 (9.8), 454 (9.6), 436 (8.2), 419 [ (M+1)^-SCH(CH3)C00H, 
17.2], 405 (7.2), 308 [(M^)-(C|2H2302S. 17.2], 290 [(M+l)^-C,oH8N203S, 
33.1], 289 (9.2), 288 (10.4), 280 [(M^)-Ci3H2502S, 10.0], 273 [ (Vf)-
C,OHioN303S, 9.6], 271 (9.4), 237 [ ( M ^ C u H j e N O j S , 100.0], 238 (15.8), 239 
(10.3), 229 (14.6), 218 (15.8), 207 (37.2), 199 (20.0), 184 (17.9), 180 (18,6), 
164 (15.2), 165 (15.0), 166 (15.5), 151 (14.9), 147 (22.7), 138 (28.9), 130 
(20.6), 121 (17.9), 108 (15.2), 87 (17.2), 75 (16.5). 
m-Nitrobenzaldehyde-ll-(2-carboxyethylthio)undecanohydrazone FBX2B 
(29) and 2-(3-nitrophenyl)-3-[ll-(2-carboxyethylthio)undecanamido]-
thiazan-4-one FBXjC (30) [Reaction of the hydrazone (24) with 3-
mercapto propionic acid] 
To a solution of the hydrazone FB (24) (1.02g, 0.0030 mol) in dry 
benzene (20 ml) was added 3-mercaptopropionic acid (0.961g, 0.009 mol) and 
refluxed for 26 h as described above. TLC examination (silica gel, pet.ether-
241 
diethyl ether, 6:4 v/v) of the products showed it to be a mixture of two 
compounds labelled as FBX2B (29) (major, upper) and FBX2C (30) (minor, 
lower). The products on purification by column chromatography (silica gel, 
pet. ether-diethyl ether, 1:1 v/v) first yielded a yellow solid which on 
crystallisation from (benzene-acetone) furnished FBX2B as white crystalline 
globules, 765 mg (58.0%), m.p 98 °C, RfO.46 (benzene-diethyl ether 6:4 v/v). 
Further elution of the column using (pet.ether-diethyl ether, 3:7 v/v) yielded 
FBX2C as a yellow oily liquid, 412 mg (26.0%),Rf 0.24 (benzene-d ie thy l 
ether, 6:4 v/v). 
Spectral data of FBX^B (29) 
IR (KBr): 3175 (N-H), 3040 (OH), 2900, 2800 (C-H), 1730 ( ^ O H ) , 
1645 ( m N H ) , 1605 (Phenyl), 1555 (C=N), 1520 (NO2 asym str), 1480 (S-
CH2), 1340 (NO2 sym str), 1415, 1380, 1215, 1 1 10, 800 cm"' . 
'H-NMR (400 MHz, acetone-t/^): 5h 8.18, 8.48 (~ 85%, 15%; IH, s, H-7), 
10.30, 10.66 ( -85%, 15%; IH, s, NH), 2.31, 2.73 ( - 1 5 % , 85%; 2H, t, J=7.48, 
7.31, H-2') , 1.56 (2H, brp, J«7.28, H-3') , 1.31 (12H, br s, H-4 '-9 ' ) , 1.69 (2H, 
br p, 7.25,H-10'), 2.55 (2H, t, J=7.33, H-11') , 2.74 (2H, t, J=6.87, H-1") , 
2.57 (2H, t, J=6.87, H-2") , 12.20 ( IH, brs, COOH), 8.51 ( IH , dd, J=1.99, 
1.82, Ar-2), 8.24 ( IH, dd, J -8 .08 , 1.98, Ar-4), 7.73 ( IH, dd, J=7.94, 7.63, Ar-
5), 8.14 ( IH, dd, J=7.94, 1.98, Ar-6). 
'H-NMR (400 MHz, DMSO-rf^.): 5H 8.11, 8.29 ( - 5 5 % , 45%; IH, s, H-7), 
1 1.41, 11.55 ( -55%, 45%; IH, s, NH), 2.23, 2.63 ( - 4 5 % , 55%; 2H, t, J=7.34, 
H-2') , 1.48 (2H, brp, J^7.33, H-3') , 1.26 (12H, br s, H-4 ' -9 ' ) , 1.59 (2H, br p, 
y^7.14, H-10') , 2.47 (2H, t, J=7.14, H-11') , 2.65 (2H, t, J= 6.77, H - l " ) , 2.49 
(2H, t, J=6.77, H-2") , 8.47 ( IH, dd, J=1.99, 1.83, Ar-2), 8.23 ( IH , dd, J= 
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8.05, 2.01, Ar-4) 7.72 ( IH, dd, J=7.88, 8.05, Ar-5), 8.08 ( IH, dd, J=7.88, 
2.01, Ar-6); 
'^C-NMR (100 MHz, DMSO-rfe,): 5c 139.97, 143.22 ( - 5 5 % , 45%; C-7), 
168.92, 174.55 ( -45%, 55%; C-1'), 31.75, 34.11 ( -55%, 45%; C-2'), 24.16 
(C-3'), 28.40-28.80 (C-4'-10') , 31.00 (C-11'), 34.53 (C-2") , 26.35 (C-1"), 
178.50 (C-3") , 136.17 (Ar-C-1), 120.50 (Ar-C-2), 148.18 (Ar-C-3), 123.69 
(Ar-C-4), 130.28 (Ar-C-5), 132.61 (Ar-C-6). 
D C I - M S (NH3): m/z (%) 438 [ ( M + l ) \ C21H31N3O5S, 63.5], 439 (41.7), 440 
(16.5), 366 (8.2), 336 (24.6), 337 (13.0), 304 [ (M>C5H902S , 14.2], 305 
(8.0), 218 [ (M>C,2Hi302S, 25.9], 219 (10.0), 220 (7.4), 201 (8.4), 186 
[(M^)-C,2Hi2N303, 18.8), 187 (9.0), 163 (8.2), 164 (9.0), 165 (7.8), 166 
(10.6). 148 [(M^)-C,5H2oN303, 24.8], 149 (16.4), 150 (15.2), 151 (15.2), 152 
(7.8). 133 (23.6), 134 [(M+1)^-C,6H23N303, 100.0], 135 (67.0), 136 (38.7), 
137 (16.8), 118 (37.7), 1 19 (18.2), 120 (26.3), 121 (88.3), 122 (35.1), 123 
(15.4), 106 (11.4), 107 (1 1.0), 108 (13.6), 109 (7.8), 94 (9.2), 72 (21.0), 73 
(9.0). 
Spectral data of FBX^C (30) 
IR (Neat): v^^, 3200 (NH), 3050 (OH), 2910, 2840 (C-H), 1710 (COOH), 
1680 (CON), 1650 (CONH), 1610 (phenyl) ,1525 (NO2 asym. str), 1430 (S-
CH2), 1375,1350 (NO2 sym. str)1230, 1170,1070, 800, 720 cm"'. 
'H-NMR (400 MHz, acetone-^/e): 5h 6.14 ( IH, s, H-2), 2.94 (2H, t, J=6.71, 
H-5) 3.10 (2H, t, J=6.71, H-6), 9.12 ( IH, s, NH), 2.09 ( IH , t, J=unresolved, 
H-2') . 1.58 (2H, br p, J=7.17, H-3 ' ) 1.29 (12H, m, H-4 ' -9 ' ) , 1.60 (2H, br p, 
J= unresolved, H-10') , 2.56 (2H, t, J=7.38, H-11') , 2.75 (2H, t, J=7.17, H-1"), 
2.58 (2H, t, J=7.17, H-2"), 8.28 ( IH, dd, J=2.14, 1.83, Ar-2), 8.23 ( IH, dd, J= 
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8.09, 2.29, Ar-4), 7.72 (IH, dd, J=8.09, 7.93, Ar-5), 7.90 ( IH, dd, J=7.93, 
1.07, Ar-6). 
'^C-NMR (100 MHz, acetone-^/g,): 5c 66.02 (C-2), 173.14 (C-4), 37.24 (C-
5), 27.59 (C-6), 172.35 (C-1'), 34.13 (C-2'), 25.97 (C-3'), 29.50-30.20 (C-4'-
11'), 24.53^ (C-1"), 35.25' (C-2"), 169.15 (C-3"), 141.89 (Ar-C-1), 122.94 
(Ar-C-2), 149.36 (Ar-C-3), 124.17 (Ar-C-4), 130.76 (Ar-C-5), 134.65 (Ar-C-
6). 
DCI-MS (NHj): m/z (%) 526 [ (M+l )^ C24H35N3O6S2, 18.8], 527 (9.3), 438 
[(M+1)^-C0(CH2)2S, 41.2], 439 (15.6), 440 (6.0), 420 (10.5), 406 (4.6), 341 
[(M^)-C8H7N02S, 100.0], 342 (31.7), 343 (10.2), 290 (13.8), 254 [(M+1)^-
C,4H2503S, 27.0], 255 (9.0), 237 [(M^)-C,4H26N03S, 71.4], 238 (15.1), 239 
(9.5), 220 (76.1), 221 (16.5), 166 (25.3), 167 (17.5), 150 (15.7), 138 (1 1.4), 
120 (1 1.4), 121 (33.1), 123 (23.8), 118 (9.1), 93 (12.1), 87 (17.2), 89 (14.0), 
81 (12.5), 77 (9.3), 72 (15.5). 
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The work described in this chapter includes the reaction of p-chloroacetophenone-
10-undecenohydrazone (31) with: 
(i) Mercaptoacetic acid in dry benzene which furnished an adduct, p-chloro-
acetophenone-1 l-(carboxymethylthio)undecanohydrazone (32) and a new 
compound, 2-(4-chlorophenyl)-2-methyl-3-[l ]-(carboxymethylthio)undec-
anamido]thiazolidin-4-one (33) and a byproduct, bis (carboxymethylthio)-4-
chloroacetophenotal (34). 
(ii) 3-Mercaptopropionic acid in dry benzene which afforded an adduct, p-chloro-
acetophenone-1 l-(2-carboxyethylthio)undecanohydrazone (35) as the sole product. 
The hydrazone (31) was also found to exist in two stereoisomeric forms as syn-periplanar 
(major) and anti-periplanar (minor) [as in (24)] as evident from its stereochemical studies. 
I N T R O D U C T I O N 
As part of our programme in searcii of biologically active compounds with 
sulphur and nitrogen containing heterocycles, we have synthesised four novel 
compounds, 2-(3-ni t rophenyl)3-[n-(carboxymethy/ethyl thio)undecanamido 
thiazolidin-4-ones/thiazan-4-ones (26), (27), (28) and (30) f rom w-nitrobenz-
aldehyde-10-undeceno-hydrazone (described in Chapter 4). In continuation of 
the above mentioned work, we have undertaken this problem on the synthesis of 
2 - (4-ch lorophenyl -2-methyl -3- [ l l - ( c a r b o x y m e t h y l / 2 - c a r b o x y e t h y l t h i o ) u n d -
e c a n a m i d o ] t h i a z o l i d i n - 4 o n e s / t h i a z a n - 4 - o n e f rom yc-ch lo roace tophenone-
1 0 - u n d e c e n o h y d r a z o n e (31) u s ing m e r c a p t o a c e t i c a c i d / 3 - m e r c a p t o -
p rop ion i c ac id . 
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Structural assignment, stereochemistry and biological assay are 
discussed. Screening results of the compounds (31) and (32) are summarised for 
cytotoxic activity against 3-cell lines of three types of human cancers: lung, 
breast, CNS. Screening results of the above compounds are also summarised for 
antimicrobial activity against four bacteria, Escherichia coli, Bacillus subtilis, 
Staphylococcus aureus, Pseudomonas aeruginosa and one fungi Candida 
albicans (details in Chapter 6) 
(31) 
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R E S U L T S A N D D I S C U S S I O N 
The synthesis of compounds (32)-(35) has been performed in two steps (Scheme 
2). The hydrazone FD (31) was first prepared following a published procedure^ by 
refluxing a solution of 10-undecenoicacid hydrazide (23) in dry benzene with j!?-chloro-
acetophenone (molar ratio, 1:1) as white crystalline needles in 83% yield. The hydrazone 
(31) was then reacted with (i) mercaptoacetic acid and (ii) 3-mercaptopropiomc acid 
(molar ratio, 1:3) in dry benzene. The products on column chromatography over a silica 
gel column using pet.ether-diethyl ether as eluent, yielded compounds FDXjA (32), 
FDX,B (33) and FDXjC (34) in (i) and FDXjA (35) a sole product in (ii). The failure of 
the reaction to yield the cyclised product in (ii) may be attributed to the increased 
nucleophilicity of the carbon at C-7 due to the presence of the electron donating methyl 
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A solution of 10-undecenohydrazide (23) in dry benzene was refluxed with 
;?-chloroacetophenone for 6 h as described in (24). The products on usual work up 
followed by crystallization from ethanol furnished FD (31) as white crystalline needles 
in 83% yield. The reaction sequence is as follows: 
O O 
MeOH/H 
NH2.NH2.H2O ^ N H - N H , 
(23) 
dry benzene 
Reflux, 6 h 
Structure Elucidation of FD (31) 
It was a needle shaped white crystalline solid, m.p 64 °C. The stereostructure of 
FD has been fully confirmed by IR, DCI-MS, 'H-NMR, '^C-NMR, APT and HETCOR 
spectra. IR spectrum (KBr) exhibited characteristic absorption bands at 3175 (NH). 
2900, 2850 (C-H), 1675, 1650 (CO), 1595 (phenyl) and 1540 (C=N) cm"'. The DCI-MS 
spectrum of the compound showed an intense [M+1]"^ signal at m/z 335/337 which is in 
consistent with the molecular formula [C19H27N2OCI]. The signals in 'H-NMR and '^C-
NMR spectra (Fig. 8a and 8b), dissolved in DMSO-c/^ could be easily assigned (Tables 
8a and 8b) by comparing the spectra with the previously established hydrazone FB (24). 
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Table 8b: " C - N M R , A P T and H E T C O R spectral data of FD (31) im 
D M S O - 4 
C-nr 8 (ppm) APT H E T C O R 
correlat ion vt'ith 
7-CH3 13.19,13.76 ( -60%, 40%) CH3 H-CH3 
7 145.43, 149.35 ( -60%, 40%) C H-7 
r 175.13, 169.16 ( -60%, 40%) C 
2' 32.25, 33.92 ( -60%, 40%) CH2 H-2' 
3' 24.20, 25.07 ( -60%, 40%) CH2 H-3' 
4'-8' 28.18-28.87 CH2 H-4'-8' 
9' 33.07 CH2 H-9' 
10' 138.73 CH H-10' 
Ar-1 133.66 C 
Ar-4 137.11 C 
Ar-2,6 127.51 CH H-Ar-2,6 
Ar-3,5 128.25 CH H-Ar-3,5 







7-CH3 2.34,2.76(~75%, 25%) 3H s 
NH 9.37,9.68 ( -75%,25%) IH s 
2' 2.28,2.73 ( -25%,75%) 2H t J2'.3' 6.71,7.62 
3' 1.66 2H br p J ~ 7.48 
4 ' -8 ' 1.31 5x2H br s 
9' 2.04 2H m 
10' 5.79 IH tdd J,O'H,17.09, J,O'he10.22, 
Jjo'.g' 6.72 
HE-11' 4.88 IH dd JHJ:, 10' 10.22, JH^, H,2.29 
H z - i r 4.95 IH dd JHZ,10'17.09, JH ,^ HE 2.29 
Ar-2,6 7.84 2H d JAr-2, 6, Ar-3,5 8.55 
Ar-3,5 7.42 2H d JAr-2,6 ,Ar-3,5 8.55 
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All the signals were found comparable with that of (24) except that it showed no signal 
corresponding to the benzylidene proton at C-7 and in place a singlet at 5 2.21, 2.24 (~ 
60%, 40%) for the methyl group protons appeared. In addition, it also showed the 
characteristic A2B2 signals for the /?-chlorophenyl ring. As for (24), here again both the 
spectra showed several double signals for 7-CH3, C-7, C-l ' , C-2', and C-3' in the '^C-
NMR spectrum and for H-7-CH3, NH and H-2' in the 'H-NMR spectrum, indicating that 
this molecule is also present in two different forms. Irradiation of NH-proton (Fig. 8c) 
resulted in a NOE-enhancement of both H-8 signals corresponding with the methyl 
group in both forms, suggesting that N-H proton and the methyl group in both forms are 
very near to each other. This can only be the case in ^'-isomer. Further, only a very weak 
enhancement of the H-2' signal is seen, so it could be impossible to make a definitive 
conclusion about the conformation of the CO-NH bond. However, it could be assumed 
that in analogy to (24), the major form is the synperiplanar conformer and the minor one 
is the antiperiplanar conformer. As in (24), the 'H-NMR spectrum of this compound 
dissolved in acetone-fig, again two forms were observed in -3 :1 ratio (Table 8c) 
indicating that the equilibrium between the stabile conformers in this case also depends 
on the polarity of the solvent. 
The structure of the compound was further confirmed by HETCOR spectra 
(Fig. 8d and 8d') . It showed cross correlation peaks between CH3-7 (60%, 40%)/CH3-7 
(60%, 40%), H-2' (60%, 40%)/C-2' (60%, 40%), H-3' (60%,40%)/C-3' (-60%,40%), H-
4'-8'/ C-4'-8', H - 9 ' / C - 9 ' , H - I O ' / C - I O , HE-11', HZ-117C-11', H-Ar-2,6/C-Ar-2,6, and H -
Ar-3,5/C-Ar-3,5 as shown in Table 8b . An APT spectrum (Fig. 8e) further confirmed 
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Based on the above spectral evidence, the compound (31) was characterised as 
p-chloroacetophenone-lO-undecenohydrozone and deduced to be its two forms as 
synperipianar (major) and antiperiplanar (minor) (Fig. 8) 









p-Chloroacetophenone-ll-(carboxymethylthio)undecanohydrazone FDXiA (32), 2-(4-
ch loroph enyl)-2-methyl-3-[ll-(carboxymethylth io) undecan amidojth iazolidm-4-one 
FDXjB (33) and bis(carboxymethylthio)-4-chloroacetophenotal FDX,C (34) 
[Reaction of the hydrazone (31) with mercaptoacetic acid] 
A mixture of the hydrazone (31) and mercaptoacetic acid (molar ratio, 1:3) 
dissolved in dry benzene was refluxed with stirring for 24 h and worked up as usual. The 
products on column chromatography first afforded a yellow solid which on 
crystallisation (EtOAc) gave FDXiA (32) (41.2%) as white amorphous solid . Further 
elution of the column yielded a colourless oily liquid FDX,B (33) (33.3%) and then a 
pale yellow solid, FDXjC (34) which on crystallization (EtOAc) afforded white 
crystalline needles (13.2%). 
HS.CH2.C00H 
dry benzene, HO 
reflux, 24 h 
FD(31) FDX,A (32) 
0 0 
OH + HO 
CHr 
0 N H — N S 
F D X , B (33) 
Structure Elucidation of FDX^A (32) 
It was a white amorphous solid, m.p. 68 °C. The structure of FDXjA has been 
fully established by IR, DCI-MS, 'H-NMR and '^C-NMR spectra. IR spectrum exhibited 
characteristic peaks at 3150 (N-H), 3050 (OH), 2900, 2850 (C-H), 1640 (CONH), 1700 
( 
( m O H ) , 1590 (phenyl), 1530 (C=N) and 825 cm"'. The DCI-MS spectrum showed a 
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set of [M+1]"^ peaks as the base peak at m/z 427/429 corresponding with the molecular 
formula [C21H31N2O3SCI], which is equal to the sum of the molecular weights of (31) 
(334/336) and mercaptoacetic acid (92). This suggested that FDXjA is an adduct of (31) 
and HS.CH2.COOH. The two prominent fragment ion peaks at m/z 168/170 [(M)-
CnHssOsS]^ and m/z 154/156 [(M+O-CnHjsNOsS]^ were formed by the cleavage of 
CO-NH and N-NH bonds respectively . 
The 'H-NMR and '^C-NMR signals have been assigned to individual H-and C-
atoms (Table 9a) by comparing with the spectra of a previously established compound 
FBXjB (25) (Table 2a). All the signals were found comparable with (25) except that it 
showed no signal at 5 8.07, 8.27 (60%, 40%) corresponding to the benzylidene proton at 
C-7 in (25) and in place a singlet at 5 2.22, 2.24 (~ 60%, 40%) for the methyl group at 
C-7 appeared in (32). In addition, it also showed the characteristic A2B2 signals for the 
jD-chlorophenyl ring. As for (25), here again both the spectra showed several double 
signals for 7-CH3, C-7, C-1', C-2', and C-3' in the '^C-NMR spectrum and for H-7-CH3, 
NH, H-2' in the 'H-NMR spectrum, indicating that this molecule is also present in two 
different forms. The two forms were found to be in the ratio -6 :4 in DMS0-<i(5 (Table 9a 
) and -3:1 in acetone-c/^ (Table 9b). 
Based on the above spectral evidence, the structure of compounnd FDXiA was 
characterised as 4-chloroacetophenone-l l-(carboxymethylthio)undecano hydrazone 
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7-CH3 2.30,2.34 3H s 
( -25%, 75%) 
NH 9.37, 9.68 IH s 
( -75%, 25%) 
2' 2.28,2.71 2H t J2.3'7.33, 7.32 
( -25%, 75%) 
3' 1.59 2H brp J«7.33 
4'-9' 1.30 6x2H brs 
10' 1.67 2H brp J»7.38 
i r 2.64 2H t JIIMO'7.48 
1" 3.22 2H s 
Ar-2,6 7.84 2H d JAr-2,6 Ar-3,5 8.55 





Structure Elucidation of FDX^B (33) 
It was a colourless oily liquid. The structure of FDXjB has been fully 
confirmed by IR, DCI-MS, "H-NMR, and '^C-NMR spectra. IR spectrum (Neat) gave 
characteristic peaks at 3240 (NH), 3050 (OH), 2900, 2850 (C-H), 1700 (COOH), 1685 
(CON) 1660 (CONH), 1600 (phenyl), 1420 (S-CH2), 825 and 780 cm"'. The DCI-MS 
spectrum showed a set of [M+1]"^ peaks at m/z 501/503, confirming its molecular 
weight 500/502 which corresponds with the molecular formula [C23H33N2O4S2CI]. 
This is equal to the sum of the molecular weights of compound (32) (426) plus 
mercaptoacetic acid (92) minus one molecule of water. This suggested that the 
formation of thiazolidinone ring has occurred by the cyclocondensation of (32) with 
mercaptoacetic acid. The mode of fragmentations is shown in Chart 7, The set of 
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peaks at m/z 456/458 was due to [ (M+1) -C00H] . The diagnostic peak of the 
thiazoiidinon ring was observed at m/z 427/429 [ (M+O-COCHjS] arised by the 
cleavage of 1-2 and 3-4 bonds. The set of peaks at m/z 212/214 was due to 
<2-cleavage (base peak) and an another set of peaks at m/z 229/231 was due to 
/^-cleavage on the long alkyl chain to the thiazolidinone ring. It also showed 
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The signals in 'H-NMR and '^C-NMR spectra dissolved in acetone-c/^ 
have been assigned to individual H-and C-atoms (Table 10). The assignments 
were made from their typical chemical shift values, multiplicity, relative 
integrations and also by comparing with the spectra of the previously established 
compound FBXjC (Tables 2a and 2b). All the signals in both the spectra were 
found comparable except the signal for C-2 proton which didn ' t appear here at 
5 6.04 and in place a new singlet at 5 1.98 for the methyl proton was observed. It 
also showed a sharp singlet at 5 9.02 for the NH proton. Also in '^C-NMR 
spectrum a new signal appeared at 6 20.21 for the methyl carbon at C-2. In 
addition, both the spectra gave characteristic signals for the aromatic 
protons/carbons of the /?-chlorophenyl ring. 
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Structure Elucidat ion of FDXj^C (34) 
It was a white needle shaped crystalline solid. The structure of the compound was 
established by IR, DCI-MS, 'H-NMR and '^C-NMR spectra. IR spectrum (KBr) 
showed characteristic peaks at 3100 (OH, br), 1720 (COOH) and 1610 (phenyl) cm"'. In 
DCI-MS spectrum the molecular ion peak was absent, but it showed a [(M)-
SCH2COOH] peak as the base peak at m/z 229/231 which corresponds with the stabile 
fragment ion: HOOC-CH2-S-C^(CH3)-C6H4Cl. 'H-NMR spectrum dissolved in acetone-
de showed a singlet at 5 2.04 for the methyl proton. It also showed two doublets for two 
methylene protons each at 5 3.36 (J=15.26, Hup) and 5 3.46 (J=15.26, Hdn). It gave 
characteristic A2B2 signals for the p-chlorophenyl ring as doublets at 5 7.75 (J=8.85, Ar-
2,6), and 6 7.40 (J=8.85, Ar-3, 5). '^C-NMR spectrum dissolved in acetone-ii^ showed 
the signals at 6c 30.25 (CH3), 61.77 (S-C-S), 34.04 (CHj), 170.80 (COOH), 142.46 (Ar-
C-1), 129.79 (Ar-C-2, 6), 129.28 (Ar-C-3, 5) and 134.03 (Ar-C-4). 
Based on the above spectral evidence, compound FDX|C was characterised as 
bis (carboxymethylthio)-4-chloroacetophenotal (34). 
CI 
H H C H j ^ ^ ^ H H 
HO. J X . . J X OH 
O 
F D X I C ( 3 4 ) 
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p-Chloroacetophenone-ll-(2-carhoxyethylthio)Jundecanohydrazone FDX2A (35) 
[Reaction of the hydrazone (31) with 3-mercaptopropionic acid]* 
*[The target compound, 2-(4-chlorophenyl)-2-methyI-3-[l l-(2-carboxyethylthio) 
undecanamido]thiazan-4-one could not be obtained probably because of increased 
nucleophilicity of N=C-CH3 group carbon] 
A solution of the hydrazone (31) in dry benzene was refluxed with 3-
mercaptopropionic acid (molar ratio, 1: 3) for 28 h. The products on purification by 
column chromatography afforded a pale yellow solid, FDX2A (35) as the sole product 
which was recrystallised (benzene-acetone) as white crystalline globules (54.2%). 
Structure Elucidation of FDX^A (35) 
It was a white globule shaped crystalline solid, m.p 72 °C. The structure of 
FDXjA was fully established by IR, DCI-MS, 'H-NMR and '^C-NMR spectra. The IR 
spectrum (KBr) gave characteristic peaks at 3175 (NH), 2900, 2850 (CH), 
1680 (COOH), 1650 (CONH), 1595 (phenyl), 1540 (C=N) and 1485 (S-CH2) cm''. 
The DCI-MS spectrum showed a set of [M+1]"^ peaks as the base peak at m/z 441/443, 
confirming its molecular weight 440/442 which corresponds with the molecular formula 
[C22H33N2O3SCI]. This is equal to the sum of the molecular weights of (31) (334/336) 
and 3-mercaptopropionic acid (106). This indicated that FDX2A is an adduct of (31) 
with HS.CH2.CH2.COOH. Other two prominent fragment ion peaks were observed at 
m/z 169/170 [(M+1)-C,3H2303S] due to the cleavage of CO-NH bond and m/z 153/155 
[(M+l)-Ci3H25N03S,] arised by the cleavage of N-NH bond. 
The 'H-NMR and '^C-NMR signals could be easily assigned to individual H-and 
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compounds FBX2B.(29)^ and FDXiA.(32) (Tables 6a, 6b and 9a, 9b). Both the spectra 
revealed the double signals corresponding to synperiplanar and antiperiplanar 
conformers around CO-NH bond as in (29) and (32). 
Based on the above spectral evidence, the structure of compound FDX2A was 
characterised as p-chloroacetophenone-1 l-(2-carboxyethylthio)undecano hydrazon (35) 
which is represented as in Fig. 10 






A mixture of 10-undecenoicacid hydrazide (23) (4.00g, 0.0202 mol) and p-
chloroacetophenone (3.122g, 0.0202 mol) dissolved in dry benzene (50 ml) was refluxed 
for 6 h as described in (24) and then worked up as usual. The products on crystallization 
from ethanol furnished FD (32) as white crystalline needles, 5.624g (83%), m.p. 64 °C, 
Rf 0.80 (benzene- diethylether, 6 : 4 v/v) 
IR (KBr): 3175 (NH), 2900, 2850 (C-H), 1675, 1650 (CO), 1595 (phenyl, 
C=C), 1540 (C=N), 1485, 1420, 1395, 1 180, 1110, 1090, 980, 900, 820 cm"'. 
' H - N M R (400 MHz, acetone-^/^,): 8H 2.34, 2.76 ( -75%, 25%; 3H, s, CH;,-?). 
9.37, 9.68 ( -75%, 25%; IH, s, NH), 2.28, 2.73 ( - 2 5 % . 75%; 2H, t, J=6.71, 7.62. 
H-2'), 1.66 (2H, br p, J^7.48, H-3'), 1.31 (lOH, brs, H-4 '-8 ' ) , 2.04 (2H, m, H-9'), 
5.79 ( IH, tdd, J -6 .72 , 17.09, 10.22, H-10') , 4.88 ( IH, dd, J=10.22, 2.29, Hg), 
4.95 ( IH, dd, J= 17.09, 2.29, Hz), 7.84 (2H, d, J= 8.55,Ar-2,6), 7.42 (2H, d, J= 
8.55, Ar-3,5). 
'H-NMR (400 MHz, DMS0-</<5,): 5 H . 2 . 2 1 , 2 . 2 4 ( - 6 0 % , 4 0 % ; 3 H , s, 7-CH3), 10 .29, 
10 .39 ( 4 0 % , 6 0 % ; I H , s, N H ) , 2 .31 , 2 . 6 4 ( 4 0 % , 6 0 % ; 2 H , t, J = 7 . 5 1 , 7 . 3 2 , H - 2 ' ) , 1.57 
( 2 H , b rp , J - 6 . 9 6 , H - 3 ' ) , 1-28 (LOH, brs , H - 4 ' - 8 ' ) , 2 . 0 0 ( 2 H , td, J = 7 . 1 4 , 6 5 9 , H - 9 ' ) , 5 .76 
( I H , ddt , J = 1 7 . 0 3 , 10.25, 6 .59 , H - 1 0 ) , 4 . 9 2 ( I H , dd , J = 1 0 . 2 5 , 2 . 1 4 , H E - 1 1 ' ) , 4 . 9 8 ( I H , 
dd , J - 1 7 . 0 3 , 2 .15 , H z - 1 1 ' ) , 7 .77 ( 2 H , d, J = 8 . 6 0 , A r - 2 , 6 ) , 7 .45 ( 2 H , d, J = 8 . 6 0 , A r - 3 , 5 ) . 
'^C-NMR (lOOMHz, DMSO-rfg): 5c 13.19, 13.76 (-60%, 40%; C-7-CH3), 145.43, 
149.35 (-60%, 40%; C-7), 175.13, 169.16 (-60%, 40%; C-1'), 32.25, 33.92 (-60%, 
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40%; C-2'), 24.20, 25.07 (-60%, 40%; C-3'), 28.18-28.87(C-4'-8'), 33.07 (C-9'), 
138.73 (C-10'), 114.49 (C- l l ' ) , 133.66 (Ar-C-1), 127.51 (Ar-C-2,6), 128.25 (Ar-C-3,5), 
137.11 (Ar-C-4). 
DCI-MS (NH3): m/z 335/337 [(M+1) 100.0/48.4; CigHjyClNzO], 336 (49.6), 338 (21.8), 
339 (7.7), 210 (7.8), 168/170 [(M+l)-CnH,90, 47.7/18.9], 169 (21.3), 171 (6.5), 167 
(6.7), 152/154 [M-CnH2oNO, 10.6/7.5] and 153 (6.3). 
p-Chloroacetophenone-ll-(carboxymethylthio)undecanohydrazone FDXjA (32), 2-(4-
cltloroplienyl)-2-methyl-3-[ll-(carboxymethylthio)undecanamido]thiazolidin-4-one 
FDX,B (33) and bis(carboxymethylthio)-4-chloroacetophenotal FDX,C (34). 
[Reaction of the hydrazone (31) with mercaptoacetic acid] 
A mixture of the hydrazone (31), (0.782 mg, 0.0085 mol) dissolved in dry 
benezene (20 ml) was refluxed with stirring for 24 h and worked up as described in (24). 
The products on purification by column chromatography (silica gel, light pet.ether-
diethyl ether, 1:1 v/v) as eluent first afforded a yellow solid, labelled as FDX,A (32) 
which on crystallization from EtOAc afforded crystalline globules, 520 mg (41.2%), m.p 
68 °C, Rf 0.49 (benezene-diethylether, 6:4 v/v). Further elution of the column using light 
pet.ether-diethylether, 3:7 v/v) furnished a colourless oily liquid, labelled as FDXjB (33) 
490 mg (33.3%), Rf 0.39 (benzene-diethylether, 6:4 v/v) and then a pale yellow solid 
labelled as FDXiB (34) which on crystallization from EtOAc gave white crystalline 
needles, 120mg (13.2%), m.p.l04 °C, RfO.33 (benzene-diethylether, 6:4v/v). 
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Spectral data of FDX^A(32) 
IR (KBr): v„ax 3150 (NH), 3050 (OH) 2900, 2850 (C-H), 1700 (COOH), 1640 
(CONH), 1590 (phenyl), 1530 (C=N), 1480 (S-CH2) 1420, 1395, 1360, 1250, 
1180, 1085, 825 cm"' 
' H - N M R (400 MHz, acetone-fiTg): 5H 2.30, 2.34 ( - 2 5 % , 75%; 3H, s, CH,-7), 
9.37, 9.68 ( - 7 5 % , 25%; IH, s, NH), 2.28, 2.71 ( - 2 5 % , 75%; 2H, t, J - 7.32. 
7.33), 1.59 (2H, br p, J«7.33, H-3'), 1.30 (12H, br s, H-4 ' -9 ' ) , 1.67 (2H,br p. 
J«7.48,H-10') , 2.64 (2H, t, J= 7.48, H-11') , 3.22 (2H, s, H-1" ) . 7.84 (2H, d, J= 
8.55, Ar-2,6), 7.42 (2H, d, J=8.55, Ar-3,5). 
' H - N M R (400 MHz, DMSO -RFG): SH 2.22, 2.24 ( - 6 0 % , 40%; 3H, s, CH,-7). 
10.29, 10.39 ( - 4 0 % , 60%; IH, s, NH), 2.31, 2.64 ( -40%, 60%, 2H, t, J= 7.17, H-
2'), 1.50 (2H, br p, J «7.63, H-3'), 1.24 (12H, br s, H-4 ' -9 ' ) , 1.58 (2H, br p, J 
-6 .87 , H-10 ' ) , 2.55 (2H, t, J =7.17, H - l l ' ) , 3.19 (2H, s, H-1" ) , 7.77 (2H, d, J = 
8.55, Ar-2,6), 7.45 (2H, d, J = 8.55, Ar-3,5). 
'^C-NMR (100 MHz, DMSO-rf^,): 5c 13.19, 13.76 ( - 6 0 % , 40%, CH3-7), 145.43, 
149.36 ( -60%, 40%; C-7), 169.16, 175.13 ( -40%, 60%; C-1') , 32.25, 33.92 
( -60%, 40%; C-2 ') 24.19 (C-3'), 28.0-28.80 (C-4'-10') . 31.64 (C-11') , 171.47 
(C-2") , 33.19 (C-1") , 133.45 (Ar-C-1), 127.51 (Ar-C-2,6), 137.10 (Ar-C-4), 
128.25 (Ar-C-3,5). 
DCI-MS (NH3): m/z 427/429 [(M+1); 100.0/57.7 C21H3J CIN2O3S], 428 (72.5), 430 
(31.6), 431 (11.3), 276 (11.1), 210 (9.3), 168/170 [(M)-Ci3H2303S, 40.4/18.9], 169 
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(24.0), 171 (10.1), 154/156 [M+1)-C,3H25N03S, 36.7/12.9], 155 (16.5), 152 (15.0), 153 
(8.8), 73 (6.9). 
Spectral data of FDXiB (33) 
IR (Neat): v^^, 3240 (N-H), 3050(OH), 2900, 2850 (C-H), 1700 (COOH), 1660 
(CON), 1640 (CONH), 1600 (phenyl), 1430 (S-CH2), 1240, 1160, 870, 780 cm"' 
'H-NMR (400 MHz, acetone-cT^,): 5h 1-98 (3H, s, CH3-2), 3.45 ( I H , d, J=15.56, 
H-5up), 3.53 ( IH , d, J=15.56, H-5dn), 9.02 ( lH,s , NH), 2.07 (2H, t, J=7.62, H-
2') , 1.49 (2H, br p, J=7.13, H-3') , 1.19 (12H, br s, H-4 ' -9 ' ) , 1.58 (2H, brp, 
J=7.24, H-10 ' ) 2.63 (2H, t, J=7.33, H-11 ' ) , 3.22 ( IH , s, H-1"), 7.30 (IH, d. 
J=8.53, Ar-2,6), 7.25 ( IH, d, J=8.53, Ar-3,5). 
'^C-NMR (100 MHz, acetone-</<5,): 5c 25.21 (2-CH3), 67.19 (C-2), 172.12 (C-
4), 33.87(C-5), 172.48 (C-T) , 34.18 (C-2') , 25.97 (C-3 ' ) , 29.48-30.30 ( C - 4 ' -
11'), 33.77 (C-1"), 169.65(C-2"), 138.13 (Ar-C-1), 128.84 (Ar-C-2,6), 129.36 
(Ar-C-3,5), 133.24(Ar-C-4). 
D C I - M S (NH3): m/z (%) 501/503[(M+1)\ 12.3/5.7], 456/458[(M+l) -C02H, 
11.7/4.8], 427/429[(M+1)-SCH2C0, 7.3/3.3], 273(10.8), 274 (10.2), 275(12.5), 
276( 53.5), 277 (21.8), 278 (8.3), 258 ( 6.7), 259 (11.3), 239 (7.2), 240 (31.8), 
241 (13.9), 242 (11.8), 230 (10.9), 231 ( 25.4), 232 (16.3), 223 (27.2), 224 
(12.2), 210 ( 34.5), 212 (100.0), 213 (47.4) 214 (72.3), 215 ( 33.5), 216 (11.8), 
217 (5.7), 218 (14.5), 197(13.4), 199 (4.1), 176 (11.8), 178 (12.7), 162 (8.1), 
163 (8.2), 164 (8.1), 165 (7.9), 166 (40.4), 148 (15.0), 149 (10.0), 150 (9.0), 151 
(15.4), 152 (16.3), 153 (7.5), 134 (42.2), 135 (20.0), 136 (32.2), 137 (19.0), 138 
(12.0), 168 (18.4), 169 (13.0), 171 (8.1), 154 (22.9), 155 (13.5), 152 (17.0). 
2 75 
S p e c t r a l da ta of FDXi^C (34) 
IR (KBr): v^^x 3100 (OH, br), 1720 (COOH), 1610 (phenyl), 1510, 1400, 1300, 1270, 
1170, 1140, 1030, 840, 760 cm"'. 
'H-NMR (acetone-rffi): 5h 2.04 (3H, s, CH3), 3.36 (2H, d, J = 15.26, H up), 3.46 (2H, d, 
J= 15.26, H dn), 7.75 (2H, d, J=8.85, Ar-2,6), 7.40 (2H, d, J=8.85, Ar-3,5). 
'^C-NMR (acetone-dg): 5c 30.25 (CH3) 61.77 (S-C-S), 34.04 (CH2), 170.80 
(COOH), 142.46 (Ar-C-1), 129.79 (Ar-C-2,6), 129.28 (Ar-C-3,5), 134.03 (Ar-
C-4) 
DCI-MS (NH3): m/z 229/231 [M-(SCH2.C00H), 100.0/231.0], 230 (39.8), 232 (14.8), 
171 (23.7), 172 (9.2), 173 (9.5), 139 (14.9), 140 (6.0), 141 (6.0), 85 (5.0) 
p-Chloroacetophenone-ll-[(2-carboxyethylthio)]undecanohydrazone F D X 2 A ( 3 5 ) 
[Reaction of the hydrazone (31) with 3-mercaptopropionic acid] 
To a solution of the hydrazone (31) (1.0 g, 0.0028 mol) in dry benzene (20 ml) 
was added 3-mercaptopropionic acid (0.903 g, 0.0085 mol) and refluxed for 28 h. The 
products on usual work up and column chromatography (silica gel, pet. ether-diethyl 
ether, 1:1 v/v) followed by crystallization from (benzene-acetone) afforded the sole 
product F D X 2 A ( 3 5 ) as white crystalline globules, 705 mg (54.2%), m.p 72 °C , RF 0.48 
(benzene-diethylether, 6:4 v/v). 
Spectral data of FDX^A (35) 
IR (KBr) : v„,ax 3175 (NH), 2900, 2850 (CH), 1680 ( m O H ) , 1650 (CONH), 1595 
(Phenyl), 1540 (C=N), 1485 (S-CH2), 1420, 1460, 1400, 1250, 1190, 1110, 1090, and 
825 cm-'. 
276 
'H-NMR (400 MHz, DMSO-^/tf ) : 6h 2.24, 2.27. ( -60%, 40%; 3H, s, 7-CH3), 
10.31, 10.40 ( -40%, 60%; IH, s, NH), 2.32, 2.66 ( -40%, 60%; 2H, t, J =7.42, H-
2'), 1.51 (2H, brp, J;^7.12, H-3'), 1.24 (6x2H, br s, H-4'-9 ' ) , 1.59 (2H, br p, J 
^7.02, H-10') , 2.48 (2H, t, J=6.96, H-11') , 2.65 (2H, t, J = 6.79, H - l " ) , 2.50 (2H, 
t, J=6.79, H-2") , 7.78(2H, d, J=8.55, H-Ar-2, 6), 7.47 (2H, d, J= 8.55, H-2") , 
7.78 (2H, d, J=8.55, H-Ar-2, 6), 7.47 (2H, d, J -8 .55 , H-Ar-3,5); 
'^C-NMR (100 MHz, DMSO-^/^,): 5c 13.20, 13.76 ( -60%, 40%; 7-CH3), 145.42, 
149.34 ( - 6 0 % , 40%; C-7), 169.14, 175.11 ( -40%, 60%; C-1 ' ) 32.24, 33.92 
( -60%, 40%; C-2') , 24.18(C-3'), 28.10-28.78 (C- 4 '-10') . 31.08 ( C - I T ) , 26.34 
(C-1"), 34.51(C-2") , 178.47 (C-3") , 133.44 (C-Ar-1). 127.50 (C-Ar-2, 6), 
137.08 (C-Ar-3, 5), 128.25 (C-Ar-4). 
DCI-MS: m/z (%) 441 (100.0), 443949.7), 169 (18.3), 170 (5.9), 171 (8.9), 153 
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Biological Screening: Study for Anticancer and Antimicrobial 
Activities 
(A) A n t i c a n c e r activity against mal ignant human t u m o u r cells: 
I N T R O D U C T I O N 
The compounds are evaluated as one dose primary anticancer assay in 3-cell 
line panel consisting of three types of human cancers: breast (MCF7), Lung (NCI-
H460) and CNS (SF-268). In the screening protocol, each cell line is inoculated and 
preincubated for 24-28 h on a microtiter plate. Test agents are then added at a single 
concentration and the culture incubated for further 48 h. End-point determinations are 
made with alamar blue'. Results for each test agent are reported as the percent of 
growth of the treated cells when compared to the untreated control cells. Compounds 
which reduce the growth of anyone of the cell lines to 32% or less (negative number 
indicates cell kill) are then passed on for evaluation in the full panel of 60- cell lines 
over a 5 -log dose range^. 
In the fiill panel of 60- cell lines, 9 types of human cancers ; leukaemia, lung 
cancer, colon cancer, central nervous system, melanoma, ovarian, renal, prostate and 
breast are used. These test agents are added in five 10- fold dilutions and a 48 hours 
continuous drug exposure protocol is used. Sulforhodamine B (SRB), a protein-
binding dye assay, is used to estimate cell viability or growth. Results are expressed 
as log 10 GI50 which is the drug concentration (M) causing a 50% reduction in the net 
protein increase in control cells during the drug incubation. 
Data Analysis: The calculated Measurement of Effect: Percentage Growth (PG) 
The measured effect of the compound on a cell line is currently calculated according 
to one or the other of the following two expressions: 
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If (Mean ODtest - Mean ODtzero) ^ 0. then 
PG = 100 X (Mean OD,est - Mean ODtzero)/ Mean OD,^ ero 
Where: 
Mean ODtzero^ The average optical density measurements of SRB-derived colour 
just before exposure of cell to the test compound. 
Mean OD,est= The average optical density measurements of SRB-derived colour after 
48 hours exposure of cell to the test compound. 
Mean ODcri = The average optical density measurements of SRB-derived colour after 
48 hours with no exposure of cell to the test compound. 
The results as obtained from experimental data are represented in three ways. 
(i) The Data Sheet: 
The first two columns of the Table describe the subpanei and cell lines 
involved. The next two columns list the Mean ODtzero and Mean OCdri: the next five 
columns list the Mean ODtest for each five different concentrations. Each concen-
tration is expressed as the logio (molar or ^g/ml). The next five columns list the 
calculated PGs for each concentration. The response parameters GI50, TGI, and 
LC50 are interpolated values represenfing the concentrations at which the PG is 
+50.0. and -50. respectively. 
(ii) Dose-Response Curves: 
The dose-response curve page of the data package is created by plotting the 
PGs against the logio of the corresponding concentration for every cell line. The cell 
line curves are grouped by subpanei: Horizontal lines are provided at the PG values 
of + 50.0.and -50. The concentrations corresponding to points where the curves cross 
these lines are the GI50, TGI, and LC50 respectively, 
(iii) The Mean Graphs: 
The mean graphs show mean graphs at each of the principal response 
parameters: GI50, TGI, and LC50. Bars extending to the right representing sensitivity 
of cell lines to the test agent in excess of the average sensitivity of all tested cell lines. 
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Since the bar scale is logarithmic a bar 2 units to the right implies the compound 
achieved the response parameters (eg. GI50) for the cell line at the concentration one-
hundredth the mean concentration required over all cell lines, and thus the cell line is 
usually sensitive to that compound. Bar extending to the left correspondingly imply 
sensitivity less than the mean. 
RESULTS AND DISCUSSION 
The compounds [FTZ (1), FBCB (4), FTZX4B (7), FTCA (9), FFjC (12), 
FZX (16), FTZX' (17), FT (20), FT' (21), FF (22), FB (24), FBX,C (26), FBX3A 
(27), FBXjC (30), FD (31), FDXiA (32)] were evaluated as one dose primary 
anticancer assay in a three cell line panel and the results are depicted in Table 1. Out 
of the sixteen compounds screened, only one compound, F B X 3 A (27) was found to 
be active. This compound was then screened for cytotoxic activity^ at five different 
concentrations against 60 cell lines of nine types of human cancers: leukaemia, lung, 
colon, CNS, melanoma, ovarian, renal, prostate and breast. A 48 h continuous drug 
exposure protocol was used and a Suphorhodamine B protein assay was used to 
estimate cell viability or growth. Results (Table 3) are expressed as logjoGI50' which 
is the drug concentration (M) causing 50% reduction in the net protein increase in 
control cells during the drug incubation. This compound showed activity only at 
higher concentration. Noteworthy results was obtained for the compound F B X 3 A in 
the case of non-small lung cancer, melanoma and renal where the reduction in growth 
is 75, 74 and 70 and 77% respectively (Table 3). 
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FTZ (1) IxlQ-'M 69 93 95 Inactive 
FBCB (4) IxlG'^M 72 98 1 12 Inactive 
FTZX4B (7) 1x10"'M 79 99 106 Inactive 
FTCA (9) IxlQ-'M 63 99 90 Inactive 
FFjC (12) I x l C ' M 52 67 71 Inactive 
FTZX(I6) IxlO'^M 49 82 113 Inactive 
FTZX' (17) I x l C ' M 84 98 107 Inactive 
FT (20) IxlQ-'M 72 96 109 Inactive 
FT' (21) IxlG'^M 94 98 114 Inactive 
FF (22) IxlQ-'M 82 96 112 Inactive 
FB (24) I x l C ' M 59 95 107 Inactive 
FBX,C (26) 1x10"'M 53 49 65 Inactive 
FBX3A (27) lxlO"'M 14 1 1 Active 
FBXjC (30) IxlQ-'M 48 53 75 Inactive 
FD (31) 1X10"'M 61 98 114 Inactive 
FDX,A (32) 1x10"'M 47 65 98 Inactive 
The dose response curves of the compound F B X 3 A (27) treated with 
malignant human tumor cell lines has been deciphered in Fig. l a (Table 2). 
In F B X 3 A , the highest percentage of retardation of growth was observed in 
NCI-H226 of non-small cell lung cancer (75%). Other significant activities 
were observed in UACC-62 (74%), SKMEL-28 (70%) of melanoma cancer, 
SN12C (72%) and U031 (70%) of renal cancer. 
The overall anticancer effect of the compound (27) on all the malignant 
human tumour cell lines is illustrated in Fig. lb . 
Mean graphs of the compound (27) which facilitate visual scanning of 
data for potential patterns of selectivity for particular cell lines with respect 
to a selected response parameters are represented in Fig. Ic. 
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Table Z National Cancer Institute Developmental Therapeut ics P r o g r a m 
In-Vitro Testing Results 
NSC: D- 722671 / I Exper iment ID: 0201NS46-28 Test T y p e : 0 8 Units: Molar 
Report Date: February 4 , 2 0 0 2 Test Date: January 14, 2 0 0 2 Q N S : M C : 
C O M ! : FBX 3A Stain Reagent: SRB Dual-Pass S S P L : OGVG 
L o g l O C o n c e n t r a t i o n 
T i m e Mean O p t i c a l D e n s i t i e s 
P a n e l / C e l l L i n e Z e r o C t r l - 8 0 - 7 0 - 6 0 - 5 0 
L e u k e m i a 
CCRF-CEM 0 2 1 0 0 7 8 4 0 7 7 6 0 . 7 5 7 0 7 8 9 0 6 1 8 
H L - 6 0 ( T B ) 0 4 2 4 1 3 5 3 1 3 6 1 1 3 4 1 1 2 5 8 1 6 8 5 
K - 5 6 2 0 1 9 6 1 0 7 2 1 0 6 2 1 0 7 9 1 0 9 8 0 7 3 6 
MOLT-4 0 2 3 3 1 1 3 6 1 1 1 9 1 1 2 0 1 0 6 3 0 8 3 0 
R P M I - 8 2 2 6 0 3 2 8 0 9 3 4 0 9 1 9 0 9 4 3 0 907 0 6 6 3 
SR 0 3 4 0 0 7 0 2 0 7 3 2 0 6 6 7 0 6 3 0 0 4 3 0 
N o n - S m a l l C e l l Lung C a n c e r 
A54 9/ATCC 0 1 6 0 0 7 2 5 0 7 7 5 0 7 8 2 0 737 0 6 3 3 
EKVX 0 4 8 0 1 374 1 4 2 6 1 4 3 9 1 467 1 3 5 6 
HOP-62 0 2 8 5 1 0 3 2 1 164 1 1 8 9 1 2 0 9 1 1 4 3 
HOP-92 0 3 6 2 0 9 5 5 0 9 1 5 0 8 9 1 0 892 0 8 1 6 
N C I - H 2 2 6 1 1 0 3 1 7 6 9 1 8 1 5 1 874 1 8 2 0 1 7 6 4 
N C I - H 2 3 0 5 2 7 1 414 1 5 0 6 1 5 7 0 1 437 1 3 5 0 
NCI-H322M 0 7 5 3 1 2 8 6 1 384 1 3 5 8 1 346 1 2 7 3 
N C I - H 4 6 0 0 4 2 4 1 5 4 5 1 5 7 9 1 6 6 8 1 567 1 4 2 7 
N C I - H 5 2 2 0 6 7 5 1 3 9 6 1 4 8 3 1 4 5 5 1 5 2 5 1 2 2 4 
C o l o n C a n c e r 
COLO 20 5 0 1 3 5 1 2 4 8 1 2 6 6 1 3 2 2 1 192 1 1 6 0 
HCC-2998 0 4 5 7 0 7 5 0 0 8 8 3 0 9 1 0 0 8 5 8 0 8 8 1 
HCT-116 0 1 1 3 0 6 3 4 0 7 4 7 0 7 8 8 0 7 5 3 0 7 3 4 
HCT-15 0 2 0 7 1 0 5 0 1 0 9 2 1 1 0 4 1 0 9 6 0 9 9 0 
HT29 0 4 57 1 2 1 5 1 2 4 1 1 244 1 2 2 1 1 1 0 8 
K«12 0 4 2 2 1 3 6 0 1 4 3 3 1 382 1 392 1 2 1 1 
SW-620 0 2 5 9 1 1 4 3 1 2 8 5 1 3 3 1 1 3 6 8 1 3 3 9 
CNS C a n c e r 
S F - 2 6 8 0 5 8 6 1 1 7 5 1 1 8 3 1 2 9 2 1 2 4 1 1 1 0 8 
S F - 2 9 5 0 4 2 1 1 4 1 7 1 4 5 9 1 4 9 8 1 4 6 8 1 2 7 6 
S F - 5 3 9 0 5 2 6 1 4 5 1 1 4 6 7 1 524 1 5 0 1 1 4 2 5 
SNB-19 0 5 3 0 0 9 6 8 0 9 9 1 1 074 1 1 1 3 1 0 1 8 
SNB-75 0 6 7 8 0 8 2 9 0 9 2 3 0 9 5 1 0 9 4 8 0 907 
U2SI 0 2 5 3 1 0 9 0 1 144 1 1 1 0 1 0 2 9 1 0 0 2 
Me lanoma 
LOX IMVI 0 3 3 3 1 0 1 0 1 0 7 3 0 914 0 914 0 8 4 0 
KALME-3M 0 7 9 2 1 3 9 6 1 4 5 7 1 4 5 4 1 4 0 7 1 359 
M14 0 3 7 6 0 9 4 4 1 0 2 9 1 1 1 3 1 0 5 8 0 9 4 5 
SK-MEL-2 0 4 8 5 0 9 9 4 1 0 6 1 1 1 4 3 1 115 1 0 4 9 
SK-MEL-28 0 7 7 1 1 4 3 3 1 4 1 8 1 4 7 6 1 474 1 4 5 1 
SK-MEL-5 0 5 2 6 1 3 4 2 1 4 5 5 1 4 8 1 1 4 7 8 1 2 6 7 
UACC-257 0 7 6 1 1 5 2 0 1 5 8 9 1 6 0 3 1 572 1 334 
UACC-62 0 7 5 0 2 1 3 5 2 1 8 5 2 2 3 9 2 1 6 5 1 6 0 3 
O v a r i a n C a n c e r 
IGROVl 0 329 0 9 3 1 1 0 1 8 1 0 1 2 0 8 8 8 0 9 4 9 
OVCAR-3 0 2 9 3 0 9 4 8 0 9 9 2 0 9 9 5 0 9 6 9 0 8 3 6 
OVCAR-4 0 8 0 1 1 5 8 8 1 5 8 5 1 6 8 1 1 5 9 3 1 3 8 4 
OVCAR-5 0 3 1 3 0 9 9 8 1 0 6 9 1 0 9 5 1 036 1 0 1 8 
OVCAR-B 0 3 7 9 1 0 5 0 1 1 2 0 1 1 4 2 1 1 4 0 1 0 7 8 
SK-OV-3 0 1 4 7 0 9 9 4 1 0 2 7 1 0 9 0 1 0 5 5 1 102 
R e n a l C a n c e r 
7 8 6 - 0 0 2 4 2 1 1 5 9 1 1 9 9 1 2 6 2 1 237 1 1 4 3 
A498 1 0 6 8 1 5 8 8 1 6 6 2 1 6 8 9 1 6 5 3 1 547 
ACHN 0 3 8 8 1 4 5 0 1 4 6 7 1 4 8 3 1 4 8 8 1 2 8 3 
C A K I - 1 0 4 8 0 1 5 6 7 1 6 1 9 1 6 6 8 1 598 1 3 3 0 
SN12C 0 4 8 6 1 5 5 2 1 5 9 6 1 624 1 569 1 4 5 1 
T K - 1 0 0 7 6 3 1 6 0 8 1 5 9 6 1 6 5 2 1 6 6 3 1 5 2 6 
U C - 3 1 0 4 6 7 1 2 6 1 1 3 5 S 1 3 6 6 1 3 2 7 1 0 7 0 
P r o s t a t e C a n c e r 
P C - 3 0 317 1 034 1 0 4 8 1 0 1 4 0 9 6 1 0 8 3 0 
D U - 1 4 5 0 274 0 9 7 0 1 0 0 8 1 0 5 6 1 0 0 5 0 964 
B r e a s t C a n c e r 
MCF7 0 5 6 7 1 1 0 7 1 0 8 3 1 2 0 9 1 1 6 1 1 0 6 1 
NCI /ADR-RES 0 5 5 3 1 4 7 5 1 5 5 4 1 6 0 7 1 574 1 364 
MDA-MP 231/ATCC 0 3 4 9 0 9 9 9 1 0 1 7 0 9 9 7 1 0 6 2 0 884 
HS 5 7 s r 0 6 8 0 0 9 3 0 1 0 2 3 1 0 6 2 0 987 0 8 5 3 
MDA-MB-435 0 5 1 8 1 8 1 1 1 9 9 7 2 0 3 2 2 0 0 9 1 6 6 1 
MDA-N 0 544 1 7 2 1 1 7 8 7 1 S92 1 906 1 6 7 7 
B T - 5 4 J 0 8 2 0 1 1 3 8 1 1 9 7 1 1 9 6 1 1 5 1 1 0 7 2 
T - 4 7 D 0 2 5 8 0 8 0 0 0 8 6 1 0 8 1 5 0 8 1 5 0 7 0 9 
-4 0 
0 519 
0 2 2 5 
0 216 
0 3 4 8 
0 208 
P e r c e n t G r o w t h 
194 
6 1 3 
2 6 3 
222 
2 7 9 
4 0 3 
344 
3 7 5 
1 7 5 
3 4 2 
2 6 9 
2 0 6 
196 
2 4 8 
3 1 6 
187 
2 5 2 
2 3 0 
226 
1 3 1 
0 3 0 6 
0 3 4 5 
0 367 
0 2 3 3 
0 210 
0 2 7 8 
0 202 
0 1 7 8 
0 3 6 6 
0 2 8 3 




0 3 6 7 
0 137 
0 2 6 7 
0 1 4 1 
0 2 6 5 
0 1 7 3 
0 4 0 3 
0 1 5 3 
C 314 
0 169 
0 3 5 2 
0 336 
- 8 0 - 7 0 - 6 0 - 5 0 - 4 0 G I 5 0 T C I LC50 
99 9 5 1 0 1 7 1 12 2 2 7 E - 0 5 > 1 OOE - 0 4 > 1 OOE - 0 4 
1 0 1 99 90 136 10 4 8 2 E - 0 5 > 1 OOE - 0 4 >1 OOE - 0 4 
99 1 0 1 1 0 3 62 3 1 e O E - C S >1 OOE - 0 4 >1 OOE - 0 4 
° 3 9 8 92 66 - 7 1 6 6 E - 0 5 7 95E - 0 5 >1 OOE - 0 4 
98 1 0 1 96 55 3 1 2 6 E - 0 5 >1 OOE 04 >1 OOE - 0 4 
lOS 90 80 2b 39 3 4 9 L 06 2 44L 05 >1 OOC 04 
109 1 1 0 102 84 6 2 7 2 E - 0 5 >1 OOL - 0 4 >1 OOE 04 
106 1 1 3 1 1 0 98 15 3 7 8 E - 0 5 >1 OOE - 0 4 >1 OOE 04 
116 1 2 1 124 115 8 3 3 8 E - 0 5 8 62E - 0 5 >1 OOE 04 
93 89 89 77 - 3 9 1 7 0 E - 0 5 4 61E - 0 5 >1 OOE 04 
107 1 1 6 1 0 8 99 75 1 9 2 E 05 3 7 2 E 0 5 7 21E 05 
1 ! 0 1 1 8 1 0 3 93 24 2 3 3 E - 0 5 b 27E 0 5 >1 OOE - 0 4 
l i s 1 1 3 111 98 54 2 0 6 E 0 5 4 39E 0 5 9 37E 05 
103 1 1 1 102 89 - 1 2 2 4 5 E - 0 5 7 66E - 0 5 >1 OOE - 0 4 
112 1 0 8 l i e 76 - 5 4 1 5 8 E 0 5 3 B3E - 0 5 9 2 7 E - 0 5 
102 1 0 7 95 92 4 2 9 9 E - 0 5 >1 OOE--04 >1 OOE 04 
1 4 5 1 5 5 137 1 4 5 25 3 6 1 E - 0 5 7 l l E - •05 >1 OOE' -04 
122 1 2 9 123 119 30 5 9 4 E 0 5 >1 OOE--04 >1 OOE' -04 
1 0 5 1 0 6 1 0 5 93 2 8 8 E 0 5 9 8SE-- 0 5 >1 OOE--04 
103 104 1 0 1 86 - 5 7 1 7 8 E 0 5 3 98E-- 0 5 3 90E^ - 0 5 
108 1 0 2 1 0 3 84 - 4 1 1 8 7 E - 0 5 4 69E 0 5 >1 OOE 04 
116 1 2 1 125 122 6 4 2 0 E 0 5 >1 OOE--04 >1 OOL •04 
1 0 1 1 2 0 1 1 1 89 50 1 9 0 E 0 5 4 37E 05 >1 OOE 04 
104 1 0 8 1 0 5 86 56 1 7 9 E - 0 5 4 04E 05 9 H E 05 
102 1 0 8 1 0 5 97 52 2 0 7 E - 0 5 4 48E-•05 9 68E-•05 
105 124 1 3 3 111 57 2 32E 0 5 4 60E 05 9 12E 05 
163 1 8 1 179 152 67 2 9 3 E - 0 5 4 96E-- 0 5 8 39E-•05 
106 1 0 2 93 89 - 4 8 1 9 3 E - 0 5 4 46E-•05 >1 OOE-•04 
109 86 86 7 5 46 1 6 1 E - 0 5 4 18E 0 5 >1 OOE-•04 
110 1 1 0 102 94 - 6 1 1 9 2 E - 0 5 4 0 2 E - •05 8 44E-•05 
115 1 3 0 1 2 0 100 8 2 9 0 E - 0 5 8 37E-•05 >1 OOE-•04 
113 1 2 9 124 1 1 1 - 2 4 2 8 2 E - 0 5 6 6 1 E - 0 5 >1 OOE-•04 
98 1 0 6 106 1 0 3 - 7 0 2 0 2 E - 0 5 3 9 4 E - 0 5 7 67E-•05 
114 1 1 7 117 9 1 - 6 0 1 8 6 E - 0 5 3 9 9 E - 0 5 8 S6E-•05 
109 1 1 1 107 76 -D3 1 5 3 E - 0 5 3 4 9 E - 05 8 OOE--05 
104 107 102 62 - 7 4 1 2 2 E - 0 5 2 B4E- 0 5 6 62E 05 
114 1 1 3 93 1 0 3 - 3 9 2 3 6 E - 0 5 5 3 3 E - 0 5 > 1 OOE--04 
107 1 0 7 1 0 3 83 - 3 9 1 8 6 E - 0 5 4 7 7 E - 0 5 >1 OOE- 04 
1 0 0 1 1 2 1 0 1 74 - 5 4 1 5 4 E - 0 5 3 7 8 E - 05 9 26E 05 
110 114 1 0 5 103 10 2 9 5 E - 0 5 8 1 9 E - 0 5 >1 OOE- 04 
110 1 1 4 1 1 3 104 3 3 22E 0 5 9 4 7 t - 0 5 >1 OOL- 04 
104 1 1 1 107 1 1 3 26 5 2 5 E - 0 5 >1 OOE- 04 >1 OOE- 04 
104 1 1 1 109 9 8 11 2 7 7 E 0 5 1 9 7 E - OS >1 OOE--04 
114 1 2 0 1 1 3 92 - 8 4 1 7 4 E - 0 5 3 3 5 E - 0 5 6 4 4 E - 05 
102 1 0 3 104 84 - 4 8 1 8 1 E - 0 5 4 3 3 E - 0 5 ' 1 OOE- 04 
105 1 0 9 103 78 24 1 8 9 E - 0 5 5 8 6 E - 0 5 >1 OOE- 04 
104 1 0 7 102 90 72 1 7 e E - 0 5 3 6 1 E - 05 7 33L--05 
99 1 0 5 106 90 - 6 5 1 8 2 E - 0 5 3 8 1 E - 0 5 8 OOE- 05 
112 1 1 3 1 0 8 76 - 7 0 1 5 1 E - 0 5 3 3 2 E 0 5 7 3 1 E - 05 
102 97 9 0 12 16 1 7 6 E 0 5 6 5 1 E 05 >1 OOL 04 
105 1 1 2 1 0 5 99 - 3 7 3 0 F - 0 5 5 36E 0 5 >1 OOt- 04 
96 1 1 9 1 1 0 91 - ? 9 2 2 1 E - 0 5 5 nc 0 5 >1 OOE 04 
109 1 1 4 1 1 1 88 - 2 7 2 1 4 E - 0 5 5 80E 0 5 >1 oot- 04 
103 1 0 0 110 82 - 5 6 1 7 1 E 0 5 3 9 2 E - 0 5 9 O l E - 05 
137 1 5 3 1 2 3 69 - 5 4 1 4 3 E - 0 5 3 6 5 E 0 5 9 31E 05 
114 1 1 7 1 1 5 88 - 6 7 1 7 6 E - 0 5 3 6 9 E - 0 5 7 72E 05 
106 115 116 96 35 ? 2 5 E - 0 5 5 3 9 F 0 5 >1 OOr 04 
118 118 104 79 59 1 6 3 E 0 5 3 7 4 L 05 8 6 0 E - 05 
111 1 0 3 1 0 3 83 13 -1 9 9 E - 0 5 >1 OOE 04 >1 OOE- 04 
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Table 3. Anticancer activity of F B X 3 A (27) against 60 cell line at the concentration of 
1.0 X 10"^ 
Type of cancer Cell line Concen-
tration 
LogioGISO Retardation of 
Growth (%) 
L e u k a e m i a CCRF-CEM 1 0 X 10^ -4 64 _ 
HL-60 (TB) l O x l O - ' -4 32 -
K-562 -4 80 -
MOLT-4 l O x l Q - ^ -4 78 7 
RPMI-8226 1 0x10"^ -4 90 -
SR I Ox 10-* -5 64 39 
Non- sma l l cell A549/ATCC - -4 57 -
L u n g cancer EKVX - -4 42 -
HOP-62 1 0 x 1 0 - " -4 47 8 
HOP-92 1 Ox ID"' -4 77 39 
NC1-H226 1 Ox 10"' -4 72 75 
NCI-H23 - -4 63 24 
NCI-H322M - -4 69 54 
NC1-H460 1 Ox 10^ -4 61 12 
NC1-H522 1 Ox 10"^ -4 80 54 
Colon cancer COLO 205 -4 52 -
HCC-2998 1 Ox lO"" -4 44 25 
HCT-116 I Ox 10"^ -4 23 
HCT-15 1 Ox lO-" -4 54 
HT29 1 Ox lO"* -4 75 57 
KM 12 1 Ox 10"^ -4 73 41 
SW-620 - -4 38 -
C N S cance r SF-268 1 Ox 10-* -4 72 50 
SF-295 l O x l O - * -4 75 56 
SF-539 1 Ox lO-* -4 68 51 
SNB-I9 l O x l O - * -4 63 57 
SNB-75 I Ox 10-' -4 53 67 
U25I 1 Ox lO"' -4 71 48 
M e l a n o m a LOX IMVI l O x l O - ' -4 79 46 
MALME-3M -4 72 61 
M14 - -4 54 8 
SK-MEL-2 1 Ox lO-" -4 55 24 
SK-MEL-28 1 Ox lO-' -4 69 97 
SK-MEL-5 1 Ox lO-* -4 73 60 
UACC-257 1 Ox lO-' -4 82 64 
UACC-62 1 Ox 10-' -4 91 74 
Ovar ian cancer IGROVI 1 Ox 10-* -4 63 39 
OVCAR-3 1 Ox 10"' -4 73 39 
OVCAR-4 1 Ox 10-* -481 54 
OVCAR-5 - -4 53 10 
OVCAR-8 1 Ox 10-* -4 49 3 
SK-OV-3 1 Ox lO-' -4 28 -
Renal c ance r 786-0 ! 0 x 1 0 - ' -4 56 11 
A498 1 0 x 1 0 - ' -4 76 84 
ACHN 1 Ox 10-* -4 74 48 
CAKI-1 - -4 72 24 
SN12C 1 0 x 1 0 - ' -4 75 72 
TK-10 l O x l O - " 4 74 65 
UO-31 1 Ox lO-' -4 82 70 
Pros ta te cance r PC-3 1 Ox lO-* -4 75 16 
DU-I45 . -4 64 37 
Breas t cance r MCF7 1 Ox 10"' -4 66 29 
NCI/ADR-RES - -4 67 27 
MDA-MB-231/ATCC -4 77 56 
HS 578T 1 Ox 10-' -4 84 54 
MDA-MB-435 - -4 75 67 
MDA-N -4 65 35 
BT-549 1 Ox 10-' -4 79 59 
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(B) A N T I M I C R O B I A L A C T I V I T Y 
INTRODUCTION 
The test organism used in the study included Escherichia coli UP2566 
(Central Drug Research Institute, Lucknow, India), Bacillus subtilis MTCC-121 
(Institute of Microbial Technology, Chandigarh, India) and clinical isolates of 
Staphylococcus aureus (IOA-106), Pseudomoms aeruginosa (IOA-110) and 
Candida albicans (IOA-109) (Department of Microbiology, J.N. Medical College, 
AMU, Aligarh, India). 
Culture Media and Inoculum 
Sabour and Dextrose (SD), Nutrient broth and agar were obtained from 
Hi-Media Pvt. Ltd. (Bombay, India) and were used for Canadida albicans and test 
bacteria respectively. Freshly grown microbial cultures at 37° were appropriately 
diluted in sterile normal saline solution to obtain a cell suspension of lO^CFU/ml. 
Antimicrobial assay 
Each synthetic compound was dissolved in DMSO to obtain a stock solution of 
different concentrations ranging from 2000 - 5000 ng/ml. The agar well diffusion 
method (Perez et. al^) as adopted by Ahmad and Arina'^ was used for our assay. 
0.1 ml of the diluted inoculum (10^ CFU/ml) of test organism was spread on 
NA/SDA (Nutrient Agar/Sabour and Dextrose Agar) plates. Wells of 8 mm diameter 
were punctured into the agar medium and filled with 100 jil of compound, solvent 
blank and an antibiotic (chloramphenicol, 100 |ig/ml) to which the test bacteria were 
sensitive. Fluconazole at the concentration of 100 i^g/ml was used as the control 
against Candida albicans. The plates were incubated for 18 h at 37 °C. Antimicrobial 
activity was evaluated by measuring the zone of inhibition against the test organism. 
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RESULTS AND DISCUSSION 
A total of 10 compounds were tested against two Gram +ve bacteria 
{Staphylococcus aureus, Bacillus subtilis) and two Gram -ve bacteria 
{Estcherichia coli, Pseudomonas aeruginosa) and a yeast, Candida albicans. The 
varying level of anti-microbial activity was detected against one or more test 
organisms. 
Antimicrobial activity of test compounds 
The results for the antimicrobial study of the tested compounds detected 
against the test organisms Escherichia coli, Bacillus subtilis. Staphylococcus aureus, 
Pseudomonas aeruginosa and Candida albicans are depicted in Table 4. Solvent 
control (DMSO) showed non-significant inhibition to test microorganisms. 
Antimicrobial activity against Gram -ve bacteria was deduced in all compounds. 
However such activity could be detected only in four compounds against Gram +ve 
bacteria. The compounds (25), (26), (30) and (31) demonstrated activity against both 
Gram +ve and Gram -ve bacteria. 
The compounds exhibited antimicrobial activity in the concentration range 
200 \ig to 500 ^g/100 fil. Two compounds, (30) and (31) also demonstrated 
antifungal (anticandidal) activity. It was interesting to note that the compound (31) 
which is structurally similar to (24) but only differs in substitution, resulted in the 
enhanced activity against fungi. However, the compound (24) is devoid of antifungal 
activity. Overall broad spectrum antimicrobial activity i.e. active against Gram +ve 
and Gram -ve was deduced in (25), (26), (30) and (31). These compounds may be 
directly explored in the preparation of topical antiinfective agents. However, further 
exploration requires detailed study on exact MIC values and least toxicity to host cell 
and system. 
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Antimicrobial activity in terms of zone of inhibition 
in mm 
SA BS EC PA CA 
FB (24) 500 - - 19 - -
FBX,B (25) 500 12 12 10 14 -
FBX.C (26) 250 - 21 13 12 -
FBXjC (30) 200 12 14 10 16 15 
FBXjA (27) 500 - - 18 22 -
FD (31) 500 22 12 28 18 18 
FDX,A (32) 500 - - 17 21 1 
FTZX4B (7) 500 - - 10 12 -
FBX3B (28) 250 - - 14 16 -
FBCB (4) 300 - - 15 18 -
Chloram- 100 |ig/well 25 20 24 30 -
phenicol 
Fluconozole 100 ^ig/well - - - - 25 
SA, Staphylococcus aureus; BS, Bacillus subtilis; EC, Escherichia coli; PA, Pseudomonas 
aeruginosa; CA, Candida albicans. 
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CONCLUSION 
The compounds synthesised in total of seventeen reactions and screened 







I 4 2 6 
II 2 2 4 
III 4 3 7 
IV 3 4 7 
V 4 1 5 
Grand Total 17 12 29 
V I - Screening for Anticancer and Antimicrobial Activities: 
(A) Anticancer Activity IG 
(B) Antimicrobial Activity l 6 
The techniques used for evaluation of structure are 'H-NMR, '^C-NMR, 
APT, NOE, 2-DNMR (COSY, HETCOR) including DC-MS, IR and FTIR. 
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